WO2016125160A1 - Prosthetic valve with axially-sliding frames - Google Patents
Prosthetic valve with axially-sliding frames Download PDFInfo
- Publication number
- WO2016125160A1 WO2016125160A1 PCT/IL2016/050125 IL2016050125W WO2016125160A1 WO 2016125160 A1 WO2016125160 A1 WO 2016125160A1 IL 2016050125 W IL2016050125 W IL 2016050125W WO 2016125160 A1 WO2016125160 A1 WO 2016125160A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- frame
- tubular portion
- valve
- upstream
- state
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9517—Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
Definitions
- Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve.
- Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
- Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
- an implant having a tubular portion, an upstream support portion and one or more flanges.
- the implant is percutaneously deliverable to a native heart valve in a compressed state, and is expandable at the native valve.
- the implant and its delivery system facilitate causing the upstream support portion and the flanges to protrude radially outward from the tubular portion without expanding the tubular portion. Expansion of the tubular portion brings the upstream support portion and the flanges closer together, for securing the implant at the native valve by sandwiching tissue of the native valve between the upstream support portion and the flanges.
- apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
- a plurality of prosthetic leaflets coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
- a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
- each of the legs coupled to the ring at a respective trough
- each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state such that the valve-frame coupling elements pull the outer- frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) increases the amplitude of the pattern of the ring.
- the ring circumscribes the tubular portion.
- the valve-frame coupling elements are disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end.
- the upstream support portion includes one or more fabric pockets disposed circumferentially, each pocket of the one or more pockets having an opening that faces a downstream direction.
- the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
- the apparatus further includes an upstream support portion that includes a plurality of arms that extend radially from the tubular portion, and:
- the upstream support portion has (i) a constrained-arm state, and (ii) a released-arm state in which the arms extend radially outward from the tubular portion,
- each leg has a tissue-engaging flange that has (i) a constrained-flange state, and (ii) a released-flange state in which the flange extends radially outward from the tubular portion, and
- the apparatus has an intermediate state in which (i) the tubular portion is in its compressed state, (ii) the upstream support portion is in its released-arm state, and (iii) the legs are in their released-flange state.
- the apparatus includes an implant that includes the valve frame, the leaflets, and the outer frame, and
- the apparatus further includes a tool:
- a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in its compressed state, (b) the upstream support portion is in its constrained-arm state, and (c) the legs are in their constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in its compressed state, and
- the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the legs into their released-f ange state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state.
- the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state.
- the fixation of the outer-frame coupling elements to the valve- frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state moves the flanges longitudinally away from the valve-frame coupling elements.
- the fixation of the outer-frame coupling elements to the valve- frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state reduces the amplitude of the pattern of the ring and passes the flanges between the arms.
- the upstream support portion further includes a covering that covers the arms to form an annular shape in the released-arm state, and, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state presses the flanges onto the covering.
- a downstream end of each leg in the compressed state of the tubular portion, a downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
- the downstream end of each leg in the expanded state of the tubular portion, is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
- apparatus for use with a native valve of a heart of a subject including an implant that includes: a valve frame that includes a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, a longitudinal length therebetween, and a diameter transverse to the longitudinal axis;
- valve member coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
- an outer frame coupled to the tubular portion, and including a tissue-engaging flange
- the implant has a first state and a second state
- the upstream support portion extends radially outward from the tubular portion
- the tissue-engaging flange extends radially outward from the tubular portion
- the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
- the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 20 percent greater than the length-decrease amount.
- tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 30 percent greater than the length-decrease amount.
- tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 40 percent greater than the length-decrease amount.
- valve frame including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
- a plurality of prosthetic leaflets coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
- an outer frame including:
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis
- each of the legs coupled to the ring at a respective trough
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on the coupling points: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) increases the amplitude of the pattern of the ring.
- the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
- valve frame including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the valve frame defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
- a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
- each of the legs coupled to the ring at a respective trough
- each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the fixation of the outer-frame coupling elements with respect to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the outer-frame coupling elements radially inward via radially-inward pulling of the valve-frame coupling elements on the outer-frame coupling elements, (ii) reduces a circumferential distance between each of the outer- frame coupling elements and its adjacent outer-frame coupling elements, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
- the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
- apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject including:
- valve frame including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
- a plurality of prosthetic leaflets coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
- an outer frame including:
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis
- each of the legs coupled to the ring at a respective trough
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
- the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
- apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject including:
- valve frame including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, and defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end;
- a plurality of prosthetic leaflets disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
- a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end,
- each of the legs coupled to the ring at a respective trough
- each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element at a respective coupling point,
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
- apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject including:
- valve frame including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end and a downstream end;
- a plurality of prosthetic leaflets disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
- an outer frame including:
- a ring defined by a pattern of alternating peaks and troughs:
- the peaks being longitudinally closer than the troughs to the upstream end
- the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor the downstream end;
- each of the legs coupled to the ring at a respective trough
- the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
- the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
- a frame assembly having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
- a valve frame including:
- tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
- the apparatus includes an implant that includes the frame assembly and the valve member, and
- the apparatus further includes a tool:
- a delivery capsule dimensioned (i) to house and retain the implant in the compressed state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and
- the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the upstream end of the tubular portion toward the coupling point.
- the coupling point is disposed closer to the downstream end of the frame assembly than are either the tissue-engaging flange or the upstream support portion.
- the leg in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis.
- the expanded state of the frame assembly is a fully-expanded state of the frame assembly
- the leg is expandable into an expanded state of the leg, independently of increasing the diameter of the tubular portion, and
- the leg in the expanded state of the leg, the leg extends away from the central longitudinal axis.
- the leg in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis
- the leg in the compressed state of the frame assembly, is generally parallel with the central longitudinal axis.
- the frame assembly is configured such that the longitudinal movement of the tissue-engaging flange away from the coupling point is a translational movement of the tissue-engaging flange that does not include rotation of the tissue- engaging flange.
- the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the tissue-engaging flange away from the coupling point. In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the upstream support portion toward the coupling point. In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state reduces a distance between the upstream support portion and the tissue-engaging flange by 5-30 mm.
- the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state moves the tissue-engaging flange longitudinally past the upstream support portion.
- the tubular portion is defined by a plurality of cells of the valve frame, and increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state:
- the leg is disposed on an outside of the tubular portion.
- the at least one leg includes a plurality of legs
- the coupling point includes a plurality of coupling points
- the frame assembly includes a leg frame that circumscribes the tubular portion, includes the plurality of legs, and is coupled to the valve frame at the plurality of coupling points, such that the plurality of legs is distributed circumferentially around the tubular portion.
- the plurality of coupling points is disposed circumferentially around the frame assembly on a transverse plane that is orthogonal to the longitudinal axis of the frame assembly.
- the plurality of legs is coupled to the valve frame via a plurality of struts, each strut:
- the leg frame is structured such that each leg of the plurality of legs is coupled to two struts of the plurality of struts, and two struts of the plurality of struts are coupled to each coupling point of the plurality of coupling points.
- the leg is coupled to the valve frame via a strut, the strut:
- the at least one leg includes at least a first leg and a second leg.
- first leg and the second leg are both coupled to the valve frame at the coupling point.
- first leg is coupled to the coupling point via a respective first strut
- second leg is coupled to the coupling point via a respective second strut.
- first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
- the coupling point is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
- the first strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the first leg, and
- the second strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the second leg.
- the coupling point includes at least a first coupling point and a second coupling point.
- the leg is coupled to the valve frame at the first coupling point and at the second coupling point.
- the leg is coupled to the first coupling point via a respective first strut, and to the second coupling point via a respective second strut.
- the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
- the leg is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
- the first strut is disposed, circumferentially with respect to the tubular portion, between the leg and the first coupling point, and
- the second strut is disposed, circumferentially with respect to the tubular portion, between the leg and the second coupling point.
- the upstream support portion extends radially outward from the tubular portion.
- the expanded state of the frame assembly is a fully-expanded state of the frame assembly
- the upstream support portion is expandable into an expanded state of the upstream support portion, independently of increasing the diameter of the tubular portion, and
- the upstream support portion in the expanded state of the upstream support portion, extends radially outward from the tubular portion.
- the upstream support portion in the compressed state of the frame assembly, is generally tubular, collinear with the tubular portion, and disposed around the central longitudinal axis.
- an inner region of the upstream support portion extends radially outward from the tubular portion at a first angle with respect to the tubular portion, and an outer region of the upstream support portion extends, from the inner region of the upstream support portion, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle.
- a frame assembly having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
- a valve frame including:
- tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
- apparatus for use with a native valve of a heart of a subject including:
- a frame assembly having an upstream end and a downstream end, and a central longitudinal axis therebetween, including:
- a valve frame including:
- tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
- valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
- apparatus for use with a native valve of a heart of a subject including:
- a frame assembly having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
- an inner frame including an inner-frame tubular portion that circumscribes the central longitudinal axis, has an upstream end and a downstream end, and defines a channel therebetween, the inner frame defining a plurality of inner-frame couplings disposed circumferentially at a longitudinal location of the inner frame, an outer frame including an outer-frame tubular portion that coaxially circumscribes at least a portion of the inner-frame tubular portion, the outer frame defining a plurality of outer-frame couplings disposed circumferentially at a longitudinal location of the outer frame, and
- each connector connecting a respective inner- frame coupling to a respective outer-frame coupling
- a liner disposed over at least part of the inner-frame tubular portion; and a plurality of prosthetic leaflets, coupled to the inner-frame tubular portion and disposed within the channel,
- the frame assembly (i) is compressible by a radially-compressive force into a compressed state in which the inner frame is in a compressed state thereof and the outer frame is in a compressed state thereof, (ii) is configured, upon removal of the radially- compressive force, to automatically expand into an expanded state thereof in which the inner frame is in an expanded state thereof and the outer frame is in an expanded state thereof,
- the prosthetic leaflets are configured to facilitate one-way fluid flow, in a downstream direction, through the channel, and
- connection of the inner-frame couplings to the respective outer-frame couplings is such that expansion of the frame assembly from the compressed state to the expanded state causes the inner-frame tubular portion to slide longitudinally in a downstream direction with respect to the outer-frame tubular portion.
- apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject including:
- tubular portion having an upstream portion that includes an upstream end, and a downstream portion that includes a downstream end, and shaped to define a lumen between the upstream portion and the downstream portion;
- annular upstream support portion a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood from the upstream portion to the downstream portion; an annular upstream support portion:
- each pocket of the one or more pockets having an opening that faces a downstream direction.
- the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the inner portion of the upstream support portion, the covering is closely-fitted between the radially-inner parts of the arms, and
- the pockets are formed by the covering being loosely-fitted between the radially-outer parts of the arms.
- the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, the radially-outer part being more flexible than the radially-inner part.
- the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the outer portion of the upstream support portion, the pockets are formed by each arm curving to form a hook shape.
- each pocket is shaped and arranged to billow in response to perivalvular flow of blood in an upstream direction.
- the apparatus is configured to be transluminally delivered to the heart, and implanted at the native valve by expansion of the apparatus, such that the upstream support portion is disposed in the atrium and the tubular portion extends from the upstream support portion into the ventricle, and each pocket is shaped and arranged such that perivalvular flow of blood in an upstream direction presses the pocket against tissue of the atrium.
- apparatus including:
- a frame assembly including:
- tubular portion defined by a repeating pattern of cells, the tubular portion extending circumferentially around a longitudinal axis so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
- an outer frame including a plurality of legs, distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange;
- an upstream support portion that includes a plurality of arms that extend radially outward from the tubular portion
- each hub has six radiating spokes, two of the six spokes being part of a first cell of the two adjacent cells, two of the six spokes being part of a second cell of the two adjacent cells, one of the six spokes being the arm, and one of the six spokes being the second end of the appendage.
- the appendages are in-plane with the tubular portion. In an application, the appendages are in-plane with the outer frame.
- a method for use with a native valve of a heart of a subject including:
- an implant percutaneously advancing to heart, an implant:
- valve frame including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and having an upstream end, a downstream end, and a central longitudinal axis therebetween;
- causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point includes causing the longitudinal movement by increasing a diameter of the lumen.
- a method for use with a native valve of a heart of a subject including:
- an implant percutaneously advancing to heart, an implant:
- valve frame including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and
- causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point includes causing the longitudinal movement by increasing a diameter of the lumen.
- a method for use with a native valve of a heart of a subject including:
- the implant percutaneously advancing an implant to the heart, the implant:
- tissue-engaging flanges including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges
- the upstream support portion extends radially outward so as to have a second support-portion span, the first support-portion span being at least 40 percent as great as the second support-portion span, and
- a method for use with a native valve of a heart of a subject including:
- the implant percutaneously advancing an implant to the heart, the implant:
- tissue-engaging flanges including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges
- FIGs. 1A-B and 2A-E are schematic illustrations of an implant for use with a native valve of a heart of a subject, in accordance with some applications of the invention
- FIGs. 3A-C are schematic illustrations that show structural changes in a frame assembly during transitioning of the assembly between its compressed and expanded states, in accordance with some applications of the invention
- Figs. 4A-F are schematic illustrations of implantation of the implant at the native valve, in accordance with some applications of the invention
- FIG. 5 is a schematic illustration of a step in the implantation of the implant, in accordance with some applications of the invention
- Fig. 6 is a schematic illustration of the implant, in accordance with some applications of the invention
- Figs. 7A-B and 8A-B are schematic illustrations of frame assemblies of respective implants, in accordance with some applications of the invention.
- Figs. 9A-C are schematic illustrations of an implant comprising a frame assembly, in accordance with some applications of the invention.
- Implant 20 comprises a frame assembly 22 that has an upstream end 24, a downstream end 26, and a central longitudinal axis axl therebetween.
- Frame assembly 22 comprises a valve frame 30 that comprises a tubular portion 32 that has an upstream end 34 and a downstream end 36, and is shaped to define a lumen 38 through the tubular portion from the upstream end to the downstream end.
- Tubular portion 32 circumscribes axis axl, and thereby defines lumen 38 along the axis.
- Valve frame 30 further comprises an upstream support portion 40, extending from upstream end 34 of tubular portion 32.
- Frame assembly 22 further comprises at least one leg 50, coupled to valve frame 30 at (e.g., via) a coupling point 52, and having a tissue-engaging flange 54.
- leg 50 is part of an outer frame (or “leg frame") 60, and frames 30 and 60 define respective coupling elements 31 and 61, which are fixed with respect to each other at coupling points 52.
- frames 30 and 60 are coupled to each other only at coupling points 52 (e.g., only via the fixation of coupling elements 31 and 61 with respect to each other).
- Implant 20 further comprises a valve member 58 (e.g., one or more prosthetic leaflets) disposed within lumen 38, and configured to facilitate one-way liquid flow through the lumen from upstream end 34 to downstream end 36 (e.g., thereby defining the orientation of the upstream and downstream ends of tubular portion 32).
- a valve member 58 e.g., one or more prosthetic leaflets
- Fig. 1A shows implant 20 in a fully-expanded state, in which frame assembly 22 is in a fully-expanded state.
- Fig. IB shows an exploded view of frame assembly 22 in its fully-expanded state.
- Figs. 2A-E show respective states of implant 20, which will be discussed in more detail hereinbelow with respect to the implantation of the implant and the anatomy in which the implant is implanted.
- Fig. 1A shows implant 20 in a fully-expanded state, in which frame assembly 22 is in a fully-expanded state.
- FIG. 2A shows implant 20 in a compressed state (in which frame assembly 22 is in a compressed state), for percutaneous delivery of the implant to the heart of the subject.
- leg 50 including flange 54 thereof
- upstream support portion 40 is generally tubular, collinear with tubular portion 32 (e.g., extending collinearly from the tubular portion), and disposed around axis axl.
- Fig. 2B shows a state of implant 20 in which tissue-engaging flange 54 of each leg 50 extends radially away from axis axl (e.g., radially away from tubular portion 32).
- Fig. 2C shows a state of implant 20 in which upstream-support portion 40 extends radially away from axis axl (and thereby radially away from tubular portion 32).
- Fig. 2D shows a state of implant 20 in which both flange 54 and portion 40 extend away from axis axl. In the fully-expanded state (Figs. 1A-B) both upstream support portion 40 and flange 54 extend radially away from axis axl.
- frame assembly 22 is biased (e.g., shape- set) to assume its fully-expanded state, which is shown in Fig. 2E. Transitioning of implant 20 between the respective states is typically controlled by delivery apparatus, such as by constraining the implant in a compressed state within a delivery tube and/or against a control rod, and selectively releasing portions of the implant to allow them to expand.
- delivery apparatus such as by constraining the implant in a compressed state within a delivery tube and/or against a control rod, and selectively releasing portions of the implant to allow them to expand.
- tubular portion 32 In the compressed state of frame assembly 22, tubular portion 32 has a diameter dl, and in the expanded state, the tubular portion has a diameter d2 that is greater that diameter dl.
- diameter dl is 4-15 mm, (e.g., 5-11 mm) and diameter d2 is 20-50 mm, (e.g., 23-33 mm).
- Frame assembly 22 is configured such that increasing the diameter of tubular portion 32 (e.g., from dl to d2) causes longitudinal movement of flange 54 away from coupling point 52. In the same way, reducing the diameter of tubular portion 32 (e.g., from d2 to dl) causes longitudinal movement of flange 54 toward coupling point 52.
- longitudinal movement means movement parallel with central longitudinal axis axl. Therefore longitudinal movement of flange 54 away from coupling point 52 means increasing a distance, measured parallel with longitudinal axis axl, between flange 54 and coupling point 52.
- longitudinal movement means movement parallel with central longitudinal axis axl.
- expansion of tubular portion 32 from its compressed state toward its expanded state increases a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., between each of outer-frame coupling elements 61 and its adjacent outer-frame coupling elements) (e.g., from d8 to d9), and (ii) moves legs 50 in a longitudinally upstream direction with respect to the tubular portion.
- frame assembly 22 is configured such that increasing the diameter of tubular portion 32 also causes longitudinal movement of upstream support portion 40 toward coupling point 52, e.g., as described in more detail with respect to Figs. 3B-C.
- frame assembly 22 is configured such that increasing the diameter of tubular portion 32 also causes longitudinal movement of upstream end 34 of tubular portion 32 toward coupling point 52.
- upstream support portion 40 comprises a plurality of arms
- upstream support portion 40 comprises a plurality of barbs
- each arm 46 may comprise one or more of barbs 48.
- Barbs 48 press into tissue upstream of the native valve (e.g., into the valve annulus), thereby inhibiting downstream movement of implant 20 (in addition to inhibition of downstream movement provided by the geometry of upstream support portion 40).
- a covering 23 typically comprises a flexible sheet, such as a fabric, e.g., comprising polyester.
- covering 23 covers at least part of tubular portion 32, typically lining an inner surface of the tubular portion, and thereby defining lumen 38.
- upstream support portion 40 is covered with covering 23, e.g., extending between arms 46 to form an annular shape. It is hypothesized that this reduces a likelihood of paravalvular leakage. For such applications, excess covering 23 may be provided between arms 46 of upstream support portion 40, so as to facilitate their independent movement.
- covering 23 covering an upstream side of upstream support portion 40, the covering typically additionally (or alternatively) covers the downstream side of the upstream support portion.
- covering 23 may extend over the tips of arms 46 and down the outside of the arms, or a separate piece of covering may be provided on the downstream side of the upstream support portion.
- each arm 46 may be individually covered in a sleeve of covering 23, thereby facilitating independent movement of the arms.
- legs 50 e.g., flanges thereof
- covering 23 At least part of legs 50 (e.g., flanges thereof) is covered with covering 23.
- frame assembly 22 comprises a plurality of legs 50 (e.g., two or more legs, e.g., 2-16 legs, such as 4-12 legs, such as 6-12 legs), arranged circumferentially around valve frame 30 (e.g., around the outside of tubular portion 32).
- frame assembly 22 comprises a plurality of coupling points 52 at which the legs are coupled to valve frame 30.
- each leg 50 is typically coupled to a coupling point 52 via a strut 70.
- each leg 50 is coupled to a plurality of (e.g., two) coupling points 52 via a respective plurality of (e.g., two) struts 70.
- frame assembly 22 is arranged such that, in the expanded state of the frame assembly, leg 50 is disposed, circumferentially with respect to tubular portion 32, between two struts, and each of the two struts are disposed, circumferentially with respect to the tubular portion, between the leg and a respective coupling point 52.
- a plurality of (e.g., two) legs are coupled to each coupling point 52 via a respective plurality of (e.g., two) struts 70.
- frame assembly 22 is arranged such that, in the expanded state of the frame assembly, coupling point 52 is disposed, circumferentially with respect to tubular portion 32, between two struts 70, and each of the two struts are disposed, circumferentially with respect to the tubular portion, between the coupling point and a respective leg 50.
- frame assembly 22 comprises an outer frame (e.g., a leg frame) 60 that circumscribes tubular portion 32, comprises (or defines) the plurality of legs 50 and the plurality of struts 70, and is coupled to valve frame 30 at the plurality of coupling points 52, such that the plurality of legs are distributed circumferentially around the tubular portion.
- outer frame 60 comprises a ring 66 that is defined by a pattern of alternating peaks 64 and troughs 62, and that typically circumscribes tubular portion 32.
- the ring may comprise struts 70, extending between the peaks and troughs.
- Peaks 64 are longitudinally closer to upstream end 34 of tubular portion 32 than to downstream end 36, and troughs 62 are longitudinally closer to the downstream end than to the upstream end. (It is to be noted that throughout this patent application, including the specification and the claims, the term “longitudinally” means with respect to longitudinal axis axl.
- peaks 64 are closer than troughs 62 to upstream end 34, and troughs 62 are closer than peaks 64 to downstream end 36.
- frame 60 comprises ring 66
- each leg 50 is coupled to the ring (or defined by frame 60) at a respective trough 62.
- the peaks and troughs are defined by ring 66 having a generally zig-zag shape.
- the scope of the invention includes ring 66 having another shape that defines peaks and troughs, such as a serpentine or sinusoid shape.
- the coupling points are disposed circumferentially around the frame assembly (e.g., around axis axl), typically on a transverse plane that is orthogonal to axis axl. This transverse plane is illustrated by the position of section A-A in Fig. 2B.
- coupling points 52 may be disposed at different longitudinal heights of frame assembly 22, e.g., such that different flanges 54 are positioned and/or moved differently to others.
- coupling points 52 (and therefore coupling elements 31 and 61) are disposed longitudinally between upstream end 24 and downstream end 26 of frame assembly 22, but not at either of these ends.
- coupling points 52 are disposed longitudinally between upstream end 34 and downstream end 36 of tubular portion 32, but not at either of these ends.
- the coupling points may be more than 3 mm (e.g., 4-10 mm) both from end 34 and from end 36. It is hypothesized that this advantageously positions the coupling points at a part of tubular portion 32 that is more rigid than end 34 or end 36.
- leg 50 is typically expandable into its expanded state (e.g., a released-flange state) such that flange 54 extends away from axis axl, independently of increasing the diameter of tubular portion 32 (e.g., as shown in Figs. 2B & 2D).
- upstream support portion 40 is typically expandable into its expanded state (e.g., a released-arm state) such that it (e.g., arms 46 thereof) extends away from axis axl, independently of increasing the diameter of tubular portion 32 (e.g., as shown in Fig. 2C & 2D).
- the state shown in Fig. 2D may be considered to be an intermediate state. Therefore, implant 20 is typically configured such that legs 50 (e.g., flanges 54 thereof) and upstream support portion 40 are expandable such that they both extend away from axis axl, while retaining a distance d3 therebetween. This distance is subsequently reducible to a distance d4 by expanding tubular portion 32 (e.g., shown in Fig. 2E).
- flange 54 can extend away from axis axl over 40 percent (e.g., 40-80 percent, such as 40- 70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion.
- a span dl5 of the flanges while tubular portion 32 is in its compressed state may be at least 40 percent (e.g., 40-80 percent, such as 40-70 percent) as great as a span dl6 of the flanges subsequent to the expansion of the tubular portion.
- span dl5 is greater than 15 mm and/or less than 50 mm (e.g., 20-30 mm).
- span dl6 is greater than 30 mm and/or less than 60 mm (e.g., 40-50 mm). It is to be noted that flange 54 is effectively fully expanded, with respect to other portions of leg 50 and/or with respect to tubular portion 32, before and after the expansion of the tubular portion.
- upstream support portion 40 (e.g., arms 46) can extend away from axis axl over 30 percent (e.g., 30-70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion. That is, for some applications, a span dl7 of the upstream support portion while tubular portion 32 is in its compressed state may be at least 30 percent (e.g., 30-70 percent) as great as a span dl8 of the upstream support portion subsequent to the expansion of the tubular portion.
- span dl7 is greater than 16 mm (e.g., greater than 20 mm) and/or less than 50 mm (e.g., 30-40 mm).
- span dl8 is greater than 40 mm and/or less than 65 mm (e.g., 45-56 mm, such as 45-50 mm). It is to be noted that upstream support portion 40 is effectively fully expanded, with respect to tubular portion 32, before and after the expansion of the tubular portion.
- flanges 54 typically translate radially outward from span dl5 to span dl6 (e.g., without deflecting).
- upstream support portion 40 behaves similarly (e.g., arms 46 translated radially outward from span dl7 to span dl8, e.g., without deflecting). That is, an orientation of each flange 54 and/or each arm 46 with respect to tubular portion 32 and/or axis axl is typically the same in the state shown in Fig. 2D as it is in the state shown in Fig. 2E. Similarly, for some applications an orientation of each flange 54 with respect to upstream support portion 40 (e.g., with respect to one or more arms 46 thereof) is the same before and after expansion of tubular portion 32.
- increasing the diameter of tubular portion 32 from dl to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5- 20 mm) of longitudinal movement of flange 54 away from coupling point 52.
- increasing the diameter of tubular portion 32 from dl to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of upstream support portion 40 toward coupling point 52.
- distance d3 is 7-30 mm.
- distance d4 is 0-15 mm (e.g., 2-15 mm).
- increasing the diameter of tubular portion 32 from dl to d2 reduces the distance between the upstream support portion and flanges 54 by more than 5 mm and/or less than 30 mm, such as 5-30 mm (e.g., 10-30 mm, such as 10-20 mm or 20-30 mm).
- the difference between d3 and d4 is generally equal to the difference between dl and d2.
- the difference between d3 and d4 is more than 1.2 and/or less than 3 times (e.g., 1.5-2.5 times, such as about 2 times) greater than the difference between dl and d2.
- flanges 54 curve such that a tip of each flange is disposed at a shallower angle with respect to inner region 42 of upstream support portion 40, than are portions of leg 50 that are closer to downstream end 26 of frame assembly 22.
- a tip of each flange may be generally parallel with inner region 42.
- a tip portion 55 of each flange 54 that extends from the tip of the flange at least 2 mm along the flange, is disposed within 2 mm of upstream support portion 40.
- tubular portion 32 while tubular portion 32 is in its expanded state, for at least 5 percent (e.g., 5-8 percent, or at least 8 percent) of span 18 of upstream support portion 40, the upstream support portion is disposed within 2 mm of a flange 54.
- flanges 54 may pass between arms 46, and press directly against covering 23.) It is hypothesized that for some applications this configuration applies greater force to the valve tissue being sandwiched, and thereby further facilitates anchoring of the implant. That is, for some applications, distance d3 is smaller than the sum of distance d5 and a distance dl4 (described with reference to Fig. 3C).
- increasing the diameter of tubular portion 32 from dl to d2 advantageously causes flanges 54 and upstream support portion 40 to move greater than 3 mm and/or less than 25 mm (e.g., greater than 5 mm and/or less than 15 mm, e.g., 5-10 mm, such as about 7 mm) with respect to each other (e.g., toward each other and then past each other).
- upstream support portion 40 has an inner region (e.g., an inner ring) 42 that extends radially outward at a first angle with respect to axis axl (and typically with respect to tubular portion 32), and an outer region (e.g., an outer ring) 44 that extends, from the inner region, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle.
- inner region e.g., an inner ring
- outer region 44 e.g., an outer ring
- inner region 42 extends radially outward at an angle alpha_l of 60-120 degrees (e.g., 70-110 degrees) with respect to axis axl
- outer region 44 extends radially outward at an angle alpha_2 of 5-70 degrees (e.g., 10-60 degrees) with respect to axis axl.
- angles alpha_l and alpha_2 are measured between the respective region support portion 40, and the portion of axis axl that extends in an upstream direction from the level of frame assembly 22 at which the respective region begins to extend radially outward.
- implant 20 is configured to be placed at an atrioventricular valve (e.g., a mitral valve or a tricuspid valve) of the subject
- region 42 is configured to be placed against the upstream surface of the annulus of the atrioventricular valve
- region 44 is configured to be placed against the walls of the atrium upstream of the valve.
- outer region 44 is more flexible than inner region 42.
- each arm 46 may have a different structure in region 44 than in region 42. It is hypothesized that the relative rigidity of region 42 provides resistance against ventricular migration of implant 20, while the relative flexibility of region 44 facilitates conformation of upstream support portion 40 to the atrial anatomy.
- arms 46 are connected by a connector (not shown), reducing the flexibility, and/or the independence of movement of the connected arms relative to each other.
- arms 46 are connected in particular sectors of upstream support portion 40, thereby making these sectors more rigid than sectors in which the arms are not connected.
- a relatively rigid sector may be provided to be placed against the posterior portion of the mitral annulus
- a relatively flexible sector may be provided to be placed against the anterior side of the mitral annulus, so as to reduce forces applied by upstream support portion 40 on the aortic sinus.
- coupling points 52 are disposed closer to downstream end 26 of frame assembly 22 than are flanges 54, or is upstream support portion 40.
- the movement of flange 54 away from coupling point 52 facilitates the sandwiching of tissue of the native valve (e.g., leaflet and/or annulus tissue) between the flange and the upstream support portion, thereby securing implant 20 at the native valve.
- tissue of the native valve e.g., leaflet and/or annulus tissue
- a downstream end of each leg 50 is longitudinally closer than valve-frame coupling elements 31 to downstream end 36, and flange 54 of each leg is disposed longitudinally closer than the valve-frame coupling elements to upstream end 34.
- Figs. 3A-C show structural changes in frame assembly 22 during transitioning of the assembly between its compressed and expanded states, in accordance with some applications of the invention.
- Figs. 3A-C each show a portion of the frame assembly, the structural changes thereof being representative of the structural changes that occur in other portions of the frame assembly.
- FIG. 3A shows a leg 50 and struts 70 (e.g., a portion of outer frame 60), and illustrates the structural changes that occur around outer frame 60.
- Fig. 3B shows a portion of valve frame 30, and illustrates the structural changes that occur around the valve frame.
- Fig. 3C shows valve frame 30 as a whole.
- state (A) illustrates the structure while frame assembly 22 (and in particular tubular portion 32) is in its compressed state
- state (B) illustrates the structure while the frame assembly (and in particular tubular portion 32) is in its expanded state.
- Fig. 3A shows structural changes in the coupling of legs 50 to coupling point 52 (e.g., structural changes of outer frame 60) during the transitioning of frame assembly 22 (and in particular tubular portion 32) between its compressed and expanded states.
- Each leg 50 is coupled to valve frame 30 via at least one strut 70, which connects the leg to coupling point 52.
- each leg 50 is coupled to valve frame 30 via a plurality of struts 70.
- a first end 72 of each strut 70 is coupled to leg 50, and a second end 74 of each strut is coupled to a coupling point 52.
- each leg 50 is coupled to the ring at a respective trough 62.
- Ring 66 may comprise struts 70, extending between the peaks and troughs, with each first end 72 at (or close to) a trough 62, and each second end 74 at (or close to) a peak 64.
- each strut 70 is disposed at a first angle in which first end 72 is disposed closer than second end 74 to the downstream end of the frame assembly.
- Expansion of frame assembly 22 (and in particular of tubular portion 32) toward its expanded state causes strut 70 to deflect to a second angle.
- This deflection moves first end 72 away from the downstream end of frame assembly 22. That is, in the expanded state of frame assembly 22, first end 72 is further from the downstream end of the frame assembly than it is when the frame assembly is in its compressed state. This movement is shown as a distance d5 between the position of end 72 in state (A) and its position in state (B).
- flanges 54 typically move the same distance d5 in response to expansion of frame assembly 22.
- outer frame 60 comprises ring 66
- the pattern of alternating peaks and troughs may be described as having an amplitude longitudinally between the peaks and troughs, i.e., measured parallel with central longitudinal axis axl of frame assembly 22, and the transition between the compressed and expanded states may be described as follows: In the compressed state of frame assembly 22 (and in particular of tubular portion 32), the pattern of ring 66 has an amplitude d20.
- the pattern of ring 66 has an amplitude d21 that is lower than amplitude d20. Because (i) it is at peaks 64 that ring 66 is coupled to valve frame 30 at coupling points 52, and (ii) it is at troughs 62 that ring 66 is coupled to legs 50, this reduction in the amplitude of the pattern of ring 66 moves legs 50 (e.g., flanges 54 thereof) longitudinally further from the downstream end of the frame assembly. The magnitude of this longitudinal movement (e.g., the difference between magnitudes d20 and d21) is equal to d5.
- distance d5 is the same distance as the distance that flange 54 moves away from coupling point 52 during expansion of the frame assembly. That is, a distance between flange 54 and the portion of leg 50 that is coupled to strut 70, typically remains constant during expansion of the frame assembly.
- the longitudinal movement of flange 54 away from coupling point 52 is a translational movement (e.g., a movement that does not include rotation or deflection of the flange).
- a distance d6, measured parallel to axis axl of frame assembly 22, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its compressed state, is 3-15 mm.
- a distance d7, measured parallel to axis axl, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its expanded state is 1-5 mm (e.g., 1-4 mm).
- amplitude d20 is 2-10 mm (e.g., 4-7 mm).
- amplitude d21 is 4-9 mm (e.g., 5-7 mm).
- first end 72 of strut 70 is disposed closer to the downstream end of frame assembly 22 than is coupling point 52.
- first end 72 of strut 70 is disposed further from the downstream end of frame assembly 22 than is coupling point 52.
- frame assembly 22 For applications in which frame assembly 22 comprises a plurality of legs 50 and a plurality of coupling points 52 (e.g., for applications in which the frame assembly comprises outer frame 60) expansion of the frame assembly increases a circumferential distance between adjacent coupling points 52, and an increase in a circumferential distance between adjacent legs 50.
- Fig. 3A shows such an increase in the circumferential distance between adjacent coupling points 52, from a circumferential distance d8 in the compressed state to a circumferential distance d9 in the expanded state.
- distance d8 is 1-6 mm.
- distance d9 is 3-15 mm.
- legs 50 are also connected to each other via connectors 78.
- Connectors 78 allow the described movement of legs 50 during expansion of frame assembly 22, but typically stabilize legs 50 relative to each other while the frame assembly is in its expanded state. For example, connectors 78 may bend and/or deflect during expansion of the frame assembly.
- FIGs. 3B-C show structural changes in valve frame 30 during the transitioning of frame assembly 22 between its compressed and expanded states.
- Tubular portion 32 of valve frame 30 is defined by a plurality of cells 80, which are defined by the repeating pattern of the valve frame.
- cells 80 When frame assembly 22 is expanded from its compressed state toward its expanded state, cells 80 (i) widen from a width dlO to a width dl l (measured orthogonal to axis axl of the frame assembly), and (ii) shorten from a height dl2 to a height dl3 (measured parallel to axis axl of the frame assembly).
- This shortening reduces the overall height (i.e., a longitudinal length between upstream end 34 and downstream end 36) of tubular portion 32 from a height d22 to a height d23, and thereby causes the above-described longitudinal movement of upstream support portion 40 toward coupling points 52 by a distance dl4 (shown in Fig. 3C).
- coupling points 52 are disposed at the widest part of each cell.
- implant 20 comprises:
- valve frame (30) that comprises a tubular portion (32) that circumscribes a longitudinal axis (axl) of the valve frame so as to define a lumen (38) along the axis, the tubular portion having an upstream end (34), a downstream end (36), a longitudinal length therebetween, and a diameter (e.g., dl or d2) transverse to the longitudinal axis; a valve member (58), coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
- the implant has a first state (e.g., as shown in Fig. 2D and Fig. 4D) and a second state (e.g., as shown in Fig. 2E and Fig. 4E),
- the upstream support portion extends radially outward from the tubular portion
- the tissue-engaging flange extends radially outward from the tubular portion
- the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
- a diameter-increase amount e.g., the difference between dl and d2
- a length-decrease amount e.g., the difference between d22 and d23
- the flange moves the flange a longitudinal distance with respect to (e.g., toward or toward-and-beyond) the upstream support portion (e.g., the difference between d3 and d4), this distance being greater than the length- decrease amount.
- valve frame 30 is typically coupled to outer frame 60 by coupling between (i) a valve-frame coupling element 31 defined by valve frame 30, and (ii) an outer-frame coupling element 61 defined by outer frame 60 (e.g., an outer-frame coupling element is coupled to end 74 of each strut).
- elements 31 and 61 are fixed with respect to each other.
- Each coupling point 52 is thereby typically defined as the point at which a valve-frame coupling element and a corresponding outer-frame coupling element 61 are coupled (e.g., are fixed with respect to each other).
- elements 31 and 61 are eyelets configured to be coupled together by a connector, such as a pin or suture.
- valve-frame coupling elements 31 are soldered or welded together.
- valve-frame coupling elements 31 are defined by tubular portion 32, and are disposed circumferentially around central longitudinal axis axl.
- Outer-frame coupling elements 61 are coupled to ring 66 (or defined by frame 60, such as by ring 66) at respective peaks 64.
- valve frame 30 e.g., tubular portion 32 thereof
- outer frame 60 e.g., ring 66 thereof
- a radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and outer frame 60 (e.g., ring 66 thereof) is typically less than 2 mm (e.g., less than 1 mm), in both the compressed and expanded states, and during the transition therebetween. This is facilitated by the coupling between frames 30 and 60, and the behavior, described hereinabove, of frame 60 in response to changes in the diameter of tubular portion 32 (e.g., rather than solely due to delivery techniques and/or tools).
- more than 50 percent (e.g., more than 60 percent) of ring 66 is disposed within 2 mm of tubular portion 32 in both the compressed and expanded states, and during the transition therebetween.
- more than 50 percent (e.g., more than 60 percent) of outer frame 60, except for flanges 54, is disposed within 2 mm of tubular portion 32 in both the compressed and expanded states, and during the transition therebetween.
- the structural changes to frame assembly 22 e.g., to outer frame 60 thereof) are described hereinabove as they occur during (e.g., as a result of) expansion of the frame assembly (in particular tubular portion 32 thereof). This is the natural way to describe these changes because, as described hereinbelow with respect to Figs.
- assembly 22 is in its compressed state during percutaneous delivery to the implant site, and is subsequently expanded.
- the nature of implant 20 may be further understood by describing structural changes that occur during compression of the frame assembly (e.g., a transition from the expanded state in Fig. 2E to the intermediate state in Fig. 2D), in particular tubular portion 32 thereof (including if tubular portion 32 were compressed by application of compressive force to the tubular portion, and not to frame 60 except via the tubular portion pulling frame 60 radially inward).
- Such descriptions may also be relevant because implant 20 is typically compressed (i.e., "crimped") soon before its percutaneous delivery, and therefore these changes may occur while implant 20 is in the care of the operating physician.
- the fixation of peaks 64 to respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on coupling points 52: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
- the fixation of outer- frame coupling elements 61 to valve- frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer- frame coupling elements (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
- the fixation of peaks 64 to the respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
- the fixation of outer-frame coupling elements 61 with respect to valve-frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state (i) pulls outer- frame coupling elements 61 radially inward via radially-inward pulling of valve-frame coupling elements 31 on outer-frame coupling elements 61, (ii) reduces a circumferential distance between each of the outer- frame coupling elements and its adjacent outer- frame coupling elements (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
- FIGs. 4A-F are schematic illustrations of implantation of implant 20 at a native valve 10 of a heart 4 of a subject, in accordance with some applications of the invention.
- Valve 10 is shown as a mitral valve of the subject, disposed between a left atrium 6 and a left ventricle 8 of the subject.
- implant 20 may be implanted at another heart valve of the subject, mutatis mutandis.
- Figs. 4A-F show implant 20 being delivered trans septally via a sheath 88, the implant may alternatively be delivered by any other suitable route, such as transatrially, or transapically.
- Implant 20 is delivered, in its compressed state, to native valve 10 using a delivery tool 89 that is operable from outside the subject (Fig. 4A).
- implant 20 is delivered within a delivery capsule 90 of tool 89, which retains the implant in its compressed state.
- a transseptal approach such as a transfemoral approach, is shown.
- implant 20 is positioned such that at least flanges 54 are disposed downstream of the native valve (i.e., within ventricle 8).
- frame assembly 22 of implant 20 is as shown in Fig. 2A.
- flanges 54 are allowed to protrude radially outward, as described hereinabove, e.g., by releasing them from capsule 90 (Fig. 4B).
- capsule 90 may comprise a distal capsule -portion 92 and a proximal capsule- portion 94, and the distal capsule-portion may be moved distally with respect to implant 20, so as to expose flanges 54.
- frame assembly 22 of implant 20 is as shown in Fig. 2B.
- implant 20 is moved upstream, such that upstream support portion
- Upstream support portion 40 in its compressed state, is disposed upstream of leaflets 12 (i.e., within atrium 6). For some applications, the upstream movement of implant 20 causes flanges 54 to engage leaflets 12. However, because of the relatively large distance d3 provided by implant 20 (described hereinabove), for some applications it is not necessary to move the implant so far upstream that flanges 54 tightly engage leaflets 12 and/or pull the leaflets upstream of the valve annulus. Upstream support portion 40 is then allowed to expand such that it protrudes radially outward, as described hereinabove, e.g., by releasing it from capsule 90 (Fig. 4D).
- proximal capsule-portion 94 may be moved proximally with respect to implant 20, so as to expose upstream support portion 40.
- frame assembly 22 of implant 20 is as shown in Fig. 2D, in which: (i) distance d3 exists between upstream support portion 40 and flanges 54, (ii) the flanges have span dl5, (iii) the upstream support portion has span dl7, and (iv) tubular portion 32 has diameter dl.
- expansion of frame assembly 22 is inhibited by distal capsule -portion 92 (e.g., by inhibiting expansion of tubular portion 32), and/or by another portion of delivery tool 89 (e.g., a portion of the delivery tool that is disposed within lumen 38).
- implant 20 is allowed to expand toward its expanded state, such that tubular portion 32 widens to diameter d2, and the distance between upstream support portion 40 and flanges 54 reduces to distance d4 (Fig. 4E).
- tissue of valve 10 typically including annular tissue and/or leaflets 12
- Fig. 4F shows delivery capsule 90 having been removed from the body of the subject, leaving implant 20 in place at valve 10.
- implant 20 is configured such that when tubular portion 32 is expanded, flanges 54 and upstream support portion 40 move a relatively large distance toward each other. This enables distance d3 to be relatively large, while distance d4 is sufficiently small to provide effective anchoring. As also described hereinabove, implant 20 is configured such that flanges 54 and upstream support portion 40 can extend radially outward a relatively large distance while tubular portion 32 remains compressed. It is hypothesized that for some applications, these configurations (independently and/or together) facilitate effective anchoring of implant 20, by facilitating placement of a relatively large proportion of valve tissue (e.g., leaflets 12) between the flanges and the upstream support portion prior to expanding tubular portion 32 and sandwiching the valve tissue.
- valve tissue e.g., leaflets 12
- valve tissue e.g., leaflets 12
- this configuration of implant 20 facilitates identifying correct positioning of the implant (i.e., with upstream support portion 40 upstream of leaflets 12 and flanges 54 downstream of the leaflets) prior to expanding tubular portion 32 and sandwiching the valve tissue.
- implant 20 defines a toroidal space 49 between flanges 54 and upstream support portion 40 (e.g., a space that is wider than distance d4).
- space 49 may have a generally triangular cross-section. It is hypothesized that for some such applications, in addition to sandwiching tissue of the native valve between upstream support portion 40 and flanges 54 (e.g., the tips of the flanges), space 49 advantageously promotes tissue growth therewithin (e.g., between leaflet tissue and covering 23), which over time further secures implant 20 within the native valve.
- FIG. 5 is a schematic illustration of a step in the implantation of implant 20, in accordance with some applications of the invention.
- Figs. 4A-F show an implantation technique in which flanges 54 are expanded prior to upstream support portion 40, for some applications the upstream support portion is expanded prior to the flanges.
- Fig. 5 shows a step in such an application.
- implant 20 may be implanted by causing flanges 54 to radially protrude before causing upstream support portion 40 to radially protrude, or may be implanted by causing the upstream support portion to protrude before causing the flanges to protrude.
- implant 20 is thereby configured to be deliverable in a downstream direction (e.g., transseptally, as shown, or transapically) or in an upstream direction (e.g., transapically or via the aortic valve).
- an operating physician may decide which delivery route is preferable for a given application (e.g., for a given subject, and/or based on available equipment and/or expertise), and implant 20 is responsively prepared for the chosen delivery route (e.g., by loading the implant into an appropriate delivery tool).
- downstream delivery of implant 20 may be performed by expanding flanges 54 first (e.g., as shown in Figs. 4A-F) or by expanding upstream support portion 40 first (e.g., as shown in Fig. 5).
- upstream delivery of implant 20 may be performed by upstream support portion 40 first, or by expanding flanges 54 first.
- FIG. 6 is a schematic illustration of implant 20, in the state and position shown in Fig. 4D, in accordance with some applications of the invention.
- leaflets 12 of valve 10 are able to move, at least in part in response to beating of the heart.
- Frame (A) shows leaflets 12 during ventricular systole
- frame (B) shows the leaflets during ventricular diastole.
- blood is thereby able to flow from atrium 6 to ventricle 8, between leaflets 12 and implant 20.
- imaging techniques may be used to verify the position of implant 20, and/or positioning of leaflets 12 between upstream support portion 40 and flanges 54.
- Figs. 7A-B and 8A-B are schematic illustrations of frame assemblies 122 and 222 of respective implants, in accordance with some applications of the invention. Except where noted otherwise, frame assemblies 122 and 222 are typically identical to frame assembly 22, mutatis mutandis. Elements of frame assemblies 122 and 222 share the name of corresponding elements of frame assembly 22. Additionally, except where noted otherwise, the implants to which frame assemblies 122 and 222 belong are similar to implant 20, mutatis mutandis.
- Frame assembly 122 comprises (i) a valve frame 130 that comprises a tubular portion 132 and an upstream support portion 140 that typically comprises a plurality of arms 146, and (ii) an outer frame (e.g., a leg frame) 160 that circumscribes the valve frame, and comprises a plurality of legs 150 that each comprise a tissue-engaging flange 154.
- outer frame 160 comprises a ring 166 to which legs 150 are coupled. Ring 166 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 130 at respective coupling points 152, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
- Frame assembly 222 comprises (i) a valve frame 230 that comprises a tubular portion 232 and an upstream support portion 240 that typically comprises a plurality of arms 246, and (ii) an outer frame (e.g., a leg frame) 260 that circumscribes the valve frame, and comprises a plurality of legs 250 that each comprise a tissue-engaging flange 254.
- outer frame 260 comprises a ring 266 to which legs 250 are coupled. Ring 266 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 230 at respective coupling points 252, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
- tubular portions 32, 132 and 232 are each defined by a repeating pattern of cells that extends around the central longitudinal axis. Typically, and as shown, tubular portions 32, 132 and 232 are each defined by two stacked, tessellating rows of cells. In the expanded state of each tubular portion, these cells are typically narrower at their upstream and downstream extremities than midway between these extremities. For example, and as shown, the cells may be roughly diamond or astroid in shape.
- each arm 46 is attached to and extends from a site 35 that is at the upstream extremity of cells of the upstream row.
- each arm 146 or 246 is attached to and extends from a site 135 (assembly 122) or 235 (assembly 222) that is at the connection between two adjacent cells of the upstream row (alternatively described as being at the upstream extremity of cells of the downstream row).
- this lower position of the arms while maintaining the length of the lumen of the tubular portion, advantageously reduces the distance that the tubular portion (i.e., the downstream end thereof) extends into the ventricle of the subject, and thereby reduces a likelihood of inhibiting blood flow out of the ventricle through the left ventricular outflow tract. It is further hypothesized that this position of the arms reduces radial compression of the tubular portion by movement of the heart, due to greater rigidity of the tubular portion at sites 135 and 235 (which is supported by two adjacent cells) than at site 35 (which is supported by only one cell).
- the legs are circumferentially staggered with the arms of the upstream support portion (46, 146 and 246, respectively). This allows the legs to move in an upstream direction between the arms during expansion of the tubular portion (32, 132 and 232, respectively), facilitating application of greater sandwiching force on tissue of the native valve.
- the lower position of the arms of assemblies 122 and 222 includes circumferentially shifting the position of the arms by the width of half a cell. In order to maintain the circumferential staggering of the arms and legs, rings 166 and 266 (and thereby legs 150 and 250) are circumferentially shifted correspondingly.
- the peaks of rings 166 and 266 are generally aligned midway between these sites (i.e., at spaces of the cellular structure of the tubular portion).
- An appendages 168 (for assembly 122) or 268 (for assembly 222) facilitate fixing of the peak with respect to the tubular structure.
- appendages 168 are defined by valve frame 130 (e.g., by tubular portion 132 thereof) and extend (in a downstream direction) to the peaks of ring 166, to which they are fixed.
- each appendage 168 may define a valve-frame coupling element 131 that is fixed to a respective outer- frame coupling element 161 defined by outer frame 260.
- appendages 168 extend from sites 135.
- appendages 168 are integral with tubular portion 132 and/or in-plane with the tubular portion (e.g., are part of its tubular shape).
- appendages 268 are defined by outer frame 260, and extend
- appendages 268 extend to sites 235, to which they are fixed.
- each appendage 268 may define an outer-frame coupling element 261 that is fixed to a respective valve-frame coupling element 231 defined by valve frame 230 (e.g., by tubular portion 232 thereof).
- appendages 268 are integral with outer frame 260 and/or in-plane with adjacent portions of outer frame 260, such as ring 266.
- frame assembly 122 defines a hub at site 135, and frame assembly 222 defines a hub at site 235.
- apparatus therefore comprises: a plurality of prosthetic valve leaflets; and
- a frame assembly comprising:
- tubular portion (132 or 232) defined by a repeating pattern of cells, the tubular portion extending circumferentially around longitudinal axis axl so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
- an outer frame (160 or 260), comprising a plurality of legs (150 or 250), distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange (154 or 254);
- an upstream support portion (140 or 240) that comprises a plurality of arms (146 or 246) that extend radially outward from the tubular portion;
- a plurality of appendages (168 or 268), each having a first end that defines a coupling element (161 or 261) via which the tubular portion is coupled to the outer frame, and a second end;
- Figs. 9A-C are schematic illustrations of an implant 320 comprising a frame assembly 322, in accordance with some applications of the invention. Except where noted otherwise, frame assembly 322 is identical to frame assembly 122, and implant 300 is identical to the implant to which frame assembly 122 belongs, mutatis mutandis.
- Fig. 9A is a side-view of implant 320
- Fig. 9B is an isometric bottom-view of the implant.
- Frame assembly 122 comprises (i) a valve frame 330 that comprises a tubular portion 332 and an upstream support portion 340 that typically comprises a plurality of arms 346, and (ii) an outer frame (e.g., a leg frame) 360 that circumscribes the valve frame, and comprises a plurality of legs 350 that each comprise a tissue-engaging flange 354.
- outer frame 360 comprises a ring 366 to which legs 350 are coupled. Ring 366 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 330 at respective coupling points 352, e.g., as described hereinabove for frame assembly 22 and/or frame assembly 122, mutatis mutandis.
- Frame assembly 322 comprises an annular upstream support portion 340 that has an inner portion 342 that extends radially outward from the upstream portion (e.g., the upstream end) of tubular portion 332.
- Upstream support portion 340 further comprises one or more fabric pockets 344 disposed circumferentially around inner portion 342, each pocket of the one or more pockets having an opening that faces a downstream direction (i.e., generally toward the downstream end of implant 320).
- upstream support portion 340 has a single toroidal pocket 344 that extends circumferentially around inner portion 342.
- a covering 323 (e.g., similar to covering 23, described hereinabove, mutatis mutandis) is disposed over arms 346, thereby forming pocket 344.
- arms 346 are shaped to form pocket 344 from covering 323. For example, and as shown, arms 346 may curve to form a hook-shape.
- portion 340 has a plurality of separate pockets 344, e.g., separated at arms 346.
- covering 323 is loosely-fitted (e.g., baggy) between radially-outward parts of arms 346, e.g., compared to inner portion 342, in which the covering is more closely-fitted between radially-inward parts of the arms.
- FIG. 9C shows implant 320 implanted at native valve 10.
- Pocket 344 is typically shaped and arranged to billow in response to perivalvular flow 302 of blood in an upstream direction. If ventricular systole forces blood in ventricle 8 between implant 320 and native valve 10, that blood inflates pocket 344 and presses it (e.g., covering 323 and/or the radially-outward part of arm 346) against tissue of atrium 6 (e.g., against the atrial wall), thereby increasing sealing responsively. It is hypothesized by the inventors that the shape and orientation of pocket 344 (e.g., the hook-shape of arms 346) facilitates this pressing radially-outward in response to the pocket's receipt of upstream-flowing blood.
- the shape and orientation of pocket 344 e.g., the hook-shape of arms 346
- Pocket(s) 344 may be used in combination with any of the implants described herein, mutatis mutandis.
- radially outward means portions of the element are disposed progressively further outward from a central point (such as longitudinal axis axl or tubular portion 32), but does not necessarily mean disposed at 90 degrees with respect to longitudinal axis axl.
- flanges 54 may extend radially outward at 90 degrees with respect to longitudinal axis axl, but may alternatively extend radially outward at a shallower angle with respect to the longitudinal axis.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
Abstract
A tubular portion (32) of a valve frame (30) circumscribes a longitudinal axis, and defines a lumen along the axis and a plurality of valve-frame coupling elements (31) disposed circumferentially around the axis. An outer frame (60): (a) comprises a ring (66) defined by a pattern of alternating peaks and troughs, the pattern having an amplitude, (b) comprises a plurality of legs (50), coupled to the ring at respective troughs, and (c) is shaped to define a plurality of outer-frame coupling elements (61), each coupled to the ring at a respective peak, and fixed with respect to a respective valve-frame coupling element. Compression of the tubular portion from an expanded state toward a compressed state reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and increases the amplitude of the pattern of the ring.
Description
PROSTHETIC VALVE WITH AXIALLY-SLIDING FRAMES
CROSS-REFERENCES TO RELATED APPLICATIONS
This application claims priority from US Provisional Patent Application 62/112,343 to Hariton et al., filed February 5, 2015, and entitled "Prosthetic valve with axially-sliding frames," which is incorporated herein by reference.
FIELD OF THE INVENTION
Some applications of the present invention relate in general to valve replacement. More specifically, some applications of the present invention relate to prosthetic valves for replacement of a cardiac valve.
BACKGROUND
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
SUMMARY OF THE INVENTION
For some applications, an implant is provided having a tubular portion, an upstream support portion and one or more flanges. The implant is percutaneously deliverable to a native heart valve in a compressed state, and is expandable at the native valve. The implant and its delivery system facilitate causing the upstream support portion and the flanges to protrude radially outward from the tubular portion without expanding the tubular portion. Expansion of the tubular portion brings the upstream support portion and the flanges closer together, for securing the implant at the native valve by sandwiching tissue of the native valve between the upstream support portion and the flanges.
There is therefore provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state such that the valve-frame coupling elements pull the outer- frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) increases the amplitude of the pattern of the ring.
In an application, the ring circumscribes the tubular portion. In an application, the valve-frame coupling elements are disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end.
In an application, the upstream support portion includes one or more fabric pockets disposed circumferentially, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
In an application, the apparatus further includes an upstream support portion that includes a plurality of arms that extend radially from the tubular portion, and:
the upstream support portion has (i) a constrained-arm state, and (ii) a released-arm state in which the arms extend radially outward from the tubular portion,
each leg has a tissue-engaging flange that has (i) a constrained-flange state, and (ii) a released-flange state in which the flange extends radially outward from the tubular portion, and
the apparatus has an intermediate state in which (i) the tubular portion is in its compressed state, (ii) the upstream support portion is in its released-arm state, and (iii) the legs are in their released-flange state.
In an application:
the apparatus includes an implant that includes the valve frame, the leaflets, and the outer frame, and
the apparatus further includes a tool:
including a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in its compressed state, (b) the upstream support portion is in its constrained-arm state, and (c) the legs are in their constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in its compressed state, and
operable from outside the subject to:
transition the implant from its compressed state into the intermediate state while retaining the tubular portion in its compressed state, and
subsequently, expand the tubular portion toward its expanded state.
In an application, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the legs into
their released-f ange state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state.
In an application, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state.
In an application, the fixation of the outer-frame coupling elements to the valve- frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state moves the flanges longitudinally away from the valve-frame coupling elements.
In an application, the fixation of the outer-frame coupling elements to the valve- frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state reduces the amplitude of the pattern of the ring and passes the flanges between the arms.
In an application, the upstream support portion further includes a covering that covers the arms to form an annular shape in the released-arm state, and, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state presses the flanges onto the covering.
In an application, in the compressed state of the tubular portion, a downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end. In an application, in the expanded state of the tubular portion, the downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including an implant that includes:
a valve frame that includes a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, a longitudinal length therebetween, and a diameter transverse to the longitudinal axis;
a valve member, coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
an upstream support portion, coupled to the tubular portion; and
an outer frame, coupled to the tubular portion, and including a tissue-engaging flange,
and:
the implant has a first state and a second state,
in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and
the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
increases the diameter of the tubular portion by a diameter-increase amount,
decreases the length of the tubular portion by a length-decrease amount, and
moves the flange a longitudinal distance toward or toward-and-beyond the upstream support portion, the distance being greater than the length-decrease amount. In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 20 percent greater than the length-decrease amount.
In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 30 percent greater than the length-decrease amount.
In an application, the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 40 percent greater than the length-decrease amount.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, including:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on the coupling points: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) increases the amplitude of the pattern of the ring. In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the valve frame defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements with respect to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the outer-frame coupling elements radially inward via radially-inward pulling of the valve-frame coupling elements on the outer-frame coupling elements, (ii) reduces a circumferential distance between each of the outer- frame coupling elements and its adjacent outer-frame coupling elements, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, including:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, and defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame:
including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end,
including a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element at a respective coupling point,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the outer-frame coupling elements and its adjacent outer- frame coupling elements, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
In an application, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end and a downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame, including:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor the downstream end; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
and:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion. In an application, the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
a valve frame, including:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that increasing the diameter of the tubular portion toward the expanded diameter causes longitudinal movement:
of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point. In an application:
the apparatus includes an implant that includes the frame assembly and the valve member, and
the apparatus further includes a tool:
including a delivery capsule dimensioned (i) to house and retain the implant in the compressed state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and
operable from outside the subject to facilitate an increase of the diameter of the tubular portion from the compressed diameter toward the expanded diameter such that the increase of the diameter actuates longitudinal movement:
of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the upstream end of the tubular portion toward the coupling point.
In an application, the coupling point is disposed closer to the downstream end of the frame assembly than are either the tissue-engaging flange or the upstream support portion. In an application, in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis.
In an application:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the leg is expandable into an expanded state of the leg, independently of increasing the diameter of the tubular portion, and
in the expanded state of the leg, the leg extends away from the central longitudinal axis.
In an application:
in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis, and
in the compressed state of the frame assembly, the leg is generally parallel with the central longitudinal axis.
In an application, the frame assembly is configured such that the longitudinal movement of the tissue-engaging flange away from the coupling point is a translational movement of the tissue-engaging flange that does not include rotation of the tissue- engaging flange.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the tissue-engaging flange away from the coupling point.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the upstream support portion toward the coupling point. In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state reduces a distance between the upstream support portion and the tissue-engaging flange by 5-30 mm.
In an application, the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state moves the tissue-engaging flange longitudinally past the upstream support portion.
In an application:
the tubular portion is defined by a plurality of cells of the valve frame, and increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state:
includes (i) increasing a width, orthogonal to the longitudinal axis of the frame assembly, of each cell, and (ii) reducing a height, parallel with the longitudinal axis of the frame assembly, of each cell, and
causes longitudinal movement of the upstream support portion toward the coupling point by reducing a height, parallel with the longitudinal axis of the frame assembly, of the tubular portion, by reducing the height of each cell.
In an application, the leg is disposed on an outside of the tubular portion.
In an application:
the at least one leg includes a plurality of legs,
the coupling point includes a plurality of coupling points, and
the frame assembly includes a leg frame that circumscribes the tubular portion, includes the plurality of legs, and is coupled to the valve frame at the plurality of coupling points, such that the plurality of legs is distributed circumferentially around the tubular portion. In an application, the plurality of coupling points is disposed circumferentially around the frame assembly on a transverse plane that is orthogonal to the longitudinal axis of the frame assembly.
In an application, the plurality of legs is coupled to the valve frame via a plurality of struts, each strut:
having a first end that is coupled to a leg of the plurality of legs, and a second end that is coupled to a coupling point of the plurality of coupling points,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point of the plurality of coupling points, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an application, the leg frame is structured such that each leg of the plurality of legs is coupled to two struts of the plurality of struts, and two struts of the plurality of struts are coupled to each coupling point of the plurality of coupling points.
In an application, the leg is coupled to the valve frame via a strut, the strut:
having a first end that is coupled to the leg, and a second end that is coupled to the coupling point,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an application, the at least one leg includes at least a first leg and a second leg.
In an application, the first leg and the second leg are both coupled to the valve frame at the coupling point. In an application, the first leg is coupled to the coupling point via a respective first strut, and the second leg is coupled to the coupling point via a respective second strut.
In an application, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the coupling point is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the first leg, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the second leg.
In an application, the coupling point includes at least a first coupling point and a second coupling point.
In an application, the leg is coupled to the valve frame at the first coupling point and at the second coupling point.
In an application, the leg is coupled to the first coupling point via a respective first strut, and to the second coupling point via a respective second strut. In an application, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the leg is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the leg and the first coupling point, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the leg and the second coupling point.
In an application, in the expanded state of the frame assembly, the upstream support portion extends radially outward from the tubular portion. In an application:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the upstream support portion is expandable into an expanded state of the upstream support portion, independently of increasing the diameter of the tubular portion, and
in the expanded state of the upstream support portion, the upstream support portion extends radially outward from the tubular portion.
In an application, in the compressed state of the frame assembly, the upstream support portion is generally tubular, collinear with the tubular portion, and disposed around the central longitudinal axis.
In an application, in the expanded state of the frame assembly, an inner region of the upstream support portion extends radially outward from the tubular portion at a first angle with respect to the tubular portion, and an outer region of the upstream support portion extends, from the inner region of the upstream support portion, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle. There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
a valve frame, including:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that reducing the diameter of the tubular portion toward the compressed diameter causes longitudinal movement:
of the upstream support portion away from the coupling point, and of the tissue-engaging flange toward the coupling point.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, including:
a valve frame, including:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
and the frame assembly:
has a compressed state, for percutaneous delivery to the heart,
is intracorporeally expandable into an expanded state in which a diameter of the tubular portion is greater than in the compressed state, and
is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the tissue- engaging flange away from the coupling point.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve of a heart of a subject, the apparatus including:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including:
an inner frame including an inner-frame tubular portion that circumscribes the central longitudinal axis, has an upstream end and a downstream end, and defines a channel therebetween, the inner frame defining a plurality of inner-frame couplings disposed circumferentially at a longitudinal location of the inner frame, an outer frame including an outer-frame tubular portion that coaxially circumscribes at least a portion of the inner-frame tubular portion, the outer frame
defining a plurality of outer-frame couplings disposed circumferentially at a longitudinal location of the outer frame, and
a plurality of connectors, each connector connecting a respective inner- frame coupling to a respective outer-frame coupling;
a liner, disposed over at least part of the inner-frame tubular portion; and a plurality of prosthetic leaflets, coupled to the inner-frame tubular portion and disposed within the channel,
and:
the frame assembly: (i) is compressible by a radially-compressive force into a compressed state in which the inner frame is in a compressed state thereof and the outer frame is in a compressed state thereof, (ii) is configured, upon removal of the radially- compressive force, to automatically expand into an expanded state thereof in which the inner frame is in an expanded state thereof and the outer frame is in an expanded state thereof,
in the expanded state of the frame assembly, the prosthetic leaflets are configured to facilitate one-way fluid flow, in a downstream direction, through the channel, and
the connection of the inner-frame couplings to the respective outer-frame couplings is such that expansion of the frame assembly from the compressed state to the expanded state causes the inner-frame tubular portion to slide longitudinally in a downstream direction with respect to the outer-frame tubular portion.
There is further provided, in accordance with an application of the present invention, apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus including:
a tubular portion, having an upstream portion that includes an upstream end, and a downstream portion that includes a downstream end, and shaped to define a lumen between the upstream portion and the downstream portion;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood from the upstream portion to the downstream portion; an annular upstream support portion:
having an inner portion that extends radially outward from the upstream portion, and
including one or more fabric pockets disposed circumferentially around the inner portion, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the inner portion of the upstream support portion, the covering is closely-fitted between the radially-inner parts of the arms, and
at the outer portion of the upstream support portion, the pockets are formed by the covering being loosely-fitted between the radially-outer parts of the arms.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, the radially-outer part being more flexible than the radially-inner part.
In an application:
the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the outer portion of the upstream support portion, the pockets are formed by each arm curving to form a hook shape.
In an application, each pocket is shaped and arranged to billow in response to perivalvular flow of blood in an upstream direction.
In an application, the apparatus is configured to be transluminally delivered to the heart, and implanted at the native valve by expansion of the apparatus, such that the upstream support portion is disposed in the atrium and the tubular portion extends from the upstream support portion into the ventricle, and each pocket is shaped and arranged such that perivalvular flow of blood in an upstream direction presses the pocket against tissue of the atrium.
There is further provided, in accordance with an application of the present invention, apparatus including:
a plurality of prosthetic valve leaflets; and
a frame assembly, including:
a tubular portion defined by a repeating pattern of cells, the tubular portion extending circumferentially around a longitudinal axis so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
an outer frame, including a plurality of legs, distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange;
an upstream support portion that includes a plurality of arms that extend radially outward from the tubular portion; and
a plurality of appendages, each having a first end that defines a coupling element via which the tubular portion is coupled to the outer frame, and a second end;
and the frame assembly defines a plurality of hubs, distributed circumferentially around the longitudinal axis on a plane that is transverse to the longitudinal axis, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages. In an application, each hub has six radiating spokes, two of the six spokes being part of a first cell of the two adjacent cells, two of the six spokes being part of a second cell of the two adjacent cells, one of the six spokes being the arm, and one of the six spokes being the second end of the appendage.
In an application, the appendages are in-plane with the tubular portion. In an application, the appendages are in-plane with the outer frame.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing to heart, an implant:
including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and
having an upstream end, a downstream end, and a central longitudinal axis therebetween;
positioning the implant within the heart such that a tissue-engaging flange of the leg is disposed downstream of the valve, and thereafter causing the flange to protrude radially outward from the axis;
subsequently, while an upstream support portion of the valve frame is disposed upstream of the valve, causing the upstream support portion to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and
subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point.
In an application, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing to heart, an implant:
including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and
having an upstream end, a downstream end, and a central longitudinal axis therebetween;
positioning the implant within the heart such that an upstream support portion of the valve frame is disposed upstream of the valve, and thereafter causing the upstream support portion to protrude radially outward from the axis;
subsequently, while a tissue-engaging flange of the leg is disposed downstream of the valve, causing the tissue-engaging flange to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and
subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point. In an application, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing an implant to the heart, the implant:
having an upstream end, a downstream end, and a central longitudinal axis therebetween, and
including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges;
positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve,
positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve,
without increasing a diameter of the tubular portion:
causing the upstream support portion to extend radially outward from the axis so as to have a first support-portion span, and
causing the flanges to extend radially outward from the axis so as to have a first flange span; and
subsequently, causing the upstream support portion and the flanges move toward each other by at least 5 mm by increasing a diameter of the tubular portion such that:
the upstream support portion extends radially outward so as to have a second support-portion span, the first support-portion span being at least 40 percent as great as the second support-portion span, and
the flanges extend radially outward so as to have a second flange span, the first flange span being at least 30 percent as great as the second flange span.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including:
percutaneously advancing an implant to the heart, the implant:
having an upstream end, a downstream end, and a central longitudinal axis therebetween, and
including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges;
positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve,
positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve,
without increasing a diameter of the tubular portion:
causing the upstream support portion to extend radially outward from the axis, and
causing the flanges to extend radially outward from the axis so as to have a first flange span; and
subsequently, by increasing a diameter of the tubular portion:
causing the upstream support portion and the flanges move toward each other by at least 5 mm,
causing the upstream support portion to move further radially outward from the axis, and
causing each flange of the plurality of flanges to translate radially outward so as to have a second flange span that is greater than the first flange span. The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1A-B and 2A-E are schematic illustrations of an implant for use with a native valve of a heart of a subject, in accordance with some applications of the invention; Figs. 3A-C are schematic illustrations that show structural changes in a frame assembly during transitioning of the assembly between its compressed and expanded states, in accordance with some applications of the invention;
Figs. 4A-F are schematic illustrations of implantation of the implant at the native valve, in accordance with some applications of the invention;
Fig. 5 is a schematic illustration of a step in the implantation of the implant, in accordance with some applications of the invention; Fig. 6 is a schematic illustration of the implant, in accordance with some applications of the invention;
Figs. 7A-B and 8A-B are schematic illustrations of frame assemblies of respective implants, in accordance with some applications of the invention; and
Figs. 9A-C are schematic illustrations of an implant comprising a frame assembly, in accordance with some applications of the invention.
DETAILED DESCRIPTION OF EMBODIMENTS
Reference is made to Figs. 1A-B and 2A-E, which are schematic illustrations of an implant 20 for use with a native valve of a heart of a subject, in accordance with some applications of the invention. Implant 20 comprises a frame assembly 22 that has an upstream end 24, a downstream end 26, and a central longitudinal axis axl therebetween. Frame assembly 22 comprises a valve frame 30 that comprises a tubular portion 32 that has an upstream end 34 and a downstream end 36, and is shaped to define a lumen 38 through the tubular portion from the upstream end to the downstream end. Tubular portion 32 circumscribes axis axl, and thereby defines lumen 38 along the axis. Valve frame 30 further comprises an upstream support portion 40, extending from upstream end 34 of tubular portion 32. Frame assembly 22 further comprises at least one leg 50, coupled to valve frame 30 at (e.g., via) a coupling point 52, and having a tissue-engaging flange 54.
Typically, and as described hereinbelow, leg 50 is part of an outer frame (or "leg frame") 60, and frames 30 and 60 define respective coupling elements 31 and 61, which are fixed with respect to each other at coupling points 52. Typically, frames 30 and 60 are coupled to each other only at coupling points 52 (e.g., only via the fixation of coupling elements 31 and 61 with respect to each other).
Implant 20 further comprises a valve member 58 (e.g., one or more prosthetic leaflets) disposed within lumen 38, and configured to facilitate one-way liquid flow through the lumen from upstream end 34 to downstream end 36 (e.g., thereby defining the orientation of the upstream and downstream ends of tubular portion 32). Fig. 1A shows
implant 20 in a fully-expanded state, in which frame assembly 22 is in a fully-expanded state. Fig. IB shows an exploded view of frame assembly 22 in its fully-expanded state. Figs. 2A-E show respective states of implant 20, which will be discussed in more detail hereinbelow with respect to the implantation of the implant and the anatomy in which the implant is implanted. Fig. 2A shows implant 20 in a compressed state (in which frame assembly 22 is in a compressed state), for percutaneous delivery of the implant to the heart of the subject. Typically, in the compressed state, leg 50 (including flange 54 thereof) is in a constrained-flange state in which the flange is generally parallel with axis axl. Further typically, in the compressed state, upstream support portion 40 is generally tubular, collinear with tubular portion 32 (e.g., extending collinearly from the tubular portion), and disposed around axis axl.
Fig. 2B shows a state of implant 20 in which tissue-engaging flange 54 of each leg 50 extends radially away from axis axl (e.g., radially away from tubular portion 32). Fig. 2C shows a state of implant 20 in which upstream-support portion 40 extends radially away from axis axl (and thereby radially away from tubular portion 32). Fig. 2D shows a state of implant 20 in which both flange 54 and portion 40 extend away from axis axl. In the fully-expanded state (Figs. 1A-B) both upstream support portion 40 and flange 54 extend radially away from axis axl. Typically, frame assembly 22 is biased (e.g., shape- set) to assume its fully-expanded state, which is shown in Fig. 2E. Transitioning of implant 20 between the respective states is typically controlled by delivery apparatus, such as by constraining the implant in a compressed state within a delivery tube and/or against a control rod, and selectively releasing portions of the implant to allow them to expand.
In the compressed state of frame assembly 22, tubular portion 32 has a diameter dl, and in the expanded state, the tubular portion has a diameter d2 that is greater that diameter dl. For some applications, diameter dl is 4-15 mm, (e.g., 5-11 mm) and diameter d2 is 20-50 mm, (e.g., 23-33 mm). Frame assembly 22 is configured such that increasing the diameter of tubular portion 32 (e.g., from dl to d2) causes longitudinal movement of flange 54 away from coupling point 52. In the same way, reducing the diameter of tubular portion 32 (e.g., from d2 to dl) causes longitudinal movement of flange 54 toward coupling point 52. It is to be noted that the term "longitudinal movement" (including the specification and the claims) means movement parallel with central longitudinal axis axl. Therefore longitudinal movement of flange 54 away from coupling point 52 means increasing a distance, measured parallel with longitudinal axis
axl, between flange 54 and coupling point 52. An example of such a configuration is described in more detail with respect to Fig. 3A.
Thus, expansion of tubular portion 32 from its compressed state toward its expanded state (i) increases a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., between each of outer-frame coupling elements 61 and its adjacent outer-frame coupling elements) (e.g., from d8 to d9), and (ii) moves legs 50 in a longitudinally upstream direction with respect to the tubular portion.
Typically, frame assembly 22 is configured such that increasing the diameter of tubular portion 32 also causes longitudinal movement of upstream support portion 40 toward coupling point 52, e.g., as described in more detail with respect to Figs. 3B-C. Typically, frame assembly 22 is configured such that increasing the diameter of tubular portion 32 also causes longitudinal movement of upstream end 34 of tubular portion 32 toward coupling point 52. In the same way, reducing the diameter of tubular portion 32 causes longitudinal movement of upstream end 34 away from coupling point 52. For some applications, upstream support portion 40 comprises a plurality of arms
46 that each extends radially outward from tubular portion 32 (e.g., from upstream end 34 of the tubular portion). Arms 46 are typically flexible. For some such applications, arms 46 are coupled to tubular portion 32 such that each arm may deflect independently of adjacent arms during implantation (e.g., due to anatomical topography). For some applications, upstream support portion 40 comprises a plurality of barbs
48 that extend out of a downstream surface of the upstream support portion. For example, each arm 46 may comprise one or more of barbs 48. Barbs 48 press into tissue upstream of the native valve (e.g., into the valve annulus), thereby inhibiting downstream movement of implant 20 (in addition to inhibition of downstream movement provided by the geometry of upstream support portion 40).
One or more surfaces of frame assembly 22 are covered with a covering 23, which typically comprises a flexible sheet, such as a fabric, e.g., comprising polyester. Typically, covering 23 covers at least part of tubular portion 32, typically lining an inner surface of the tubular portion, and thereby defining lumen 38. Further typically, upstream support portion 40 is covered with covering 23, e.g., extending between arms 46 to form an annular shape. It is hypothesized that this reduces a likelihood of paravalvular leakage. For such applications, excess covering 23 may be
provided between arms 46 of upstream support portion 40, so as to facilitate their independent movement. Although Fig. 1A shows covering 23 covering an upstream side of upstream support portion 40, the covering typically additionally (or alternatively) covers the downstream side of the upstream support portion. For example, covering 23 may extend over the tips of arms 46 and down the outside of the arms, or a separate piece of covering may be provided on the downstream side of the upstream support portion.
Alternatively, each arm 46 may be individually covered in a sleeve of covering 23, thereby facilitating independent movement of the arms.
For some applications, at least part of legs 50 (e.g., flanges thereof) is covered with covering 23.
Typically, frame assembly 22 comprises a plurality of legs 50 (e.g., two or more legs, e.g., 2-16 legs, such as 4-12 legs, such as 6-12 legs), arranged circumferentially around valve frame 30 (e.g., around the outside of tubular portion 32). Typically, frame assembly 22 comprises a plurality of coupling points 52 at which the legs are coupled to valve frame 30.
As described in more detail hereinbelow (e.g., with reference to Fig. 3A), each leg 50 is typically coupled to a coupling point 52 via a strut 70. For some applications, each leg 50 is coupled to a plurality of (e.g., two) coupling points 52 via a respective plurality of (e.g., two) struts 70. For some such applications, frame assembly 22 is arranged such that, in the expanded state of the frame assembly, leg 50 is disposed, circumferentially with respect to tubular portion 32, between two struts, and each of the two struts are disposed, circumferentially with respect to the tubular portion, between the leg and a respective coupling point 52.
For some applications, a plurality of (e.g., two) legs are coupled to each coupling point 52 via a respective plurality of (e.g., two) struts 70. For some such applications, frame assembly 22 is arranged such that, in the expanded state of the frame assembly, coupling point 52 is disposed, circumferentially with respect to tubular portion 32, between two struts 70, and each of the two struts are disposed, circumferentially with respect to the tubular portion, between the coupling point and a respective leg 50. For some applications, frame assembly 22 comprises an outer frame (e.g., a leg frame) 60 that circumscribes tubular portion 32, comprises (or defines) the plurality of legs 50 and the plurality of struts 70, and is coupled to valve frame 30 at the plurality of
coupling points 52, such that the plurality of legs are distributed circumferentially around the tubular portion. For such applications, outer frame 60 comprises a ring 66 that is defined by a pattern of alternating peaks 64 and troughs 62, and that typically circumscribes tubular portion 32. For example, the ring may comprise struts 70, extending between the peaks and troughs. Peaks 64 are longitudinally closer to upstream end 34 of tubular portion 32 than to downstream end 36, and troughs 62 are longitudinally closer to the downstream end than to the upstream end. (It is to be noted that throughout this patent application, including the specification and the claims, the term "longitudinally" means with respect to longitudinal axis axl. For example, "longitudinally closer" means closer along axis axl (whether positioned on axis axl or lateral to axis axl), and "longitudinal movement" means a change in position along axis axl (which may be in additional to movement toward or away from axis axl).) Therefore, peaks 64 are closer than troughs 62 to upstream end 34, and troughs 62 are closer than peaks 64 to downstream end 36. For applications in which frame 60 comprises ring 66, each leg 50 is coupled to the ring (or defined by frame 60) at a respective trough 62.
In the embodiment shown, the peaks and troughs are defined by ring 66 having a generally zig-zag shape. However, the scope of the invention includes ring 66 having another shape that defines peaks and troughs, such as a serpentine or sinusoid shape.
For applications in which frame assembly 22 has a plurality of coupling points 52, the coupling points (and therefore coupling elements 31 and 61) are disposed circumferentially around the frame assembly (e.g., around axis axl), typically on a transverse plane that is orthogonal to axis axl. This transverse plane is illustrated by the position of section A-A in Fig. 2B. Alternatively, coupling points 52 may be disposed at different longitudinal heights of frame assembly 22, e.g., such that different flanges 54 are positioned and/or moved differently to others. Typically, coupling points 52 (and therefore coupling elements 31 and 61) are disposed longitudinally between upstream end 24 and downstream end 26 of frame assembly 22, but not at either of these ends. Further typically, coupling points 52 are disposed longitudinally between upstream end 34 and downstream end 36 of tubular portion 32, but not at either of these ends. For example, the coupling points may be more than 3 mm (e.g., 4-10 mm) both from end 34 and from end 36. It is hypothesized that this advantageously positions the coupling points at a part of tubular portion 32 that is more rigid than end 34 or end 36.
It is to be noted that leg 50 is typically expandable into its expanded state (e.g., a released-flange state) such that flange 54 extends away from axis axl, independently of increasing the diameter of tubular portion 32 (e.g., as shown in Figs. 2B & 2D). Similarly, upstream support portion 40 is typically expandable into its expanded state (e.g., a released-arm state) such that it (e.g., arms 46 thereof) extends away from axis axl, independently of increasing the diameter of tubular portion 32 (e.g., as shown in Fig. 2C & 2D). The state shown in Fig. 2D may be considered to be an intermediate state. Therefore, implant 20 is typically configured such that legs 50 (e.g., flanges 54 thereof) and upstream support portion 40 are expandable such that they both extend away from axis axl, while retaining a distance d3 therebetween. This distance is subsequently reducible to a distance d4 by expanding tubular portion 32 (e.g., shown in Fig. 2E).
For some applications, while tubular portion 32 remains in its compressed state, flange 54 can extend away from axis axl over 40 percent (e.g., 40-80 percent, such as 40- 70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion. For example, for applications in which implant 20 comprises a flange on opposing sides of the implant, a span dl5 of the flanges while tubular portion 32 is in its compressed state may be at least 40 percent (e.g., 40-80 percent, such as 40-70 percent) as great as a span dl6 of the flanges subsequent to the expansion of the tubular portion. For some applications, span dl5 is greater than 15 mm and/or less than 50 mm (e.g., 20-30 mm). For some applications, span dl6 is greater than 30 mm and/or less than 60 mm (e.g., 40-50 mm). It is to be noted that flange 54 is effectively fully expanded, with respect to other portions of leg 50 and/or with respect to tubular portion 32, before and after the expansion of the tubular portion.
Similarly, for some applications, while tubular portion 32 remains in its compressed state, upstream support portion 40 (e.g., arms 46) can extend away from axis axl over 30 percent (e.g., 30-70 percent) of the distance that it extends from the axis subsequent to the expansion of the tubular portion. That is, for some applications, a span dl7 of the upstream support portion while tubular portion 32 is in its compressed state may be at least 30 percent (e.g., 30-70 percent) as great as a span dl8 of the upstream support portion subsequent to the expansion of the tubular portion. For some applications, span dl7 is greater than 16 mm (e.g., greater than 20 mm) and/or less than 50 mm (e.g., 30-40 mm). For some applications, span dl8 is greater than 40 mm and/or less than 65 mm (e.g., 45-56 mm, such as 45-50 mm). It is to be noted that upstream support portion
40 is effectively fully expanded, with respect to tubular portion 32, before and after the expansion of the tubular portion.
It is to be noted that when tubular portion 32 is expanded, flanges 54 typically translate radially outward from span dl5 to span dl6 (e.g., without deflecting). Typically upstream support portion 40 behaves similarly (e.g., arms 46 translated radially outward from span dl7 to span dl8, e.g., without deflecting). That is, an orientation of each flange 54 and/or each arm 46 with respect to tubular portion 32 and/or axis axl is typically the same in the state shown in Fig. 2D as it is in the state shown in Fig. 2E. Similarly, for some applications an orientation of each flange 54 with respect to upstream support portion 40 (e.g., with respect to one or more arms 46 thereof) is the same before and after expansion of tubular portion 32.
For some applications, increasing the diameter of tubular portion 32 from dl to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5- 20 mm) of longitudinal movement of flange 54 away from coupling point 52. For some applications, increasing the diameter of tubular portion 32 from dl to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of upstream support portion 40 toward coupling point 52. For some applications, distance d3 is 7-30 mm. For some applications, distance d4 is 0-15 mm (e.g., 2-15 mm). For some applications, increasing the diameter of tubular portion 32 from dl to d2 reduces the distance between the upstream support portion and flanges 54 by more than 5 mm and/or less than 30 mm, such as 5-30 mm (e.g., 10-30 mm, such as 10-20 mm or 20-30 mm). For some applications, the difference between d3 and d4 is generally equal to the difference between dl and d2. For some applications, the difference between d3 and d4 is more than 1.2 and/or less than 3 times (e.g., 1.5-2.5 times, such as about 2 times) greater than the difference between dl and d2.
For some applications, flanges 54 curve such that a tip of each flange is disposed at a shallower angle with respect to inner region 42 of upstream support portion 40, than are portions of leg 50 that are closer to downstream end 26 of frame assembly 22. For some such applications, a tip of each flange may be generally parallel with inner region 42. For some such applications, while tubular portion 32 is in its expanded state, a tip portion 55 of each flange 54 that extends from the tip of the flange at least 2 mm along the flange, is disposed within 2 mm of upstream support portion 40. Thus, for some applications, while tubular portion 32 is in its expanded state, for at least 5 percent (e.g., 5-8 percent, or at
least 8 percent) of span 18 of upstream support portion 40, the upstream support portion is disposed within 2 mm of a flange 54.
For some applications, in the absence of any obstruction (such as tissue of the valve or covering 23) between flange 54 and upstream support portion 40, increasing the diameter of tubular portion 32 from dl to d2 causes the flange and the upstream support portion to move past each other (e.g., the flange may move between arms 46 of the upstream support portion), such that the flange is closer to the upstream end of implant 20 than is the upstream support portion, e.g., as shown hereinbelow for frame assemblies 122 and 222, mutatis mutandis. (For applications in which upstream support portion 40 is covered by covering 23, flanges 54 typically don't pass the covering. For example, in the absence of any obstruction, flanges 54 may pass between arms 46, and press directly against covering 23.) It is hypothesized that for some applications this configuration applies greater force to the valve tissue being sandwiched, and thereby further facilitates anchoring of the implant. That is, for some applications, distance d3 is smaller than the sum of distance d5 and a distance dl4 (described with reference to Fig. 3C). For some applications, increasing the diameter of tubular portion 32 from dl to d2 advantageously causes flanges 54 and upstream support portion 40 to move greater than 3 mm and/or less than 25 mm (e.g., greater than 5 mm and/or less than 15 mm, e.g., 5-10 mm, such as about 7 mm) with respect to each other (e.g., toward each other and then past each other). For some applications, in the expanded state of frame assembly 22, upstream support portion 40 has an inner region (e.g., an inner ring) 42 that extends radially outward at a first angle with respect to axis axl (and typically with respect to tubular portion 32), and an outer region (e.g., an outer ring) 44 that extends, from the inner region, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle. For example, for some applications inner region 42 extends radially outward at an angle alpha_l of 60-120 degrees (e.g., 70-110 degrees) with respect to axis axl, and outer region 44 extends radially outward at an angle alpha_2 of 5-70 degrees (e.g., 10-60 degrees) with respect to axis axl. It is to be noted that angles alpha_l and alpha_2 are measured between the respective region support portion 40, and the portion of axis axl that extends in an upstream direction from the level of frame assembly 22 at which the respective region begins to extend radially outward.
For some applications in which implant 20 is configured to be placed at an atrioventricular valve (e.g., a mitral valve or a tricuspid valve) of the subject, region 42 is configured to be placed against the upstream surface of the annulus of the atrioventricular valve, and region 44 is configured to be placed against the walls of the atrium upstream of the valve.
For some applications, outer region 44 is more flexible than inner region 42. For example, and as shown, each arm 46 may have a different structure in region 44 than in region 42. It is hypothesized that the relative rigidity of region 42 provides resistance against ventricular migration of implant 20, while the relative flexibility of region 44 facilitates conformation of upstream support portion 40 to the atrial anatomy.
For some applications, two or more of arms 46 are connected by a connector (not shown), reducing the flexibility, and/or the independence of movement of the connected arms relative to each other. For some applications, arms 46 are connected in particular sectors of upstream support portion 40, thereby making these sectors more rigid than sectors in which the arms are not connected. For example, a relatively rigid sector may be provided to be placed against the posterior portion of the mitral annulus, and a relatively flexible sector may be provided to be placed against the anterior side of the mitral annulus, so as to reduce forces applied by upstream support portion 40 on the aortic sinus.
For some applications, and as shown, coupling points 52 are disposed closer to downstream end 26 of frame assembly 22 than are flanges 54, or is upstream support portion 40.
As described in more detail with respect to Figs. 4A-F, the movement of flange 54 away from coupling point 52 (and the typical movement of upstream support portion 40 toward the coupling point) facilitates the sandwiching of tissue of the native valve (e.g., leaflet and/or annulus tissue) between the flange and the upstream support portion, thereby securing implant 20 at the native valve.
Typically, in the compressed state of tubular portion 32, a downstream end of each leg 50 is longitudinally closer than valve-frame coupling elements 31 to downstream end 36, and flange 54 of each leg is disposed longitudinally closer than the valve-frame coupling elements to upstream end 34. Typically, this is also the case in the expanded state of tubular portion 32.
Figs. 3A-C show structural changes in frame assembly 22 during transitioning of the assembly between its compressed and expanded states, in accordance with some applications of the invention. Figs. 3A-C each show a portion of the frame assembly, the structural changes thereof being representative of the structural changes that occur in other portions of the frame assembly. Fig. 3A shows a leg 50 and struts 70 (e.g., a portion of outer frame 60), and illustrates the structural changes that occur around outer frame 60. Fig. 3B shows a portion of valve frame 30, and illustrates the structural changes that occur around the valve frame. Fig. 3C shows valve frame 30 as a whole. In each of Figs. 3A-C, state (A) illustrates the structure while frame assembly 22 (and in particular tubular portion 32) is in its compressed state, and state (B) illustrates the structure while the frame assembly (and in particular tubular portion 32) is in its expanded state.
Fig. 3A shows structural changes in the coupling of legs 50 to coupling point 52 (e.g., structural changes of outer frame 60) during the transitioning of frame assembly 22 (and in particular tubular portion 32) between its compressed and expanded states. Each leg 50 is coupled to valve frame 30 via at least one strut 70, which connects the leg to coupling point 52. Typically, each leg 50 is coupled to valve frame 30 via a plurality of struts 70. A first end 72 of each strut 70 is coupled to leg 50, and a second end 74 of each strut is coupled to a coupling point 52. As described hereinabove, for applications in which frame 60 comprises ring 66, each leg 50 is coupled to the ring at a respective trough 62. Ring 66 may comprise struts 70, extending between the peaks and troughs, with each first end 72 at (or close to) a trough 62, and each second end 74 at (or close to) a peak 64.
In the compressed state of frame assembly 22 (and in particular of tubular portion 32), each strut 70 is disposed at a first angle in which first end 72 is disposed closer than second end 74 to the downstream end of the frame assembly. Expansion of frame assembly 22 (and in particular of tubular portion 32) toward its expanded state causes strut 70 to deflect to a second angle. This deflection moves first end 72 away from the downstream end of frame assembly 22. That is, in the expanded state of frame assembly 22, first end 72 is further from the downstream end of the frame assembly than it is when the frame assembly is in its compressed state. This movement is shown as a distance d5 between the position of end 72 in state (A) and its position in state (B). This movement causes the above-described movement of flanges 54 away from coupling points 52. As shown, flanges 54 typically move the same distance d5 in response to expansion of frame assembly 22.
For applications in which outer frame 60 comprises ring 66, the pattern of alternating peaks and troughs may be described as having an amplitude longitudinally between the peaks and troughs, i.e., measured parallel with central longitudinal axis axl of frame assembly 22, and the transition between the compressed and expanded states may be described as follows: In the compressed state of frame assembly 22 (and in particular of tubular portion 32), the pattern of ring 66 has an amplitude d20. In the expanded state frame assembly 22 (and in particular of tubular portion 32), the pattern of ring 66 has an amplitude d21 that is lower than amplitude d20. Because (i) it is at peaks 64 that ring 66 is coupled to valve frame 30 at coupling points 52, and (ii) it is at troughs 62 that ring 66 is coupled to legs 50, this reduction in the amplitude of the pattern of ring 66 moves legs 50 (e.g., flanges 54 thereof) longitudinally further from the downstream end of the frame assembly. The magnitude of this longitudinal movement (e.g., the difference between magnitudes d20 and d21) is equal to d5.
Typically, distance d5 is the same distance as the distance that flange 54 moves away from coupling point 52 during expansion of the frame assembly. That is, a distance between flange 54 and the portion of leg 50 that is coupled to strut 70, typically remains constant during expansion of the frame assembly. For some applications, the longitudinal movement of flange 54 away from coupling point 52 is a translational movement (e.g., a movement that does not include rotation or deflection of the flange). For some applications, a distance d6, measured parallel to axis axl of frame assembly 22, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its compressed state, is 3-15 mm. For some applications, a distance d7, measured parallel to axis axl, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its expanded state, is 1-5 mm (e.g., 1-4 mm). For some applications, amplitude d20 is 2-10 mm (e.g., 4-7 mm). For some applications, amplitude d21 is 4-9 mm (e.g., 5-7 mm).
For some applications, and as shown, in the expanded state, first end 72 of strut 70 is disposed closer to the downstream end of frame assembly 22 than is coupling point 52. For some applications, in the expanded state, first end 72 of strut 70 is disposed further from the downstream end of frame assembly 22 than is coupling point 52.
For applications in which frame assembly 22 comprises a plurality of legs 50 and a plurality of coupling points 52 (e.g., for applications in which the frame assembly comprises outer frame 60) expansion of the frame assembly increases a circumferential
distance between adjacent coupling points 52, and an increase in a circumferential distance between adjacent legs 50. Fig. 3A shows such an increase in the circumferential distance between adjacent coupling points 52, from a circumferential distance d8 in the compressed state to a circumferential distance d9 in the expanded state. For some applications, distance d8 is 1-6 mm. For some applications, distance d9 is 3-15 mm.
For some applications, in addition to being coupled via ring 66 (e.g., struts 70 thereof) legs 50 are also connected to each other via connectors 78. Connectors 78 allow the described movement of legs 50 during expansion of frame assembly 22, but typically stabilize legs 50 relative to each other while the frame assembly is in its expanded state. For example, connectors 78 may bend and/or deflect during expansion of the frame assembly.
Figs. 3B-C show structural changes in valve frame 30 during the transitioning of frame assembly 22 between its compressed and expanded states. Tubular portion 32 of valve frame 30 is defined by a plurality of cells 80, which are defined by the repeating pattern of the valve frame. When frame assembly 22 is expanded from its compressed state toward its expanded state, cells 80 (i) widen from a width dlO to a width dl l (measured orthogonal to axis axl of the frame assembly), and (ii) shorten from a height dl2 to a height dl3 (measured parallel to axis axl of the frame assembly). This shortening reduces the overall height (i.e., a longitudinal length between upstream end 34 and downstream end 36) of tubular portion 32 from a height d22 to a height d23, and thereby causes the above-described longitudinal movement of upstream support portion 40 toward coupling points 52 by a distance dl4 (shown in Fig. 3C). For some applications, and as shown, coupling points 52 are disposed at the widest part of each cell.
Due to the configurations described herein, the distance by which flanges 54 move with respect to (e.g., toward, or toward-and-beyond) upstream support portion 40 (e.g., arms 46 thereof), is typically greater than the reduction in the overall height of tubular portion 32 (e.g., more than 20 percent greater, such as more than 30 percent greater, such as more than 40 percent greater). That is, implant 20 comprises:
a valve frame (30) that comprises a tubular portion (32) that circumscribes a longitudinal axis (axl) of the valve frame so as to define a lumen (38) along the axis, the tubular portion having an upstream end (34), a downstream end (36), a longitudinal length therebetween, and a diameter (e.g., dl or d2) transverse to the longitudinal axis;
a valve member (58), coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
an upstream support portion (40), coupled to the tubular portion; and an outer frame (60), coupled to the tubular portion, and comprising a tissue-engaging flange (54),
wherein:
the implant has a first state (e.g., as shown in Fig. 2D and Fig. 4D) and a second state (e.g., as shown in Fig. 2E and Fig. 4E),
in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and
the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
increases the diameter of the tubular portion by a diameter-increase amount (e.g., the difference between dl and d2),
decreases the length of the tubular portion by a length-decrease amount (e.g., the difference between d22 and d23), and
moves the flange a longitudinal distance with respect to (e.g., toward or toward-and-beyond) the upstream support portion (e.g., the difference between d3 and d4), this distance being greater than the length- decrease amount.
As shown in the figures, valve frame 30 is typically coupled to outer frame 60 by coupling between (i) a valve-frame coupling element 31 defined by valve frame 30, and (ii) an outer-frame coupling element 61 defined by outer frame 60 (e.g., an outer-frame coupling element is coupled to end 74 of each strut). Typically, elements 31 and 61 are fixed with respect to each other. Each coupling point 52 is thereby typically defined as the point at which a valve-frame coupling element and a corresponding outer-frame coupling element 61 are coupled (e.g., are fixed with respect to each other). For some applications, and as shown, elements 31 and 61 are eyelets configured to be coupled together by a connector, such as a pin or suture. For some applications, elements 31 and 61 are soldered or welded together.
Typically, and as shown, valve-frame coupling elements 31 are defined by tubular portion 32, and are disposed circumferentially around central longitudinal axis axl. Outer-frame coupling elements 61 are coupled to ring 66 (or defined by frame 60, such as by ring 66) at respective peaks 64. As shown (e.g., in Figs. 2A-E), valve frame 30 (e.g., tubular portion 32 thereof) and outer frame 60 (e.g., ring 66 thereof) are arranged in a close-fitting coaxial arrangement, in both the expanded and compressed states of frame assembly 22. Ignoring spaces due to the cellular structure of the frames, a radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and outer frame 60 (e.g., ring 66 thereof) is typically less than 2 mm (e.g., less than 1 mm), in both the compressed and expanded states, and during the transition therebetween. This is facilitated by the coupling between frames 30 and 60, and the behavior, described hereinabove, of frame 60 in response to changes in the diameter of tubular portion 32 (e.g., rather than solely due to delivery techniques and/or tools). For some applications, more than 50 percent (e.g., more than 60 percent) of ring 66 is disposed within 2 mm of tubular portion 32 in both the compressed and expanded states, and during the transition therebetween. For some applications, more than 50 percent (e.g., more than 60 percent) of outer frame 60, except for flanges 54, is disposed within 2 mm of tubular portion 32 in both the compressed and expanded states, and during the transition therebetween. The structural changes to frame assembly 22 (e.g., to outer frame 60 thereof) are described hereinabove as they occur during (e.g., as a result of) expansion of the frame assembly (in particular tubular portion 32 thereof). This is the natural way to describe these changes because, as described hereinbelow with respect to Figs. 4A-6, assembly 22 is in its compressed state during percutaneous delivery to the implant site, and is subsequently expanded. However, the nature of implant 20 may be further understood by describing structural changes that occur during compression of the frame assembly (e.g., a transition from the expanded state in Fig. 2E to the intermediate state in Fig. 2D), in particular tubular portion 32 thereof (including if tubular portion 32 were compressed by application of compressive force to the tubular portion, and not to frame 60 except via the tubular portion pulling frame 60 radially inward). Such descriptions may also be relevant because implant 20 is typically compressed (i.e., "crimped") soon before its percutaneous delivery, and therefore these changes may occur while implant 20 is in the care of the operating physician.
For some applications, the fixation of peaks 64 to respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on coupling points 52: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
For some applications, the fixation of outer- frame coupling elements 61 to valve- frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer- frame coupling elements (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20). For some applications, the fixation of peaks 64 to the respective sites of tubular portion 32 is such that compression of the tubular portion from its expanded state toward its compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
For some applications, the fixation of outer-frame coupling elements 61 with respect to valve-frame coupling elements 31 is such that compression of tubular portion 32 from its expanded state toward its compressed state (i) pulls outer- frame coupling elements 61 radially inward via radially-inward pulling of valve-frame coupling elements 31 on outer-frame coupling elements 61, (ii) reduces a circumferential distance between each of the outer- frame coupling elements and its adjacent outer- frame coupling elements (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap dl9 between valve frame 30 (e.g., tubular portion 32 thereof) and the ring by more than 1.5 mm.
Reference is made to Figs. 4A-F, which are schematic illustrations of implantation of implant 20 at a native valve 10 of a heart 4 of a subject, in accordance with some
applications of the invention. Valve 10 is shown as a mitral valve of the subject, disposed between a left atrium 6 and a left ventricle 8 of the subject. However implant 20 may be implanted at another heart valve of the subject, mutatis mutandis. Similarly, although Figs. 4A-F show implant 20 being delivered trans septally via a sheath 88, the implant may alternatively be delivered by any other suitable route, such as transatrially, or transapically.
Implant 20 is delivered, in its compressed state, to native valve 10 using a delivery tool 89 that is operable from outside the subject (Fig. 4A). Typically, implant 20 is delivered within a delivery capsule 90 of tool 89, which retains the implant in its compressed state. A transseptal approach, such as a transfemoral approach, is shown. Typically, implant 20 is positioned such that at least flanges 54 are disposed downstream of the native valve (i.e., within ventricle 8). At this stage, frame assembly 22 of implant 20 is as shown in Fig. 2A.
Subsequently, flanges 54 are allowed to protrude radially outward, as described hereinabove, e.g., by releasing them from capsule 90 (Fig. 4B). For example, and as shown, capsule 90 may comprise a distal capsule -portion 92 and a proximal capsule- portion 94, and the distal capsule-portion may be moved distally with respect to implant 20, so as to expose flanges 54. At this stage, frame assembly 22 of implant 20 is as shown in Fig. 2B. Subsequently, implant 20 is moved upstream, such that upstream support portion
40, in its compressed state, is disposed upstream of leaflets 12 (i.e., within atrium 6). For some applications, the upstream movement of implant 20 causes flanges 54 to engage leaflets 12. However, because of the relatively large distance d3 provided by implant 20 (described hereinabove), for some applications it is not necessary to move the implant so far upstream that flanges 54 tightly engage leaflets 12 and/or pull the leaflets upstream of the valve annulus. Upstream support portion 40 is then allowed to expand such that it protrudes radially outward, as described hereinabove, e.g., by releasing it from capsule 90 (Fig. 4D). For example, and as shown, proximal capsule-portion 94 may be moved proximally with respect to implant 20, so as to expose upstream support portion 40. At this stage, frame assembly 22 of implant 20 is as shown in Fig. 2D, in which: (i) distance d3 exists between upstream support portion 40 and flanges 54, (ii) the flanges have span dl5, (iii) the upstream support portion has span dl7, and (iv) tubular portion 32 has diameter dl.
Typically, expansion of frame assembly 22 is inhibited by distal capsule -portion 92 (e.g., by inhibiting expansion of tubular portion 32), and/or by another portion of delivery tool 89 (e.g., a portion of the delivery tool that is disposed within lumen 38).
Subsequently, implant 20 is allowed to expand toward its expanded state, such that tubular portion 32 widens to diameter d2, and the distance between upstream support portion 40 and flanges 54 reduces to distance d4 (Fig. 4E). This sandwiches tissue of valve 10 (typically including annular tissue and/or leaflets 12) between upstream support portion 40 and flanges 54, thereby securing implant 20 at the valve. Fig. 4F shows delivery capsule 90 having been removed from the body of the subject, leaving implant 20 in place at valve 10.
As described hereinabove, implant 20 is configured such that when tubular portion 32 is expanded, flanges 54 and upstream support portion 40 move a relatively large distance toward each other. This enables distance d3 to be relatively large, while distance d4 is sufficiently small to provide effective anchoring. As also described hereinabove, implant 20 is configured such that flanges 54 and upstream support portion 40 can extend radially outward a relatively large distance while tubular portion 32 remains compressed. It is hypothesized that for some applications, these configurations (independently and/or together) facilitate effective anchoring of implant 20, by facilitating placement of a relatively large proportion of valve tissue (e.g., leaflets 12) between the flanges and the upstream support portion prior to expanding tubular portion 32 and sandwiching the valve tissue.
It is further hypothesized that the relatively great radially-outward extension of flanges 54 and upstream support portion 40 prior to expansion of tubular portion 32, further facilitates the anchoring/sandwiching step by reducing radially-outward pushing of the valve tissue (e.g., leaflets 12) during the expansion of the tubular portion, and thereby increasing the amount of valve tissue that is sandwiched.
It is yet further hypothesized that this configuration of implant 20 facilitates identifying correct positioning of the implant (i.e., with upstream support portion 40 upstream of leaflets 12 and flanges 54 downstream of the leaflets) prior to expanding tubular portion 32 and sandwiching the valve tissue.
As shown in Fig. 1A, for some applications, in the expanded state of frame assembly 22, implant 20 defines a toroidal space 49 between flanges 54 and upstream support portion 40 (e.g., a space that is wider than distance d4). For example, space 49
may have a generally triangular cross-section. It is hypothesized that for some such applications, in addition to sandwiching tissue of the native valve between upstream support portion 40 and flanges 54 (e.g., the tips of the flanges), space 49 advantageously promotes tissue growth therewithin (e.g., between leaflet tissue and covering 23), which over time further secures implant 20 within the native valve.
Reference is now made to Fig. 5, which is a schematic illustration of a step in the implantation of implant 20, in accordance with some applications of the invention. Whereas Figs. 4A-F show an implantation technique in which flanges 54 are expanded prior to upstream support portion 40, for some applications the upstream support portion is expanded prior to the flanges. Fig. 5 shows a step in such an application.
Reference is again made to Figs. 2A-5. As noted hereinabove, implant 20 may be implanted by causing flanges 54 to radially protrude before causing upstream support portion 40 to radially protrude, or may be implanted by causing the upstream support portion to protrude before causing the flanges to protrude. For some applications, implant 20 is thereby configured to be deliverable in a downstream direction (e.g., transseptally, as shown, or transapically) or in an upstream direction (e.g., transapically or via the aortic valve). Thus, for some applications, an operating physician may decide which delivery route is preferable for a given application (e.g., for a given subject, and/or based on available equipment and/or expertise), and implant 20 is responsively prepared for the chosen delivery route (e.g., by loading the implant into an appropriate delivery tool).
It is to be noted that for some applications, downstream delivery of implant 20 may be performed by expanding flanges 54 first (e.g., as shown in Figs. 4A-F) or by expanding upstream support portion 40 first (e.g., as shown in Fig. 5). Similarly, for some applications upstream delivery of implant 20 may be performed by upstream support portion 40 first, or by expanding flanges 54 first.
Reference is now made to Fig. 6, which is a schematic illustration of implant 20, in the state and position shown in Fig. 4D, in accordance with some applications of the invention. For some applications, while implant 20 is in the state and position shown in Fig. 4D, leaflets 12 of valve 10 are able to move, at least in part in response to beating of the heart. Frame (A) shows leaflets 12 during ventricular systole, and frame (B) shows the leaflets during ventricular diastole. For some such applications, blood is thereby able to flow from atrium 6 to ventricle 8, between leaflets 12 and implant 20. It is hypothesized that this advantageously facilitates a more relaxed implantation procedure, e.g., facilitating
retaining of implant 20 in this state and position for a duration of greater than 8 minutes. During this time, imaging techniques may be used to verify the position of implant 20, and/or positioning of leaflets 12 between upstream support portion 40 and flanges 54.
Reference is made to Figs. 7A-B and 8A-B, which are schematic illustrations of frame assemblies 122 and 222 of respective implants, in accordance with some applications of the invention. Except where noted otherwise, frame assemblies 122 and 222 are typically identical to frame assembly 22, mutatis mutandis. Elements of frame assemblies 122 and 222 share the name of corresponding elements of frame assembly 22. Additionally, except where noted otherwise, the implants to which frame assemblies 122 and 222 belong are similar to implant 20, mutatis mutandis.
Frame assembly 122 comprises (i) a valve frame 130 that comprises a tubular portion 132 and an upstream support portion 140 that typically comprises a plurality of arms 146, and (ii) an outer frame (e.g., a leg frame) 160 that circumscribes the valve frame, and comprises a plurality of legs 150 that each comprise a tissue-engaging flange 154. Typically, outer frame 160 comprises a ring 166 to which legs 150 are coupled. Ring 166 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 130 at respective coupling points 152, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
Frame assembly 222 comprises (i) a valve frame 230 that comprises a tubular portion 232 and an upstream support portion 240 that typically comprises a plurality of arms 246, and (ii) an outer frame (e.g., a leg frame) 260 that circumscribes the valve frame, and comprises a plurality of legs 250 that each comprise a tissue-engaging flange 254. Typically, outer frame 260 comprises a ring 266 to which legs 250 are coupled. Ring 266 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 230 at respective coupling points 252, e.g., as described hereinabove for frame assembly 22, mutatis mutandis.
Whereas arms 46 of frame assembly 22 are shown as extending from upstream end 34 of tubular portion 32, arms 146 and 246 of frame assemblies 122 and 222, respectively, extend from sites further downstream. (This difference may also be made to frame assembly 22, mutatis mutandis.) Tubular portions 32, 132 and 232 are each defined by a repeating pattern of cells that extends around the central longitudinal axis. Typically, and as shown, tubular portions 32, 132 and 232 are each defined by two stacked, tessellating rows of cells. In the expanded state of each tubular portion, these cells are typically
narrower at their upstream and downstream extremities than midway between these extremities. For example, and as shown, the cells may be roughly diamond or astroid in shape. In frame assembly 22, each arm 46 is attached to and extends from a site 35 that is at the upstream extremity of cells of the upstream row. In contrast, in frame assemblies 122 and 222, each arm 146 or 246 is attached to and extends from a site 135 (assembly 122) or 235 (assembly 222) that is at the connection between two adjacent cells of the upstream row (alternatively described as being at the upstream extremity of cells of the downstream row).
It is hypothesized by the inventors that this lower position of the arms, while maintaining the length of the lumen of the tubular portion, advantageously reduces the distance that the tubular portion (i.e., the downstream end thereof) extends into the ventricle of the subject, and thereby reduces a likelihood of inhibiting blood flow out of the ventricle through the left ventricular outflow tract. It is further hypothesized that this position of the arms reduces radial compression of the tubular portion by movement of the heart, due to greater rigidity of the tubular portion at sites 135 and 235 (which is supported by two adjacent cells) than at site 35 (which is supported by only one cell).
As shown, in the expanded state of frame assemblies 22, 122 and 222, the legs (50, 150 and 250, respectively) are circumferentially staggered with the arms of the upstream support portion (46, 146 and 246, respectively). This allows the legs to move in an upstream direction between the arms during expansion of the tubular portion (32, 132 and 232, respectively), facilitating application of greater sandwiching force on tissue of the native valve. The lower position of the arms of assemblies 122 and 222 includes circumferentially shifting the position of the arms by the width of half a cell. In order to maintain the circumferential staggering of the arms and legs, rings 166 and 266 (and thereby legs 150 and 250) are circumferentially shifted correspondingly. As a result, whereas the peaks of ring 66 generally align with connections between adjacent cells of the downstream row of cells of tubular portion 32 (and are fixed to these sites), the peaks of rings 166 and 266 are generally aligned midway between these sites (i.e., at spaces of the cellular structure of the tubular portion). An appendages 168 (for assembly 122) or 268 (for assembly 222) facilitate fixing of the peak with respect to the tubular structure.
For assembly 122, appendages 168 are defined by valve frame 130 (e.g., by tubular portion 132 thereof) and extend (in a downstream direction) to the peaks of ring 166, to which they are fixed. For example, each appendage 168 may define a valve-frame
coupling element 131 that is fixed to a respective outer- frame coupling element 161 defined by outer frame 260. Typically, appendages 168 extend from sites 135. Typically, appendages 168 are integral with tubular portion 132 and/or in-plane with the tubular portion (e.g., are part of its tubular shape).
For assembly 222, appendages 268 are defined by outer frame 260, and extend
(e.g., in an upstream direction) from the peaks of ring 266. Typically, appendages 268 extend to sites 235, to which they are fixed. For example, each appendage 268 may define an outer-frame coupling element 261 that is fixed to a respective valve-frame coupling element 231 defined by valve frame 230 (e.g., by tubular portion 232 thereof). Typically, appendages 268 are integral with outer frame 260 and/or in-plane with adjacent portions of outer frame 260, such as ring 266.
Therefore, frame assembly 122 defines a hub at site 135, and frame assembly 222 defines a hub at site 235. For some applications, apparatus therefore comprises: a plurality of prosthetic valve leaflets; and
a frame assembly, comprising:
a tubular portion (132 or 232) defined by a repeating pattern of cells, the tubular portion extending circumferentially around longitudinal axis axl so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
an outer frame (160 or 260), comprising a plurality of legs (150 or 250), distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange (154 or 254);
an upstream support portion (140 or 240) that comprises a plurality of arms (146 or 246) that extend radially outward from the tubular portion; and
a plurality of appendages (168 or 268), each having a first end that defines a coupling element (161 or 261) via which the tubular portion is coupled to the outer frame, and a second end;
wherein the frame assembly defines a plurality of hubs (135 or 235), distributed circumferentially around the longitudinal axis on a plane that is transverse to longitudinal axis axl, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages.
Reference is made to Figs. 9A-C, which are schematic illustrations of an implant 320 comprising a frame assembly 322, in accordance with some applications of the invention. Except where noted otherwise, frame assembly 322 is identical to frame assembly 122, and implant 300 is identical to the implant to which frame assembly 122 belongs, mutatis mutandis. Fig. 9A is a side-view of implant 320, and Fig. 9B is an isometric bottom-view of the implant.
Frame assembly 122 comprises (i) a valve frame 330 that comprises a tubular portion 332 and an upstream support portion 340 that typically comprises a plurality of arms 346, and (ii) an outer frame (e.g., a leg frame) 360 that circumscribes the valve frame, and comprises a plurality of legs 350 that each comprise a tissue-engaging flange 354. Typically, outer frame 360 comprises a ring 366 to which legs 350 are coupled. Ring 366 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 330 at respective coupling points 352, e.g., as described hereinabove for frame assembly 22 and/or frame assembly 122, mutatis mutandis. Frame assembly 322 comprises an annular upstream support portion 340 that has an inner portion 342 that extends radially outward from the upstream portion (e.g., the upstream end) of tubular portion 332. Upstream support portion 340 further comprises one or more fabric pockets 344 disposed circumferentially around inner portion 342, each pocket of the one or more pockets having an opening that faces a downstream direction (i.e., generally toward the downstream end of implant 320). In the figures, upstream support portion 340 has a single toroidal pocket 344 that extends circumferentially around inner portion 342.
Typically, a covering 323 (e.g., similar to covering 23, described hereinabove, mutatis mutandis) is disposed over arms 346, thereby forming pocket 344. Further typically, arms 346 are shaped to form pocket 344 from covering 323. For example, and as shown, arms 346 may curve to form a hook-shape.
For some applications, portion 340 has a plurality of separate pockets 344, e.g., separated at arms 346. For some such applications, covering 323 is loosely-fitted (e.g., baggy) between radially-outward parts of arms 346, e.g., compared to inner portion 342, in which the covering is more closely-fitted between radially-inward parts of the arms.
Fig. 9C shows implant 320 implanted at native valve 10. Pocket 344 is typically shaped and arranged to billow in response to perivalvular flow 302 of blood in an upstream direction. If ventricular systole forces blood in ventricle 8 between implant 320
and native valve 10, that blood inflates pocket 344 and presses it (e.g., covering 323 and/or the radially-outward part of arm 346) against tissue of atrium 6 (e.g., against the atrial wall), thereby increasing sealing responsively. It is hypothesized by the inventors that the shape and orientation of pocket 344 (e.g., the hook-shape of arms 346) facilitates this pressing radially-outward in response to the pocket's receipt of upstream-flowing blood.
Pocket(s) 344 may be used in combination with any of the implants described herein, mutatis mutandis.
Reference is again made to Figs. 1A-9C. It is to be noted that unless specifically stated otherwise, the term "radially outward" (e.g., used to describe upstream support portion 40 and flanges 54) means portions of the element are disposed progressively further outward from a central point (such as longitudinal axis axl or tubular portion 32), but does not necessarily mean disposed at 90 degrees with respect to longitudinal axis axl. For example, flanges 54 may extend radially outward at 90 degrees with respect to longitudinal axis axl, but may alternatively extend radially outward at a shallower angle with respect to the longitudinal axis.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. Apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
comprising a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
comprising a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state such that the valve-frame coupling elements pull the outer- frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) increases the amplitude of the pattern of the ring.
2. The apparatus according to claim 1, wherein the ring circumscribes the tubular portion.
3. The apparatus according to claim 1, wherein the valve-frame coupling elements are disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end.
4. The apparatus according to claim 1, wherein the upstream support portion comprises one or more fabric pockets disposed circumferentially, each pocket of the one or more pockets having an opening that faces a downstream direction.
5. The apparatus according to claim 1, wherein the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
6. The apparatus according to any one of claims 1-5, further comprising an upstream support portion that comprises a plurality of arms that extend radially from the tubular portion, wherein:
the upstream support portion has (i) a constrained-arm state, and (ii) a released-arm state in which the arms extend radially outward from the tubular portion,
each leg has a tissue-engaging flange that has (i) a constrained-flange state, and (ii) a released-flange state in which the flange extends radially outward from the tubular portion, and
the apparatus has an intermediate state in which (i) the tubular portion is in its compressed state, (ii) the upstream support portion is in its released-arm state, and (iii) the legs are in their released-flange state.
7. The apparatus according to claim 6, wherein:
the apparatus comprises an implant that comprises the valve frame, the leaflets, and the outer frame, and
the apparatus further comprises a tool:
comprising a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in its compressed state, (b) the upstream support portion is in its constrained-arm state, and (c) the legs are in their constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in its compressed state, and
operable from outside the subject to:
transition the implant from its compressed state into the intermediate state while retaining the tubular portion in its compressed state, and
subsequently, expand the tubular portion toward its expanded state.
8. The apparatus according to claim 7, wherein the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state.
9. The apparatus according to claim 7, wherein the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state.
10. The apparatus according to claim 6, wherein the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state moves the flanges longitudinally away from the valve-frame coupling elements.
11. The apparatus according to claim 6, wherein the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state reduces the amplitude of the pattern of the ring and passes the flanges between the arms.
12. The apparatus according to claim 11, wherein the upstream support portion further comprises a covering that covers the arms to form an annular shape in the released-arm state, and wherein, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state presses the flanges onto the covering.
13. The apparatus according to any one of claims 1-5, wherein in the compressed state of the tubular portion, a downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is
disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
14. The apparatus according to claim 13, wherein in the expanded state of the tubular portion, the downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
15. Apparatus for use with a native valve of a heart of a subject, the apparatus comprising an implant that comprises:
a valve frame that comprises a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, a longitudinal length therebetween, and a diameter transverse to the longitudinal axis;
a valve member, coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen;
an upstream support portion, coupled to the tubular portion; and
an outer frame, coupled to the tubular portion, and comprising a tissue-engaging flange,
wherein:
the implant has a first state and a second state,
in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and
the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state:
increases the diameter of the tubular portion by a diameter-increase amount,
decreases the length of the tubular portion by a length-decrease amount, and
moves the flange a longitudinal distance toward or toward-and-beyond the upstream support portion, the distance being greater than the length-decrease amount.
16. The apparatus according to claim 15, wherein the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 20 percent greater than the length-decrease amount.
17. The apparatus according to claim 16, wherein the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 30 percent greater than the length-decrease amount.
18. The apparatus according to claim 17, wherein the tubular portion, the upstream support portion, and the outer frame are arranged such that the longitudinal distance is more than 40 percent greater than the length-decrease amount.
19. Apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, comprising:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state
such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on the coupling points: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) increases the amplitude of the pattern of the ring.
20. The apparatus according to claim 19, wherein the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
21. Apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the valve frame defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame:
comprising a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs,
comprising a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the outer-frame coupling elements with respect to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state
toward the compressed state (i) pulls the outer-frame coupling elements radially inward via radially-inward pulling of the valve-frame coupling elements on the outer-frame coupling elements, (ii) reduces a circumferential distance between each of the outer- frame coupling elements and its adjacent outer-frame coupling elements, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
22. The apparatus according to claim 21, wherein the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
23. Apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis;
a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen;
an outer frame, comprising:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and
the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state
(i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
24. The apparatus according to claim 23, wherein the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
25. Apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, and defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame:
comprising a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end,
comprising a plurality of legs, each of the legs coupled to the ring at a respective trough, and
shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element at a respective coupling point,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the outer-frame coupling elements and its adjacent outer- frame coupling elements, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
26. The apparatus according to claim 25, wherein the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
27. Apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a valve frame, comprising a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end and a downstream end;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen;
an outer frame, comprising:
a ring defined by a pattern of alternating peaks and troughs:
the peaks being longitudinally closer than the troughs to the upstream end,
the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor the downstream end; and
a plurality of legs, each of the legs coupled to the ring at a respective trough,
wherein:
the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
28. The apparatus according to claim 27, wherein the outer frame is coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
29. Apparatus for use with a native valve of a heart of a subject, the apparatus comprising:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and comprising:
a valve frame, comprising:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
wherein the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that increasing the diameter of the tubular portion toward the expanded diameter causes longitudinal movement:
of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point.
30. The apparatus according to claim 29, wherein:
the apparatus comprises an implant that comprises the frame assembly and the valve member, and
the apparatus further comprises a tool:
comprising a delivery capsule dimensioned (i) to house and retain the implant in the compressed state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and
operable from outside the subject to facilitate an increase of the diameter of the tubular portion from the compressed diameter toward the expanded diameter such that the increase of the diameter actuates longitudinal movement:
of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point.
31. The apparatus according to claim 29, wherein the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the upstream end of the tubular portion toward the coupling point.
32. The apparatus according to claim 29, wherein the coupling point is disposed closer to the downstream end of the frame assembly than are either the tissue-engaging flange or the upstream support portion.
33. The apparatus according to claim 29, wherein in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis.
34. The apparatus according to claim 29, wherein:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the leg is expandable into an expanded state of the leg, independently of increasing the diameter of the tubular portion, and
in the expanded state of the leg, the leg extends away from the central longitudinal axis.
35. The apparatus according to claim 29, wherein:
in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis, and
in the compressed state of the frame assembly, the leg is generally parallel with the central longitudinal axis.
36. The apparatus according to claim 29, wherein the frame assembly is configured such that the longitudinal movement of the tissue-engaging flange away from the coupling point is a translational movement of the tissue-engaging flange that does not include rotation of the tissue-engaging flange.
37. The apparatus according to claim 29, wherein the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly
toward the expanded state causes 1-20 mm of longitudinal movement of the tissue- engaging flange away from the coupling point.
38. The apparatus according to claim 29, wherein the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the upstream support portion toward the coupling point.
39. The apparatus according to claim 29, wherein the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state reduces a distance between the upstream support portion and the tissue-engaging flange by 5-30 mm.
40. The apparatus according to claim 29, wherein the frame assembly is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state moves the tissue-engaging flange longitudinally past the upstream support portion.
41. The apparatus according to claim 29, wherein:
the tubular portion is defined by a plurality of cells of the valve frame, and increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state:
comprises (i) increasing a width, orthogonal to the longitudinal axis of the frame assembly, of each cell, and (ii) reducing a height, parallel with the longitudinal axis of the frame assembly, of each cell, and
causes longitudinal movement of the upstream support portion toward the coupling point by reducing a height, parallel with the longitudinal axis of the frame assembly, of the tubular portion, by reducing the height of each cell.
42. The apparatus according to claim 29, wherein the leg is disposed on an outside of the tubular portion.
43. The apparatus according to any one of claims 29-42, wherein:
the at least one leg comprises a plurality of legs,
the coupling point comprises a plurality of coupling points, and
the frame assembly comprises a leg frame that circumscribes the tubular portion, comprises the plurality of legs, and is coupled to the valve frame at the plurality of
coupling points, such that the plurality of legs is distributed circumferentially around the tubular portion.
44. The apparatus according to claim 43, wherein the plurality of coupling points is disposed circumferentially around the frame assembly on a transverse plane that is orthogonal to the longitudinal axis of the frame assembly.
45. The apparatus according to claim 43, wherein the plurality of legs is coupled to the valve frame via a plurality of struts, each strut:
having a first end that is coupled to a leg of the plurality of legs, and a second end that is coupled to a coupling point of the plurality of coupling points,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point of the plurality of coupling points, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
46. The apparatus according to claim 45, wherein the leg frame is structured such that each leg of the plurality of legs is coupled to two struts of the plurality of struts, and two struts of the plurality of struts are coupled to each coupling point of the plurality of coupling points.
47. The apparatus according to any one of claims 29-42, wherein the leg is coupled to the valve frame via a strut, the strut:
having a first end that is coupled to the leg, and a second end that is coupled to the coupling point,
in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and
being deflectable with respect to the coupling point, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
48. The apparatus according to claim 47, wherein the at least one leg comprises at least a first leg and a second leg.
49. The apparatus according to claim 48, wherein the first leg and the second leg are both coupled to the valve frame at the coupling point.
50. The apparatus according to claim 48, wherein the first leg is coupled to the coupling point via a respective first strut, and the second leg is coupled to the coupling point via a respective second strut.
51. The apparatus according to claim 50, wherein the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the coupling point is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the first leg, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the second leg.
52. The apparatus according to claim 47, wherein the coupling point comprises at least a first coupling point and a second coupling point.
53. The apparatus according to claim 52, wherein the leg is coupled to the valve frame at the first coupling point and at the second coupling point.
54. The apparatus according to claim 52, wherein the leg is coupled to the first coupling point via a respective first strut, and to the second coupling point via a respective second strut.
55. The apparatus according to claim 54, wherein the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly:
the leg is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut,
the first strut is disposed, circumferentially with respect to the tubular portion, between the leg and the first coupling point, and
the second strut is disposed, circumferentially with respect to the tubular portion, between the leg and the second coupling point.
56. The apparatus according to any one of claims 29-42, wherein in the expanded state of the frame assembly, the upstream support portion extends radially outward from the tubular portion.
57. The apparatus according to claim 56, wherein:
the expanded state of the frame assembly is a fully-expanded state of the frame assembly,
the upstream support portion is expandable into an expanded state of the upstream support portion, independently of increasing the diameter of the tubular portion, and
in the expanded state of the upstream support portion, the upstream support portion extends radially outward from the tubular portion.
58. The apparatus according to claim 56, wherein in the compressed state of the frame assembly, the upstream support portion is generally tubular, collinear with the tubular portion, and disposed around the central longitudinal axis.
59. The apparatus according to claim 56, wherein in the expanded state of the frame assembly, an inner region of the upstream support portion extends radially outward from the tubular portion at a first angle with respect to the tubular portion, and an outer region of the upstream support portion extends, from the inner region of the upstream support portion, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle.
60. Apparatus for use with a native valve of a heart of a subject, the apparatus comprising:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and comprising:
a valve frame, comprising:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
wherein the frame assembly:
has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter,
is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and
is configured such that reducing the diameter of the tubular portion toward the compressed diameter causes longitudinal movement:
of the upstream support portion away from the coupling point, and of the tissue-engaging flange toward the coupling point.
61. Apparatus for use with a native valve of a heart of a subject, the apparatus comprising:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, comprising:
a valve frame, comprising:
a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and
an upstream support portion, extending from the upstream end of the tubular portion; and
at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and
a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion,
wherein the frame assembly:
has a compressed state, for percutaneous delivery to the heart,
is intracorporeally expandable into an expanded state in which a diameter of the tubular portion is greater than in the compressed state, and
is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the tissue- engaging flange away from the coupling point.
62. Apparatus for use with a native valve of a heart of a subject, the apparatus comprising:
a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and comprising:
an inner frame comprising an inner-frame tubular portion that circumscribes the central longitudinal axis, has an upstream end and a downstream end, and defines a channel therebetween, the inner frame defining a plurality of inner-frame couplings disposed circumferentially at a longitudinal location of the inner frame,
an outer frame comprising an outer-frame tubular portion that coaxially circumscribes at least a portion of the inner-frame tubular portion, the outer frame defining a plurality of outer-frame couplings disposed circumferentially at a longitudinal location of the outer frame, and
a plurality of connectors, each connector connecting a respective inner- frame coupling to a respective outer- frame coupling;
a liner, disposed over at least part of the inner-frame tubular portion; and a plurality of prosthetic leaflets, coupled to the inner-frame tubular portion and disposed within the channel,
wherein:
the frame assembly: (i) is compressible by a radially-compressive force into a compressed state in which the inner frame is in a compressed state thereof and the outer frame is in a compressed state thereof, (ii) is configured, upon removal of the radially- compressive force, to automatically expand into an expanded state thereof in which the inner frame is in an expanded state thereof and the outer frame is in an expanded state thereof,
in the expanded state of the frame assembly, the prosthetic leaflets are configured to facilitate one-way fluid flow, in a downstream direction, through the channel, and
the connection of the inner-frame couplings to the respective outer-frame couplings is such that expansion of the frame assembly from the compressed state to the expanded state causes the inner-frame tubular portion to slide longitudinally in a downstream direction with respect to the outer-frame tubular portion.
63. Apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject, the apparatus comprising:
a tubular portion, having an upstream portion that includes an upstream end, and a downstream portion that includes a downstream end, and shaped to define a lumen between the upstream portion and the downstream portion;
a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood from the upstream portion to the downstream portion; an annular upstream support portion:
having an inner portion that extends radially outward from the upstream portion, and
comprising one or more fabric pockets disposed circumferentially around the inner portion, each pocket of the one or more pockets having an opening that faces a downstream direction.
64. The apparatus according to claim 63, wherein:
the upstream support portion comprises (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the inner portion of the upstream support portion, the covering is closely-fitted between the radially-inner parts of the arms, and
at the outer portion of the upstream support portion, the pockets are formed by the covering being loosely-fitted between the radially-outer parts of the arms.
65. The apparatus according to claim 63, wherein:
the upstream support portion comprises (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, the radially-outer part being more flexible than the radially-inner part.
66. The apparatus according to claim 63, wherein:
the upstream support portion comprises (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the outer portion of the upstream support portion, the pockets are formed by each arm curving to form a hook shape.
67. The apparatus according to claim 63, wherein each pocket is shaped and arranged to billow in response to perivalvular flow of blood in an upstream direction.
68. The apparatus according to any one of claims 63-67, wherein the apparatus is configured to be transluminally delivered to the heart, and implanted at the native valve by expansion of the apparatus, such that the upstream support portion is disposed in the atrium and the tubular portion extends from the upstream support portion into the ventricle, and wherein each pocket is shaped and arranged such that perivalvular flow of blood in an upstream direction presses the pocket against tissue of the atrium.
69. Apparatus comprising:
a plurality of prosthetic valve leaflets; and
a frame assembly, comprising:
a tubular portion defined by a repeating pattern of cells, the tubular portion extending circumferentially around a longitudinal axis so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen;
an outer frame, comprising a plurality of legs, distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange;
an upstream support portion that comprises a plurality of arms that extend radially outward from the tubular portion; and
a plurality of appendages, each having a first end that defines a coupling element via which the tubular portion is coupled to the outer frame, and a second end;
wherein the frame assembly defines a plurality of hubs, distributed circumferentially around the longitudinal axis on a plane that is transverse to the longitudinal axis, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages.
70. The apparatus according to claim 69, wherein each hub has six radiating spokes, two of the six spokes being part of a first cell of the two adjacent cells, two of the six spokes being part of a second cell of the two adjacent cells, one of the six spokes being the arm, and one of the six spokes being the second end of the appendage.
71. The apparatus according to claim 69, wherein the appendages are in-plane with the tubular portion.
72. The apparatus according to claim 69, wherein the appendages are in-plane with the outer frame.
Priority Applications (28)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201680008328.5A CN107205818B (en) | 2015-02-05 | 2016-02-03 | Artificial valve with the frame that slides axially |
US15/541,783 US9974651B2 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
CA2973940A CA2973940C (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
EP16706913.7A EP3253333B1 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
US15/668,659 US10918481B2 (en) | 2015-02-05 | 2017-08-03 | Techniques for deployment of a prosthetic valve |
US15/682,789 US10449047B2 (en) | 2015-02-05 | 2017-08-22 | Prosthetic heart valve with compressible frames |
US15/970,314 US10758344B2 (en) | 2015-02-05 | 2018-05-03 | Prosthetic valve with angularly offset frames |
US15/978,494 US10357360B2 (en) | 2015-02-05 | 2018-05-14 | Prosthetic valve with aligned inner and outer frames |
US15/979,686 US10426610B2 (en) | 2015-02-05 | 2018-05-15 | Prosthetic valve with radially-deflectable tissue anchors |
US15/994,022 US10390952B2 (en) | 2015-02-05 | 2018-05-31 | Prosthetic valve with flexible tissue anchor portions |
US15/995,725 US10682227B2 (en) | 2015-02-05 | 2018-06-01 | Prosthetic valve with pivoting tissue anchor portions |
US16/008,618 US10507105B2 (en) | 2015-02-05 | 2018-06-14 | Prosthetic valve with tissue anchors free from lateral interconnections |
US16/041,208 US10667908B2 (en) | 2015-02-05 | 2018-07-20 | Prosthetic valve with S-shaped tissue anchors |
US16/042,028 US10463487B2 (en) | 2015-02-05 | 2018-07-23 | Prosthetic valve delivery system with independently-movable capsule portions |
US16/042,129 US10463488B2 (en) | 2015-02-05 | 2018-07-23 | Prosthetic valve with separably-deployable valve body and tissue anchors |
US16/507,357 US10524903B2 (en) | 2015-02-05 | 2019-07-10 | Prosthetic valve with aligned inner and outer frames |
US16/520,289 US10888422B2 (en) | 2015-02-05 | 2019-07-23 | Prosthetic valve with flexible tissue anchor portions |
US16/559,365 US10722360B2 (en) | 2015-02-05 | 2019-09-03 | Prosthetic valve with radially-deflectable tissue anchors |
US16/585,349 US10849748B2 (en) | 2015-02-05 | 2019-09-27 | Prosthetic valve delivery system with independently-movable capsule portions |
US16/591,330 US10736742B2 (en) | 2015-02-05 | 2019-10-02 | Prosthetic valve with atrial arms |
US16/660,231 US10864078B2 (en) | 2015-02-05 | 2019-10-22 | Prosthetic valve with separably-deployable valve body and tissue anchors |
US16/678,355 US10973636B2 (en) | 2015-02-05 | 2019-11-08 | Prosthetic valve with tissue anchors free from lateral interconnections |
US16/730,090 US10695177B2 (en) | 2015-02-05 | 2019-12-30 | Prosthetic valve with aligned inner and outer frames |
US16/879,952 US11534298B2 (en) | 2015-02-05 | 2020-05-21 | Prosthetic valve with s-shaped tissue anchors |
US16/896,858 US11793638B2 (en) | 2015-02-05 | 2020-06-09 | Prosthetic valve with pivoting tissue anchor portions |
US16/907,615 US11672658B2 (en) | 2015-02-05 | 2020-06-22 | Prosthetic valve with aligned inner and outer frames |
US17/004,693 US11793635B2 (en) | 2015-02-05 | 2020-08-27 | Prosthetic valve with angularly offset frames |
US17/141,853 US11801135B2 (en) | 2015-02-05 | 2021-01-05 | Techniques for deployment of a prosthetic valve |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562112343P | 2015-02-05 | 2015-02-05 | |
US62/112,343 | 2015-02-05 |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/541,783 Continuation-In-Part US9974651B2 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
PCT/IL2016/050125 Continuation-In-Part WO2016125160A1 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
Related Child Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/541,783 A-371-Of-International US9974651B2 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
PCT/IL2016/050125 Continuation-In-Part WO2016125160A1 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
US15/668,659 Continuation-In-Part US10918481B2 (en) | 2015-02-05 | 2017-08-03 | Techniques for deployment of a prosthetic valve |
US15/682,789 Continuation US10449047B2 (en) | 2015-02-05 | 2017-08-22 | Prosthetic heart valve with compressible frames |
US15/970,314 Continuation US10758344B2 (en) | 2015-02-05 | 2018-05-03 | Prosthetic valve with angularly offset frames |
US15/978,494 Continuation US10357360B2 (en) | 2015-02-05 | 2018-05-14 | Prosthetic valve with aligned inner and outer frames |
US15/979,686 Continuation US10426610B2 (en) | 2015-02-05 | 2018-05-15 | Prosthetic valve with radially-deflectable tissue anchors |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016125160A1 true WO2016125160A1 (en) | 2016-08-11 |
Family
ID=55443277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2016/050125 WO2016125160A1 (en) | 2015-02-05 | 2016-02-03 | Prosthetic valve with axially-sliding frames |
Country Status (5)
Country | Link |
---|---|
US (20) | US10918481B2 (en) |
EP (1) | EP3253333B1 (en) |
CN (2) | CN110141399B (en) |
CA (2) | CA3162308A1 (en) |
WO (1) | WO2016125160A1 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3058631A1 (en) * | 2016-11-14 | 2018-05-18 | Laboratoires Invalv | IMPLANT FOR TREATING A BIOLOGICAL VALVE |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
WO2019026059A1 (en) | 2017-08-03 | 2019-02-07 | Cardiovalve Ltd. | Prosthetic heart valve |
WO2019030753A1 (en) | 2016-08-10 | 2019-02-14 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
USD841812S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
US20190083254A1 (en) * | 2017-09-19 | 2019-03-21 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors configured to exert opposing clamping forces on native valve tissue |
WO2019116369A1 (en) | 2017-12-13 | 2019-06-20 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US10376361B2 (en) | 2011-08-05 | 2019-08-13 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10390952B2 (en) | 2015-02-05 | 2019-08-27 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
WO2019202579A1 (en) | 2018-04-19 | 2019-10-24 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10492908B2 (en) | 2014-07-30 | 2019-12-03 | Cardiovalve Ltd. | Anchoring of a prosthetic valve |
US10500040B2 (en) | 2012-11-13 | 2019-12-10 | Cardiovalve Ltd. | Percutaneously-deliverable dual-frame valve |
US10512456B2 (en) | 2010-07-21 | 2019-12-24 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10548726B2 (en) | 2009-12-08 | 2020-02-04 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10631982B2 (en) | 2013-01-24 | 2020-04-28 | Cardiovale Ltd. | Prosthetic valve and upstream support therefor |
US10702385B2 (en) | 2011-08-05 | 2020-07-07 | Cardiovalve Ltd. | Implant for heart valve |
US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10952850B2 (en) | 2016-08-01 | 2021-03-23 | Cardiovalve Ltd. | Minimally-invasive delivery systems |
US11065122B2 (en) | 2017-10-19 | 2021-07-20 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
EP3570779B1 (en) | 2017-01-23 | 2023-02-15 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11633277B2 (en) | 2018-01-10 | 2023-04-25 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US12029646B2 (en) | 2017-08-03 | 2024-07-09 | Cardiovalve Ltd. | Prosthetic heart valve |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3593760B1 (en) | 2004-10-02 | 2021-03-31 | Edwards Lifesciences CardiAQ LLC | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support (ii) |
EP1951352B1 (en) | 2005-11-10 | 2017-01-11 | Edwards Lifesciences CardiAQ LLC | Balloon-expandable, self-expanding, vascular prosthesis connecting stent |
WO2008013915A2 (en) | 2006-07-28 | 2008-01-31 | Arshad Quadri | Percutaneous valve prosthesis and system and method for implanting same |
WO2010037141A1 (en) | 2008-09-29 | 2010-04-01 | Cardiaq Valve Technologies, Inc. | Heart valve |
US8925181B2 (en) * | 2009-03-24 | 2015-01-06 | Travel Caddy, Inc. | Cut-proof anti-theft bag construction |
EP2419050B2 (en) | 2009-04-15 | 2023-10-18 | Edwards Lifesciences CardiAQ LLC | Vascular implant and delivery system |
US8652203B2 (en) | 2010-09-23 | 2014-02-18 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
WO2011163275A2 (en) | 2010-06-21 | 2011-12-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valve |
US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
WO2015127283A1 (en) | 2014-02-21 | 2015-08-27 | Cardiaq Valve Technologies, Inc. | Delivery device for controlled deployement of a replacement valve |
WO2015179423A1 (en) | 2014-05-19 | 2015-11-26 | Cardiaq Valve Technologies, Inc. | Replacement mitral valve with annular flap |
WO2016154166A1 (en) * | 2015-03-24 | 2016-09-29 | St. Jude Medical, Cardiology Division, Inc. | Prosthetic mitral valve |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3307207A1 (en) * | 2015-06-12 | 2018-04-18 | St. Jude Medical, Cardiology Division, Inc. | Heart valve repair and replacement |
WO2016209970A1 (en) | 2015-06-22 | 2016-12-29 | Edwards Lifescience Cardiaq Llc | Actively controllable heart valve implant and methods of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
US10575951B2 (en) | 2015-08-26 | 2020-03-03 | Edwards Lifesciences Cardiaq Llc | Delivery device and methods of use for transapical delivery of replacement mitral valve |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
WO2017117109A1 (en) | 2015-12-28 | 2017-07-06 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
DE102016106575A1 (en) * | 2016-04-11 | 2017-10-12 | Biotronik Ag | Heart valve prosthesis |
US10350062B2 (en) * | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
EP4209196A1 (en) * | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US12029647B2 (en) | 2017-03-07 | 2024-07-09 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
CN110602997B (en) * | 2017-05-01 | 2023-05-05 | 血管移植解决方案有限公司 | Instrument and method for use in surgical vascular anastomosis procedures |
CN114631913A (en) * | 2017-05-22 | 2022-06-17 | 爱德华兹生命科学公司 | Valve anchors and methods of installation |
US12036113B2 (en) | 2017-06-14 | 2024-07-16 | 4C Medical Technologies, Inc. | Delivery of heart chamber prosthetic valve implant |
WO2019010303A1 (en) | 2017-07-06 | 2019-01-10 | Edwards Lifesciences Corporation | Steerable delivery system and components |
US10722349B2 (en) * | 2017-12-07 | 2020-07-28 | Medtronic Vascular, Inc. | Adjustable prosthetic heart valve |
CN110013356B (en) * | 2018-01-07 | 2023-08-01 | 苏州杰成医疗科技有限公司 | Heart valve prosthesis delivery system |
CN118044923A (en) * | 2018-01-16 | 2024-05-17 | 迈德福瑞公司 | Tissue grasping device and related method |
US10874513B2 (en) * | 2018-02-12 | 2020-12-29 | 4C Medical Technologies, Inc. | Expandable frames and paravalvular leak mitigation systems for implantable prosthetic heart valve devices |
US11051934B2 (en) | 2018-02-28 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic mitral valve with improved anchors and seal |
CN108578016B (en) * | 2018-04-26 | 2020-09-08 | 赛诺医疗科学技术股份有限公司 | Trans-apex implantable mitral valve device |
CN108904101A (en) * | 2018-06-29 | 2018-11-30 | 金仕生物科技(常熟)有限公司 | Intervene valve component, the fixed device of intervention valve and its application |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US11648115B2 (en) * | 2018-10-03 | 2023-05-16 | Edwards Lifesciences Corporation | Expandable introducer sheath |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US12053375B2 (en) | 2020-03-05 | 2024-08-06 | 4C Medical Technologies, Inc. | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation |
US11992403B2 (en) | 2020-03-06 | 2024-05-28 | 4C Medical Technologies, Inc. | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells |
WO2022012010A1 (en) * | 2020-07-15 | 2022-01-20 | 上海臻亿医疗科技有限公司 | Heart valve prosthesis |
US20240074853A1 (en) * | 2021-10-12 | 2024-03-07 | Laguna Tech Usa, Inc. | Prosthetic heart valve device, delivery system, interventional system and related method |
KR20240121823A (en) * | 2021-12-13 | 2024-08-09 | 캡스턴 메디컬 인크. | Systems, devices, and methods having stent frame features |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029296A2 (en) * | 2006-02-16 | 2008-03-13 | Endocor Pte Ltd. | Minimally invasive heart valve replacement |
WO2013059747A1 (en) * | 2011-10-19 | 2013-04-25 | Foundry Newco Xii, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US20140222136A1 (en) * | 2013-02-04 | 2014-08-07 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2014164364A1 (en) * | 2013-03-13 | 2014-10-09 | Aortic Innovations, Llc | Dual frame stent and valve devices and implantation |
US20140358224A1 (en) * | 2013-05-30 | 2014-12-04 | Tendyne Holdlings, Inc. | Six cell inner stent device for prosthetic mitral valves |
Family Cites Families (1367)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL143127B (en) | 1969-02-04 | 1974-09-16 | Rhone Poulenc Sa | REINFORCEMENT DEVICE FOR A DEFECTIVE HEART VALVE. |
US3604488A (en) | 1969-11-19 | 1971-09-14 | Vermont American Corp | Screwdriver attachment |
US3840018A (en) | 1973-01-31 | 1974-10-08 | M Heifetz | Clamp for occluding tubular conduits in the human body |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3898701A (en) | 1974-01-17 | 1975-08-12 | Russa Joseph | Implantable heart valve |
US4340091A (en) | 1975-05-07 | 1982-07-20 | Albany International Corp. | Elastomeric sheet materials for heart valve and other prosthetic implants |
US4042979A (en) | 1976-07-12 | 1977-08-23 | Angell William W | Valvuloplasty ring and prosthetic method |
US4118805A (en) | 1977-02-28 | 1978-10-10 | Codman & Shurtleff, Inc. | Artificial sphincter |
ES474582A1 (en) | 1978-10-26 | 1979-11-01 | Aranguren Duo Iker | Process for installing mitral valves in their anatomical space by attaching cords to an artificial stent |
US4214349A (en) | 1978-11-30 | 1980-07-29 | Midland-Ross Corporation | Tie wrap |
US4222126A (en) | 1978-12-14 | 1980-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare | Unitized three leaflet heart valve |
US4275469A (en) | 1979-12-13 | 1981-06-30 | Shelhigh Inc. | Prosthetic heart valve |
GB2084468B (en) | 1980-09-25 | 1984-06-06 | South African Inventions | Surgical implant |
US4473928A (en) | 1980-11-20 | 1984-10-02 | Tridon Limited | Hose clamps |
IT1144379B (en) | 1981-07-14 | 1986-10-29 | Sorin Biomedica Spa | CARDIAC VALVE PROSTHESIS |
DE3230858C2 (en) | 1982-08-19 | 1985-01-24 | Ahmadi, Ali, Dr. med., 7809 Denzlingen | Ring prosthesis |
US4892541A (en) | 1982-11-29 | 1990-01-09 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4434828A (en) | 1982-12-20 | 1984-03-06 | Richard Trincia | Screwdriver with handle for storing bits |
JPS6137235A (en) | 1984-07-31 | 1986-02-22 | テルモ株式会社 | Artificial valve |
US4625727A (en) | 1985-01-24 | 1986-12-02 | Leiboff Arnold R | Anastomosis device with excisable frame |
US4712549A (en) | 1985-07-01 | 1987-12-15 | Edward Weck & Co. | Automatic hemostatic clip applier |
US4853986A (en) | 1986-01-02 | 1989-08-08 | The Awareness Marketing Corporation | Water level control |
CA1303298C (en) | 1986-08-06 | 1992-06-16 | Alain Carpentier | Flexible cardiac valvular support prosthesis |
US4961738A (en) | 1987-01-28 | 1990-10-09 | Mackin Robert A | Angioplasty catheter with illumination and visualization within angioplasty balloon |
US4972494A (en) | 1988-02-26 | 1990-11-20 | R. J. Reynolds Tobacco Company | Package inspection system |
DE3831196A1 (en) | 1988-09-14 | 1990-03-22 | Bosch Gmbh Robert | ELECTROMAGNETICALLY ACTUABLE VALVE |
US4917698A (en) | 1988-12-22 | 1990-04-17 | Baxter International Inc. | Multi-segmented annuloplasty ring prosthesis |
CH678393A5 (en) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
CA2049971C (en) | 1989-02-13 | 2001-08-21 | Hung L. Lam | Selectively flexible annuloplasty ring |
US4994077A (en) | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5314473A (en) | 1989-07-20 | 1994-05-24 | Godin Norman J | Prosthesis for preventing gastric reflux into the esophagus |
US5290300A (en) | 1989-07-31 | 1994-03-01 | Baxter International Inc. | Flexible suture guide and holder |
US5632746A (en) | 1989-08-16 | 1997-05-27 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5078739A (en) | 1990-07-20 | 1992-01-07 | Janus Biomedical, Inc. | Bileaflet heart valve with external leaflets |
SE467459B (en) | 1990-09-25 | 1992-07-20 | Allset Marine Lashing Ab | WIRELESS BEFORE HEARING CHARGES TO CONTAINERS |
US5626609A (en) | 1990-10-05 | 1997-05-06 | United States Surgical Corporation | Endoscopic surgical instrument |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5329923A (en) | 1991-02-15 | 1994-07-19 | Lundquist Ingemar H | Torquable catheter |
US5397351A (en) | 1991-05-13 | 1995-03-14 | Pavcnik; Dusan | Prosthetic valve for percutaneous insertion |
DE69229604T2 (en) | 1991-11-29 | 2000-03-02 | William Cook Europe A/S, Bjaeverskov | CLOSURE PROSTHESIS FOR CATHETER PLACEMENT |
US5201880A (en) | 1992-01-27 | 1993-04-13 | Pioneering Technologies, Inc. | Mitral and tricuspid annuloplasty rings |
US5306296A (en) | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
CA2127701C (en) | 1992-01-27 | 1999-06-15 | John T. M. Wright | Annuloplasty and suture rings |
FR2688401B1 (en) | 1992-03-12 | 1998-02-27 | Thierry Richard | EXPANDABLE STENT FOR HUMAN OR ANIMAL TUBULAR MEMBER, AND IMPLEMENTATION TOOL. |
US5201757A (en) | 1992-04-03 | 1993-04-13 | Schneider (Usa) Inc. | Medial region deployment of radially self-expanding stents |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5405378A (en) | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5325845A (en) | 1992-06-08 | 1994-07-05 | Adair Edwin Lloyd | Steerable sheath for use with selected removable optical catheter |
US5300034A (en) | 1992-07-29 | 1994-04-05 | Minnesota Mining And Manufacturing Company | Iv injection site for the reception of a blunt cannula |
US5258008A (en) | 1992-07-29 | 1993-11-02 | Wilk Peter J | Surgical stapling device and associated method |
US6074417A (en) | 1992-11-16 | 2000-06-13 | St. Jude Medical, Inc. | Total mitral heterologous bioprosthesis to be used in mitral or tricuspid heart replacement |
US6283127B1 (en) | 1992-12-03 | 2001-09-04 | Wesley D. Sterman | Devices and methods for intracardiac procedures |
US6010531A (en) | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5972030A (en) | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
US6125852A (en) | 1993-02-22 | 2000-10-03 | Heartport, Inc. | Minimally-invasive devices and methods for treatment of congestive heart failure |
US6346074B1 (en) | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5374286A (en) | 1993-03-31 | 1994-12-20 | Medtronic, Inc. | Torque indicator for fixed screw leads |
US5715817A (en) | 1993-06-29 | 1998-02-10 | C.R. Bard, Inc. | Bidirectional steering catheter |
US5450860A (en) | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
US5651785A (en) | 1993-09-20 | 1997-07-29 | Abela Laser Systems, Inc. | Optical fiber catheter and method |
US5713950A (en) | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
US5607444A (en) | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
AU1011595A (en) | 1994-01-13 | 1995-07-20 | Ethicon Inc. | Spiral surgical tack |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US6217610B1 (en) | 1994-07-29 | 2001-04-17 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
US5582616A (en) | 1994-08-05 | 1996-12-10 | Origin Medsystems, Inc. | Surgical helical fastener with applicator |
US5593424A (en) | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5765682A (en) | 1994-10-13 | 1998-06-16 | Menlo Care, Inc. | Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same |
US5647857A (en) | 1995-03-16 | 1997-07-15 | Endotex Interventional Systems, Inc. | Protective intraluminal sheath |
US5607470A (en) | 1995-05-01 | 1997-03-04 | Milo; Simcha | Suture rings for prosthetic heart valves |
WO1996040006A1 (en) | 1995-06-07 | 1996-12-19 | St. Jude Medical, Inc. | Adjustable sizing apparatus for heart annulus |
US6010530A (en) | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US5716417A (en) | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
US5676653A (en) | 1995-06-27 | 1997-10-14 | Arrow International Investment Corp. | Kink-resistant steerable catheter assembly |
US5713948A (en) | 1995-07-19 | 1998-02-03 | Uflacker; Renan | Adjustable and retrievable graft and graft delivery system for stent-graft system |
US5662683A (en) | 1995-08-22 | 1997-09-02 | Ortho Helix Limited | Open helical organic tissue anchor and method of facilitating healing |
US6193745B1 (en) | 1995-10-03 | 2001-02-27 | Medtronic, Inc. | Modular intraluminal prosteheses construction and methods |
US5749371A (en) | 1995-10-06 | 1998-05-12 | Zadini; Filiberto P. | Automatic guidewire placement device for medical catheters |
AU720907B2 (en) | 1995-12-01 | 2000-06-15 | Medtronic, Inc. | Annuloplasty prosthesis |
US5730150A (en) | 1996-01-16 | 1998-03-24 | B. Braun Medical Inc. | Guidewire dispenser |
EP0932426A4 (en) | 1996-02-02 | 2003-07-30 | Transvascular Inc | Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures |
US5957953A (en) | 1996-02-16 | 1999-09-28 | Smith & Nephew, Inc. | Expandable suture anchor |
US5702397A (en) | 1996-02-20 | 1997-12-30 | Medicinelodge, Inc. | Ligament bone anchor and method for its use |
US5716370A (en) | 1996-02-23 | 1998-02-10 | Williamson, Iv; Warren | Means for replacing a heart valve in a minimally invasive manner |
US6402780B2 (en) | 1996-02-23 | 2002-06-11 | Cardiovascular Technologies, L.L.C. | Means and method of replacing a heart valve in a minimally invasive manner |
US6132390A (en) | 1996-02-28 | 2000-10-17 | Eupalamus Llc | Handle for manipulation of a stylet used for deflecting a tip of a lead or catheter |
US6702846B2 (en) | 1996-04-09 | 2004-03-09 | Endocare, Inc. | Urological stent therapy system and method |
US5885228A (en) | 1996-05-08 | 1999-03-23 | Heartport, Inc. | Valve sizer and method of use |
US6007544A (en) | 1996-06-14 | 1999-12-28 | Beth Israel Deaconess Medical Center | Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo |
US5776140A (en) | 1996-07-16 | 1998-07-07 | Cordis Corporation | Stent delivery system |
US6569188B2 (en) | 1996-08-05 | 2003-05-27 | Arthrex, Inc. | Hex drive bioabsorbable tissue anchor |
US5669919A (en) | 1996-08-16 | 1997-09-23 | Medtronic, Inc. | Annuloplasty system |
US5741297A (en) | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5830221A (en) | 1996-09-20 | 1998-11-03 | United States Surgical Corporation | Coil fastener applier |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US5716397A (en) | 1996-12-06 | 1998-02-10 | Medtronic, Inc. | Annuloplasty device with removable stiffening element |
EP1014895B1 (en) | 1996-12-10 | 2006-03-08 | Purdue Research Foundation | Artificial vascular valves |
US6364901B1 (en) | 1996-12-20 | 2002-04-02 | Kanji Inoue | Appliance collapsible for insertion into a human organ and capable of resilient restoration |
US5935098A (en) | 1996-12-23 | 1999-08-10 | Conceptus, Inc. | Apparatus and method for accessing and manipulating the uterus |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US5961440A (en) | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6074401A (en) | 1997-01-09 | 2000-06-13 | Coalescent Surgical, Inc. | Pinned retainer surgical fasteners, instruments and methods for minimally invasive vascular and endoscopic surgery |
US5961539A (en) | 1997-01-17 | 1999-10-05 | Segmed, Inc. | Method and apparatus for sizing, stabilizing and/or reducing the circumference of an anatomical structure |
DE69831935T2 (en) | 1997-01-24 | 2006-07-27 | Paragon Intellectual Properties, LLC, Charleston | BISTABLE SPRING CONSTRUCTION FOR A STENT |
US5702398A (en) | 1997-02-21 | 1997-12-30 | Tarabishy; Sam | Tension screw |
US5961549A (en) | 1997-04-03 | 1999-10-05 | Baxter International Inc. | Multi-leaflet bioprosthetic heart valve |
US5876373A (en) | 1997-04-04 | 1999-03-02 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
EP1006905A1 (en) | 1997-04-11 | 2000-06-14 | Taccor, Inc. | Steerable catheter with rotatable tip electrode and method of use |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6409755B1 (en) | 1997-05-29 | 2002-06-25 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
EP2133030A1 (en) | 1997-06-27 | 2009-12-16 | The Trustees of Columbia University of the City of New York | Method and apparatus for circulatory valve repair |
EP1009332A2 (en) | 1997-09-04 | 2000-06-21 | Endocore, Inc. | Artificial chordae replacement |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US5954766A (en) | 1997-09-16 | 1999-09-21 | Zadno-Azizi; Gholam-Reza | Body fluid flow control device |
US5984959A (en) | 1997-09-19 | 1999-11-16 | United States Surgical | Heart valve replacement tools and procedures |
US6206888B1 (en) | 1997-10-01 | 2001-03-27 | Scimed Life Systems, Inc. | Stent delivery system using shape memory retraction |
US5980565A (en) | 1997-10-20 | 1999-11-09 | Iowa-India Investments Company Limited | Sandwich stent |
US6120534A (en) | 1997-10-29 | 2000-09-19 | Ruiz; Carlos E. | Endoluminal prosthesis having adjustable constriction |
US6174332B1 (en) | 1997-12-05 | 2001-01-16 | St. Jude Medical, Inc. | Annuloplasty ring with cut zone |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
DE69841333D1 (en) | 1997-12-29 | 2010-01-07 | Cleveland Clinic Foundation | SYSTEM FOR THE MINIMAL INVASIVE INTRODUCTION OF A HEARTLAP BIOPROTHESIS |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US6251092B1 (en) | 1997-12-30 | 2001-06-26 | Medtronic, Inc. | Deflectable guiding catheter |
AU1923999A (en) | 1998-01-30 | 1999-08-16 | Vascular Science Inc. | Medical graft connector or plug structures, and methods of making and installingsame |
US6533807B2 (en) | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
EP2280398A3 (en) | 1998-02-23 | 2011-03-09 | Kabushiki Kaisha Toshiba | Information storage medium, information playback method and apparatus and information recording method |
US20020087048A1 (en) | 1998-02-24 | 2002-07-04 | Brock David L. | Flexible instrument |
FR2777446B1 (en) | 1998-04-17 | 2000-12-01 | Perouse Implant Lab | LINK FOR ANASTOMOSIS, FASTENING DEVICE AND IMPLANT COMPRISING SAME |
US6074418A (en) | 1998-04-20 | 2000-06-13 | St. Jude Medical, Inc. | Driver tool for heart valve prosthesis fasteners |
US6059827A (en) | 1998-05-04 | 2000-05-09 | Axya Medical, Inc. | Sutureless cardiac valve prosthesis, and devices and methods for implanting them |
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
US6143024A (en) | 1998-06-04 | 2000-11-07 | Sulzer Carbomedics Inc. | Annuloplasty ring having flexible anterior portion |
US6250308B1 (en) | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6106550A (en) | 1998-07-10 | 2000-08-22 | Sulzer Carbomedics Inc. | Implantable attaching ring |
US7569062B1 (en) | 1998-07-15 | 2009-08-04 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6264700B1 (en) | 1998-08-27 | 2001-07-24 | Endonetics, Inc. | Prosthetic gastroesophageal valve |
US6159240A (en) | 1998-08-31 | 2000-12-12 | Medtronic, Inc. | Rigid annuloplasty device that becomes compliant after implantation |
FR2783153B1 (en) | 1998-09-14 | 2000-12-01 | Jerome Dargent | GASTRIC CONSTRICTION DEVICE |
US6334873B1 (en) | 1998-09-28 | 2002-01-01 | Autogenics | Heart valve having tissue retention with anchors and an outer sheath |
US6102945A (en) | 1998-10-16 | 2000-08-15 | Sulzer Carbomedics, Inc. | Separable annuloplasty ring |
US6152937A (en) | 1998-11-06 | 2000-11-28 | St. Jude Medical Cardiovascular Group, Inc. | Medical graft connector and methods of making and installing same |
US6113612A (en) | 1998-11-06 | 2000-09-05 | St. Jude Medical Cardiovascular Group, Inc. | Medical anastomosis apparatus |
US20040267349A1 (en) | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
US6254609B1 (en) | 1999-01-11 | 2001-07-03 | Scimed Life Systems, Inc. | Self-expanding stent delivery system with two sheaths |
AU771852B2 (en) | 1999-01-26 | 2004-04-01 | Edwards Lifesciences Corporation | Anatomical orifice sizers and methods of orifice sizing |
US6736845B2 (en) | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
US6558418B2 (en) | 1999-01-26 | 2003-05-06 | Edwards Lifesciences Corporation | Flexible heart valve |
US6315784B1 (en) | 1999-02-03 | 2001-11-13 | Zarija Djurovic | Surgical suturing unit |
US6425916B1 (en) | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
DE19910233A1 (en) | 1999-03-09 | 2000-09-21 | Jostra Medizintechnik Ag | Anuloplasty prosthesis |
AU3729400A (en) | 1999-03-09 | 2000-09-28 | St. Jude Medical Cardiovascular Group, Inc. | Medical grafting methods and apparatus |
US6319281B1 (en) | 1999-03-22 | 2001-11-20 | Kumar R. Patel | Artificial venous valve and sizing catheter |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
EP2078498B1 (en) | 1999-04-09 | 2010-12-22 | Evalve, Inc. | Apparatus for cardiac valve repair |
US7666204B2 (en) | 1999-04-09 | 2010-02-23 | Evalve, Inc. | Multi-catheter steerable guiding system and methods of use |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
WO2006116558A2 (en) | 1999-04-09 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US6183512B1 (en) | 1999-04-16 | 2001-02-06 | Edwards Lifesciences Corporation | Flexible annuloplasty system |
US6231602B1 (en) | 1999-04-16 | 2001-05-15 | Edwards Lifesciences Corporation | Aortic annuloplasty ring |
US20050222665A1 (en) | 1999-04-23 | 2005-10-06 | Ernest Aranyi | Endovascular fastener applicator |
WO2000064385A1 (en) | 1999-04-26 | 2000-11-02 | Li Medical Technologies, Inc. | Prosthetic apparatus and method |
US6674993B1 (en) | 1999-04-30 | 2004-01-06 | Microvision, Inc. | Method and system for identifying data locations associated with real world observations |
US6187040B1 (en) | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
US6558396B1 (en) | 1999-05-06 | 2003-05-06 | Kanji Inoue | Apparatus for folding instrument and use of the same apparatus |
US6964686B2 (en) | 1999-05-17 | 2005-11-15 | Vanderbilt University | Intervertebral disc replacement prosthesis |
US6428550B1 (en) | 1999-05-18 | 2002-08-06 | Cardica, Inc. | Sutureless closure and deployment system for connecting blood vessels |
US6790229B1 (en) | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
US6287339B1 (en) | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
US7628803B2 (en) | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
US6699256B1 (en) | 1999-06-04 | 2004-03-02 | St. Jude Medical Atg, Inc. | Medical grafting apparatus and methods |
US6602289B1 (en) | 1999-06-08 | 2003-08-05 | S&A Rings, Llc | Annuloplasty rings of particular use in surgery for the mitral valve |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
SE514718C2 (en) | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US6193686B1 (en) | 1999-06-30 | 2001-02-27 | Advanced Cardiovascular Systems, Inc. | Catheter with enhanced flexibility |
US6997951B2 (en) | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6312465B1 (en) | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US7462162B2 (en) | 2001-09-04 | 2008-12-09 | Broncus Technologies, Inc. | Antiproliferative devices for maintaining patency of surgically created channels in a body organ |
US6592609B1 (en) | 1999-08-09 | 2003-07-15 | Bonutti 2003 Trust-A | Method and apparatus for securing tissue |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
JP3553432B2 (en) | 1999-09-24 | 2004-08-11 | 本田技研工業株式会社 | Riding simulation device |
US6533806B1 (en) | 1999-10-01 | 2003-03-18 | Scimed Life Systems, Inc. | Balloon yielded delivery system and endovascular graft design for easy deployment |
FR2799364B1 (en) | 1999-10-12 | 2001-11-23 | Jacques Seguin | MINIMALLY INVASIVE CANCELING DEVICE |
US6626930B1 (en) | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
US6440164B1 (en) | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
WO2001030245A1 (en) | 1999-10-26 | 2001-05-03 | H Randall Craig | Helical suture instrument |
AUPQ366099A0 (en) | 1999-10-26 | 1999-11-18 | Queensland University Of Technology | Ortho paedic screw |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
KR20010046894A (en) | 1999-11-16 | 2001-06-15 | 오태준 | Electric razor |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US20070043435A1 (en) | 1999-11-17 | 2007-02-22 | Jacques Seguin | Non-cylindrical prosthetic valve system for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US6911032B2 (en) | 1999-11-18 | 2005-06-28 | Scimed Life Systems, Inc. | Apparatus and method for compressing body tissue |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6711444B2 (en) | 1999-11-22 | 2004-03-23 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US6602263B1 (en) | 1999-11-30 | 2003-08-05 | St. Jude Medical Atg, Inc. | Medical grafting methods and apparatus |
EP1108400A1 (en) | 1999-12-13 | 2001-06-20 | Biomedix S.A. | Removable fixation apparatus for a prosthesis in a body vessel |
US6494908B1 (en) | 1999-12-22 | 2002-12-17 | Ethicon, Inc. | Removable stent for body lumens |
US7169187B2 (en) | 1999-12-22 | 2007-01-30 | Ethicon, Inc. | Biodegradable stent |
WO2001050985A1 (en) | 2000-01-14 | 2001-07-19 | Viacor Incorporated | Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same |
NL1014095C2 (en) | 2000-01-17 | 2001-07-18 | Cornelis Hendrikus Anna Witten | Implant valve for implantation into a blood vessel. |
US6769434B2 (en) | 2000-06-30 | 2004-08-03 | Viacor, Inc. | Method and apparatus for performing a procedure on a cardiac valve |
US7011682B2 (en) | 2000-01-31 | 2006-03-14 | Edwards Lifesciences Ag | Methods and apparatus for remodeling an extravascular tissue structure |
US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
EP1255510B3 (en) | 2000-01-31 | 2009-03-04 | Cook Biotech, Inc. | Stent valves |
US6458076B1 (en) | 2000-02-01 | 2002-10-01 | 5 Star Medical | Multi-lumen medical device |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US6821297B2 (en) | 2000-02-02 | 2004-11-23 | Robert V. Snyders | Artificial heart valve, implantation instrument and method therefor |
AU2001233227A1 (en) | 2000-02-02 | 2001-08-14 | Robert V. Snyders | Artificial heart valve |
US20050070999A1 (en) | 2000-02-02 | 2005-03-31 | Spence Paul A. | Heart valve repair apparatus and methods |
US6470892B1 (en) | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Mechanical heartburn and reflux treatment |
DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
US7993368B2 (en) | 2003-03-13 | 2011-08-09 | C.R. Bard, Inc. | Suture clips, delivery devices and methods |
US8474460B2 (en) | 2000-03-04 | 2013-07-02 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
CA2403718A1 (en) | 2000-03-17 | 2001-09-27 | Panacos Pharmaceuticals, Inc. | A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins |
US6953476B1 (en) | 2000-03-27 | 2005-10-11 | Neovasc Medical Ltd. | Device and method for treating ischemic heart disease |
IL153753A0 (en) | 2002-12-30 | 2003-07-06 | Neovasc Medical Ltd | Varying-diameter vascular implant and balloon |
US6569198B1 (en) | 2000-03-31 | 2003-05-27 | Richard A. Wilson | Mitral or tricuspid valve annuloplasty prosthetic device |
US6689125B1 (en) | 2000-04-04 | 2004-02-10 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6533772B1 (en) | 2000-04-07 | 2003-03-18 | Innex Corporation | Guide wire torque device |
US20020049490A1 (en) | 2000-04-11 | 2002-04-25 | Pollock David T. | Single-piece endoprosthesis with high expansion ratios |
US6497713B1 (en) | 2000-04-28 | 2002-12-24 | Autogenics | Rotary tissue cutting die |
US7083628B2 (en) | 2002-09-03 | 2006-08-01 | Edwards Lifesciences Corporation | Single catheter mitral valve repair device and method for use |
US6610088B1 (en) | 2000-05-03 | 2003-08-26 | Shlomo Gabbay | Biologically covered heart valve prosthesis |
WO2001087190A2 (en) | 2000-05-17 | 2001-11-22 | St. Jude Medical, Inc. | Two piece bioprosthetic heart valve |
US7220266B2 (en) | 2000-05-19 | 2007-05-22 | C. R. Bard, Inc. | Tissue capturing and suturing device and method |
WO2001089426A1 (en) | 2000-05-25 | 2001-11-29 | Bioring S.A. | Device for shrinking or reinforcing the heart valvular orifices |
US8366769B2 (en) | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
US6406493B1 (en) | 2000-06-02 | 2002-06-18 | Hosheng Tu | Expandable annuloplasty ring and methods of use |
US6805711B2 (en) | 2000-06-02 | 2004-10-19 | 3F Therapeutics, Inc. | Expandable medical implant and percutaneous delivery |
US7632303B1 (en) | 2000-06-07 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Variable stiffness medical devices |
US6478807B1 (en) | 2000-06-08 | 2002-11-12 | Advanced Cardiovascular Systems, Inc. | Pre-formed expandable member having grooves |
SE522805C2 (en) | 2000-06-22 | 2004-03-09 | Jan Otto Solem | Stent Application System |
EP1330189B1 (en) | 2000-06-23 | 2007-12-19 | Viacor Incorporated | Automated annular plication for mitral valve repair |
US6676698B2 (en) | 2000-06-26 | 2004-01-13 | Rex Medicol, L.P. | Vascular device with valve for approximating vessel wall |
US7144414B2 (en) | 2000-06-27 | 2006-12-05 | Smith & Nephew, Inc. | Surgical procedures and instruments |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US7077861B2 (en) | 2000-07-06 | 2006-07-18 | Medtentia Ab | Annuloplasty instrument |
US6613078B1 (en) | 2000-08-02 | 2003-09-02 | Hector Daniel Barone | Multi-component endoluminal graft assembly, use thereof and method of implanting |
SE0002878D0 (en) | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
US6524338B1 (en) | 2000-08-25 | 2003-02-25 | Steven R. Gundry | Method and apparatus for stapling an annuloplasty band in-situ |
WO2002019951A1 (en) | 2000-09-07 | 2002-03-14 | Viacor, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US7510572B2 (en) | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
US6554845B1 (en) | 2000-09-15 | 2003-04-29 | PARÉ Surgical, Inc. | Suturing apparatus and method |
US6893459B1 (en) | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
US20080091264A1 (en) | 2002-11-26 | 2008-04-17 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US20060106278A1 (en) | 2004-05-14 | 2006-05-18 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system |
US8784482B2 (en) | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
WO2004030570A2 (en) | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Devices for retaining native heart valve leaflet |
US20090287179A1 (en) | 2003-10-01 | 2009-11-19 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US6602288B1 (en) | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6918917B1 (en) | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US20020082525A1 (en) | 2000-10-18 | 2002-06-27 | Oslund John C. | Rapid exchange delivery catheter |
US6913608B2 (en) | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US6491711B1 (en) | 2000-11-14 | 2002-12-10 | Advanced Cardiovascular Systems, Inc. | Balloon catheter with non-circular balloon taper and method of use |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6974476B2 (en) | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US6884257B1 (en) | 2000-11-28 | 2005-04-26 | Advanced Cardiovascular Systems, Inc. | Stent delivery system with adjustable length balloon |
US7211101B2 (en) | 2000-12-07 | 2007-05-01 | Abbott Vascular Devices | Methods for manufacturing a clip and clip |
US6695867B2 (en) | 2002-02-21 | 2004-02-24 | Integrated Vascular Systems, Inc. | Plunger apparatus and methods for delivering a closure device |
US6623510B2 (en) | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US6716244B2 (en) | 2000-12-20 | 2004-04-06 | Carbomedics, Inc. | Sewing cuff assembly for heart valves |
US7591826B2 (en) | 2000-12-28 | 2009-09-22 | Cardiac Dimensions, Inc. | Device implantable in the coronary sinus to provide mitral valve therapy |
US7510576B2 (en) | 2001-01-30 | 2009-03-31 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
JP4097924B2 (en) | 2001-02-05 | 2008-06-11 | オリンパス株式会社 | Biological tissue clip device |
EP1363559A4 (en) | 2001-02-05 | 2008-10-01 | Viacor Inc | Apparatus and method for reducing mitral regurgitation |
US20050182483A1 (en) | 2004-02-11 | 2005-08-18 | Cook Incorporated | Percutaneously placed prosthesis with thromboresistant valve portion |
US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US6786924B2 (en) | 2001-03-15 | 2004-09-07 | Medtronic, Inc. | Annuloplasty band and method |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US7374571B2 (en) | 2001-03-23 | 2008-05-20 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of manufacture |
AUPR389201A0 (en) | 2001-03-23 | 2001-04-12 | Lane, Rodney James | Improvements in design of external vendus valve stents for the correction fo incompetent vendods valves |
US7186264B2 (en) | 2001-03-29 | 2007-03-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
EP1383557B1 (en) | 2001-04-02 | 2008-05-21 | Bladder Management Systems, LLC. | Conformable balloonless catheter |
US6958076B2 (en) | 2001-04-16 | 2005-10-25 | Biomedical Research Associates Inc. | Implantable venous valve |
DE10119096A1 (en) | 2001-04-19 | 2002-10-24 | Keramed Medizintechnik Gmbh | New biologically functionalized coatings, useful for e.g. accelerating osteo-integration of implants, e.g. dental or joint implants, comprise resorbable calcium-phosphorus phase containing adhesion and/or signal proteins |
US20050125011A1 (en) | 2001-04-24 | 2005-06-09 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
US6619291B2 (en) | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
US20060069429A1 (en) | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
WO2002085252A1 (en) | 2001-04-24 | 2002-10-31 | Dhc Systems, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US7037334B1 (en) | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
GB0110551D0 (en) | 2001-04-30 | 2001-06-20 | Angiomed Ag | Self-expanding stent delivery service |
US6682558B2 (en) | 2001-05-10 | 2004-01-27 | 3F Therapeutics, Inc. | Delivery system for a stentless valve bioprosthesis |
ITMI20011012A1 (en) | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
FI114150B (en) | 2001-05-17 | 2004-08-31 | Inion Ltd | Magazine for surgical fixation instruments and arrangement for a magazine for surgical fixation instruments |
US7935145B2 (en) | 2001-05-17 | 2011-05-03 | Edwards Lifesciences Corporation | Annuloplasty ring for ischemic mitral valve insuffuciency |
US6858039B2 (en) | 2002-07-08 | 2005-02-22 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
US20030069635A1 (en) | 2001-05-29 | 2003-04-10 | Cartledge Richard G. | Prosthetic heart valve |
KR100393548B1 (en) | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
ATE278367T1 (en) | 2001-06-11 | 2004-10-15 | Sorin Biomedica Cardio Spa | ANNULOPLASTY PROSTHESIS AND PRODUCTION METHOD THEREOF |
US20030078653A1 (en) | 2001-06-15 | 2003-04-24 | Ivan Vesely | Tissue engineered mitral valve chordae and methods of making and using same |
JP4159805B2 (en) | 2001-06-15 | 2008-10-01 | ラディ・メディカル・システムズ・アクチェボラーグ | Pushing mechanism for closing method |
US6958079B1 (en) | 2001-07-03 | 2005-10-25 | Reflux Corporation | Perorally insertable/removable anti-reflux valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US7150737B2 (en) | 2001-07-13 | 2006-12-19 | Sci/Med Life Systems, Inc. | Methods and apparatuses for navigating the subarachnoid space |
US7377938B2 (en) | 2001-07-19 | 2008-05-27 | The Cleveland Clinic Foundation | Prosthetic cardiac value and method for making same |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
US7179265B2 (en) | 2001-08-21 | 2007-02-20 | Microline Pentax, Inc. | Reduced diameter clip applying arrangement |
US6726716B2 (en) | 2001-08-24 | 2004-04-27 | Edwards Lifesciences Corporation | Self-molding annuloplasty ring |
US6908482B2 (en) | 2001-08-28 | 2005-06-21 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring and template |
US6749630B2 (en) | 2001-08-28 | 2004-06-15 | Edwards Lifesciences Corporation | Tricuspid ring and template |
US7125421B2 (en) | 2001-08-31 | 2006-10-24 | Mitral Interventions, Inc. | Method and apparatus for valve repair |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US20030050693A1 (en) | 2001-09-10 | 2003-03-13 | Quijano Rodolfo C. | Minimally invasive delivery system for annuloplasty rings |
DE10148185B4 (en) | 2001-09-28 | 2005-08-11 | Alveolus, Inc. | Instrument for implanting vascular prostheses |
JP4458845B2 (en) | 2001-10-01 | 2010-04-28 | アンプル メディカル,インコーポレイテッド | Medical device |
ATE471124T1 (en) | 2001-10-04 | 2010-07-15 | Neovasc Medical Ltd | FLOW-REDUCING IMPLANT |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7144363B2 (en) | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
US20060020336A1 (en) | 2001-10-23 | 2006-01-26 | Liddicoat John R | Automated annular plication for mitral valve repair |
US7052487B2 (en) | 2001-10-26 | 2006-05-30 | Cohn William E | Method and apparatus for reducing mitral regurgitation |
GB0125925D0 (en) | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
US7311729B2 (en) | 2002-01-30 | 2007-12-25 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6805710B2 (en) | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US8231639B2 (en) | 2001-11-28 | 2012-07-31 | Aptus Endosystems, Inc. | Systems and methods for attaching a prosthesis within a body lumen or hollow organ |
US20090099650A1 (en) | 2001-11-28 | 2009-04-16 | Lee Bolduc | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
EP1448117B1 (en) | 2001-11-28 | 2013-05-22 | Aptus Endosystems, Inc. | Endovascular aneurysm repair system |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
US20030176914A1 (en) | 2003-01-21 | 2003-09-18 | Rabkin Dmitry J. | Multi-segment modular stent and methods for manufacturing stents |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
EP1450732A1 (en) | 2001-12-04 | 2004-09-01 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template system |
US6976995B2 (en) | 2002-01-30 | 2005-12-20 | Cardiac Dimensions, Inc. | Fixed length anchor and pull mitral valve device and method |
US7179282B2 (en) | 2001-12-05 | 2007-02-20 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
DE10161543B4 (en) | 2001-12-11 | 2004-02-19 | REITAN, Öyvind | Implant for the treatment of heart valve insufficiency |
US6755857B2 (en) | 2001-12-12 | 2004-06-29 | Sulzer Carbomedics Inc. | Polymer heart valve with perforated stent and sewing cuff |
US6740107B2 (en) | 2001-12-19 | 2004-05-25 | Trimedyne, Inc. | Device for treatment of atrioventricular valve regurgitation |
US8123801B2 (en) | 2001-12-21 | 2012-02-28 | QuickRing Medical Technologies, Ltd. | Implantation system for annuloplasty rings |
WO2003053289A1 (en) | 2001-12-21 | 2003-07-03 | Simcha Milo | Implantation system for annuloplasty rings |
US7201771B2 (en) | 2001-12-27 | 2007-04-10 | Arbor Surgical Technologies, Inc. | Bioprosthetic heart valve |
SE524709C2 (en) | 2002-01-11 | 2004-09-21 | Edwards Lifesciences Ag | Device for delayed reshaping of a heart vessel and a heart valve |
US7033390B2 (en) | 2002-01-02 | 2006-04-25 | Medtronic, Inc. | Prosthetic heart valve system |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
CA2688796A1 (en) | 2002-01-11 | 2003-07-10 | Edwards Lifesciences Ag. | Delayed memory device |
US20030139819A1 (en) | 2002-01-18 | 2003-07-24 | Beer Nicholas De | Method and apparatus for closing septal defects |
US7029482B1 (en) | 2002-01-22 | 2006-04-18 | Cardica, Inc. | Integrated anastomosis system |
US6989024B2 (en) | 2002-02-28 | 2006-01-24 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
US7048754B2 (en) | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US8430934B2 (en) | 2002-03-01 | 2013-04-30 | Regents Of The University Of Minnesota | Vascular occlusion device |
US6797001B2 (en) | 2002-03-11 | 2004-09-28 | Cardiac Dimensions, Inc. | Device, assembly and method for mitral valve repair |
US6719786B2 (en) | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7118595B2 (en) | 2002-03-18 | 2006-10-10 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
US7094244B2 (en) | 2002-03-26 | 2006-08-22 | Edwards Lifesciences Corporation | Sequential heart valve leaflet repair device and method of use |
US7288111B1 (en) | 2002-03-26 | 2007-10-30 | Thoratec Corporation | Flexible stent and method of making the same |
ATE451080T1 (en) | 2002-03-27 | 2009-12-15 | Sorin Biomedica Cardio Srl | ANULOPLASTY PROSTHESIS WITH A PIERCED COMPONENT |
US20030199974A1 (en) | 2002-04-18 | 2003-10-23 | Coalescent Surgical, Inc. | Annuloplasty apparatus and methods |
US7229452B2 (en) | 2002-04-22 | 2007-06-12 | Tyco Healthcare Group Lp | Tack and tack applier |
US7105016B2 (en) | 2002-04-23 | 2006-09-12 | Medtronic Vascular, Inc. | Integrated mechanical handle with quick slide mechanism |
US6951565B2 (en) | 2002-04-24 | 2005-10-04 | Linvatec Biomaterials Ltd. | Device for inserting surgical implants |
US7077850B2 (en) | 2002-05-01 | 2006-07-18 | Scimed Life Systems, Inc. | Tissue fastening devices and related insertion tools and methods |
WO2003094785A1 (en) | 2002-05-09 | 2003-11-20 | Egan Thomas D | Gastric bypass prosthesis |
JP2005525169A (en) | 2002-05-10 | 2005-08-25 | コーディス・コーポレイション | Method of making a medical device having a thin wall tubular membrane on a structural frame |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
DE10221076A1 (en) | 2002-05-11 | 2003-11-27 | Ruesch Willy Gmbh | stent |
US6830638B2 (en) | 2002-05-24 | 2004-12-14 | Advanced Cardiovascular Systems, Inc. | Medical devices configured from deep drawn nickel-titanium alloys and nickel-titanium clad alloys and method of making the same |
DE60325355D1 (en) | 2002-06-04 | 2009-01-29 | Abbott Vascular Inc | SURGICAL CLOSURE AND MOUNTING DEVICE FOR VASCULAR SEALING |
AU2003247526A1 (en) | 2002-06-12 | 2003-12-31 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US7588582B2 (en) | 2002-06-13 | 2009-09-15 | Guided Delivery Systems Inc. | Methods for remodeling cardiac tissue |
US7753922B2 (en) | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
US6986775B2 (en) | 2002-06-13 | 2006-01-17 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060241656A1 (en) | 2002-06-13 | 2006-10-26 | Starksen Niel F | Delivery devices and methods for heart valve repair |
US20050107811A1 (en) | 2002-06-13 | 2005-05-19 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8641727B2 (en) | 2002-06-13 | 2014-02-04 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US6679836B2 (en) | 2002-06-21 | 2004-01-20 | Scimed Life Systems, Inc. | Universal programmable guide catheter |
AU2003288896B2 (en) | 2002-06-28 | 2008-01-24 | Cook Incorporated | Thoracic deployment device |
US7608103B2 (en) | 2002-07-08 | 2009-10-27 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
US7172625B2 (en) | 2002-07-16 | 2007-02-06 | Medtronic, Inc. | Suturing rings for implantable heart valve prostheses |
IL150855A (en) | 2002-07-22 | 2007-06-03 | Leonid Monassevitch | Intratubular anastomosis apparatus |
EP1534146B1 (en) | 2002-08-13 | 2008-01-23 | The General Hospital Corporation | Cardiac devices for percutaneous repair of atrioventricular valves |
US7041132B2 (en) | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
US7211114B2 (en) | 2002-08-26 | 2007-05-01 | The Trustees Of Columbia University In The City Of New York | Endoscopic gastric bypass |
US20040092858A1 (en) | 2002-08-28 | 2004-05-13 | Heart Leaflet Technologies, Inc. | Leaflet valve |
US8758372B2 (en) | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US7297150B2 (en) | 2002-08-29 | 2007-11-20 | Mitralsolutions, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
WO2007136783A2 (en) | 2002-08-29 | 2007-11-29 | Mitralsolutions, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
DE60221828T2 (en) | 2002-09-04 | 2008-05-08 | Endoart S.A. | Surgical ring with remote control device for reversible diameter changes |
US7666195B2 (en) | 2002-09-09 | 2010-02-23 | Brian Kelleher | Device and method for endoluminal therapy |
US20040059413A1 (en) | 2002-09-20 | 2004-03-25 | Claudio Argento | Suture template for facilitating implantation of a prosthetic heart valve |
US7137184B2 (en) | 2002-09-20 | 2006-11-21 | Edwards Lifesciences Corporation | Continuous heart valve support frame and method of manufacture |
CO5500017A1 (en) | 2002-09-23 | 2005-03-31 | 3F Therapeutics Inc | MITRAL PROTESTIC VALVE |
AU2003276999A1 (en) | 2002-09-26 | 2004-04-19 | Savacor, Inc. | Cardiovascular anchoring device and method of deploying same |
AU2003277115A1 (en) | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
CA2498030A1 (en) | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US8460371B2 (en) | 2002-10-21 | 2013-06-11 | Mitralign, Inc. | Method and apparatus for performing catheter-based annuloplasty using local plications |
US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
US6733536B1 (en) | 2002-10-22 | 2004-05-11 | Scimed Life Systems | Male urethral stent device |
CN1711467A (en) | 2002-11-06 | 2005-12-21 | 皇家飞利浦电子股份有限公司 | Method of adhesion measurement at the interface between layers |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7247134B2 (en) | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
AU2003290979A1 (en) | 2002-11-15 | 2004-06-15 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method and device for catheter-based repair of cardiac valves |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US7335213B1 (en) | 2002-11-15 | 2008-02-26 | Abbott Cardiovascular Systems Inc. | Apparatus and methods for heart valve repair |
US8187324B2 (en) | 2002-11-15 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Telescoping apparatus for delivering and adjusting a medical device in a vessel |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US6984242B2 (en) | 2002-12-20 | 2006-01-10 | Gore Enterprise Holdings, Inc. | Implantable medical device assembly |
US7316710B1 (en) | 2002-12-30 | 2008-01-08 | Advanced Cardiovascular Systems, Inc. | Flexible stent |
US6849084B2 (en) | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
US6931338B2 (en) | 2003-01-07 | 2005-08-16 | Guide Technology, Inc. | System for providing a calibrated path for multi-signal cables in testing of integrated circuits |
US6830585B1 (en) | 2003-01-14 | 2004-12-14 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve and methods of implantation |
US7753945B2 (en) | 2003-01-17 | 2010-07-13 | Gore Enterprise Holdings, Inc. | Deployment system for an endoluminal device |
US7314485B2 (en) | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040176788A1 (en) | 2003-03-07 | 2004-09-09 | Nmt Medical, Inc. | Vacuum attachment system |
US20040186566A1 (en) | 2003-03-18 | 2004-09-23 | Hindrichs Paul J. | Body tissue remodeling methods and apparatus |
US20050107871A1 (en) | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
EP1608294B1 (en) | 2003-04-02 | 2007-12-26 | Boston Scientific Limited | Detachable and retrievable stent assembly |
US7159593B2 (en) | 2003-04-17 | 2007-01-09 | 3F Therapeutics, Inc. | Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US7530995B2 (en) | 2003-04-17 | 2009-05-12 | 3F Therapeutics, Inc. | Device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US7175656B2 (en) | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
US7717952B2 (en) | 2003-04-24 | 2010-05-18 | Cook Incorporated | Artificial prostheses with preferred geometries |
EP2926772A1 (en) | 2003-04-24 | 2015-10-07 | Cook Medical Technologies LLC | Artificial valve prosthesis with improved flow dynamics |
DE602004023350D1 (en) | 2003-04-30 | 2009-11-12 | Medtronic Vascular Inc | Percutaneous inserted provisional valve |
US20040220593A1 (en) | 2003-05-01 | 2004-11-04 | Secant Medical, Llc | Restraining clip for mitral valve repair |
US20040230208A1 (en) | 2003-05-13 | 2004-11-18 | Vafa Shayani | Article for positioning mesh over tissue |
US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
CA2526347C (en) | 2003-05-20 | 2010-07-06 | The Cleveland Clinic Foundation | Apparatus and methods for repair of a cardiac valve |
US7341584B1 (en) | 2003-05-30 | 2008-03-11 | Thomas David Starkey | Device and method to limit filling of the heart |
AU2004249161B9 (en) | 2003-06-13 | 2010-04-08 | Covidien Lp | Multiple member interconnect for surgical instrument and absorbable screw fastener |
US7967850B2 (en) | 2003-06-18 | 2011-06-28 | Jackson Roger P | Polyaxial bone anchor with helical capture connection, insert and dual locking assembly |
US7316706B2 (en) | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
EP1648346A4 (en) | 2003-06-20 | 2006-10-18 | Medtronic Vascular Inc | Valve annulus reduction system |
US20040260394A1 (en) | 2003-06-20 | 2004-12-23 | Medtronic Vascular, Inc. | Cardiac valve annulus compressor system |
EP1648341A4 (en) | 2003-06-25 | 2009-01-14 | Georgia Tech Res Inst | Annuloplasty chain |
US8052751B2 (en) | 2003-07-02 | 2011-11-08 | Flexcor, Inc. | Annuloplasty rings for repairing cardiac valves |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
BRPI0412362A (en) | 2003-07-08 | 2006-09-05 | Ventor Technologies Ltd | prosthetic implant devices particularly for transarterial transport in the treatment of aortic stenoses and implantation methods for such devices |
NZ527025A (en) | 2003-07-16 | 2007-01-26 | David Peter Shaw | Prosthetic valves for medical application |
EP1646332B1 (en) | 2003-07-18 | 2015-06-17 | Edwards Lifesciences AG | Remotely activated mitral annuloplasty system |
EP1653888B1 (en) | 2003-07-21 | 2009-09-09 | The Trustees of The University of Pennsylvania | Percutaneous heart valve |
US20050016560A1 (en) | 2003-07-21 | 2005-01-27 | Dee Voughlohn | Unique hair-styling system and method |
DE10335648A1 (en) | 2003-07-30 | 2005-03-03 | Eberhard-Karls-Universität Tübingen | Closing plug for an opening in a wall of a vessel or hollow organ |
WO2005011534A1 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve devices and methods of making such devices |
WO2005011535A2 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
US8784472B2 (en) | 2003-08-15 | 2014-07-22 | Boston Scientific Scimed, Inc. | Clutch driven stent delivery system |
WO2005018728A2 (en) | 2003-08-19 | 2005-03-03 | Nmt Medical, Inc. | Expandable sheath tubing |
US8298280B2 (en) | 2003-08-21 | 2012-10-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20050049692A1 (en) | 2003-09-02 | 2005-03-03 | Numamoto Michael J. | Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
CN1838924A (en) | 2003-09-02 | 2006-09-27 | 百欧梅迪克斯股份有限公司 | Gastrointestinal anti-reflux prosthesis device and method |
US20050075725A1 (en) | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US20050075729A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
US20060259137A1 (en) | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
US10219899B2 (en) | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
EP1682880A1 (en) | 2003-10-08 | 2006-07-26 | Philips Intellectual Property & Standards GmbH | Bulk acoustic wave sensor |
US7553324B2 (en) | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US7226647B2 (en) | 2003-10-16 | 2007-06-05 | Hewlett-Packard Development Company, L.P. | Permanent fixation of dyes to surface-modified inorganic particulate-coated media |
US7004176B2 (en) | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20060184242A1 (en) | 2003-10-20 | 2006-08-17 | Samuel Lichtenstein | Method and apparatus for percutaneous reduction of anterior-posterior diameter of mitral valve |
ITBO20030631A1 (en) | 2003-10-23 | 2005-04-24 | Roberto Erminio Parravicini | VALVULAR PROSTHETIC EQUIPMENT, IN PARTICULAR FOR HEART APPLICATIONS. |
US20050090827A1 (en) | 2003-10-28 | 2005-04-28 | Tewodros Gedebou | Comprehensive tissue attachment system |
EP1680173B1 (en) | 2003-10-31 | 2011-01-12 | Trudell Medical International | System for manipulating a catheter for delivering a substance to a body cavity |
WO2005046530A1 (en) | 2003-11-12 | 2005-05-26 | Medtronic Vascular, Inc. | Coronary sinus approach for repair of mitral valve reguritation |
US7955384B2 (en) | 2003-11-12 | 2011-06-07 | Medtronic Vascular, Inc. | Coronary sinus approach for repair of mitral valve regurgitation |
EP1689329A2 (en) | 2003-11-12 | 2006-08-16 | Medtronic Vascular, Inc. | Cardiac valve annulus reduction system |
IL158960A0 (en) | 2003-11-19 | 2004-05-12 | Neovasc Medical Ltd | Vascular implant |
CA2552857A1 (en) | 2003-12-04 | 2005-06-23 | Brigham And Women's Hospital, Inc. | Aortic valve annuloplasty rings |
US7186265B2 (en) | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US20050177228A1 (en) | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20050273138A1 (en) | 2003-12-19 | 2005-12-08 | Guided Delivery Systems, Inc. | Devices and methods for anchoring tissue |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
EP2526898B1 (en) | 2003-12-23 | 2013-04-17 | Sadra Medical, Inc. | Repositionable heart valve |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US20050137686A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
AU2003299404A1 (en) | 2003-12-23 | 2005-08-11 | Laboratoires Perouse | Kit which is intended to be implanted in a conduit |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137691A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7166127B2 (en) | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7887574B2 (en) | 2003-12-23 | 2011-02-15 | Scimed Life Systems, Inc. | Stent delivery catheter |
US7288115B2 (en) | 2004-01-02 | 2007-10-30 | Zimmer Technology, Inc. | Multipart component for an orthopaedic implant |
US9254213B2 (en) | 2004-01-09 | 2016-02-09 | Rubicon Medical, Inc. | Stent delivery device |
US20050159728A1 (en) | 2004-01-15 | 2005-07-21 | Thomas Medical Products, Inc. | Steerable sheath |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US7597711B2 (en) | 2004-01-26 | 2009-10-06 | Arbor Surgical Technologies, Inc. | Heart valve assembly with slidable coupling connections |
JP2007527742A (en) | 2004-02-03 | 2007-10-04 | アトリア メディカル インク | Apparatus and method for controlling pressure in a living body |
US7311730B2 (en) | 2004-02-13 | 2007-12-25 | Shlomo Gabbay | Support apparatus and heart valve prosthesis for sutureless implantation |
US20050187568A1 (en) | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
US7955375B2 (en) | 2004-02-20 | 2011-06-07 | Cook Medical Technologies Llc | Prosthetic valve with spacing member |
US8206439B2 (en) | 2004-02-23 | 2012-06-26 | International Heart Institute Of Montana Foundation | Internal prosthesis for reconstruction of cardiac geometry |
WO2005084595A1 (en) | 2004-02-27 | 2005-09-15 | Cardiacmd, Inc. | Prosthetic heart valve delivery systems and methods |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US20050203549A1 (en) | 2004-03-09 | 2005-09-15 | Fidel Realyvasquez | Methods and apparatus for off pump aortic valve replacement with a valve prosthesis |
US20050203606A1 (en) | 2004-03-09 | 2005-09-15 | Vancamp Daniel H. | Stent system for preventing restenosis |
EP3308744B2 (en) | 2004-03-11 | 2023-08-02 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
US7942927B2 (en) | 2004-03-15 | 2011-05-17 | Baker Medical Research Institute | Treating valve failure |
NL1025830C2 (en) | 2004-03-26 | 2005-02-22 | Eric Berreklouw | Prosthesis e.g. heart valve secured in place by ring with shape memory material anchor, includes anchor temperature control system |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US7993397B2 (en) | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
GB0407908D0 (en) | 2004-04-07 | 2004-05-12 | Univ York | Ionic liquids |
EP2856949B2 (en) | 2004-04-08 | 2019-09-11 | Aga Medical Corporation | Flanged occlusion devices |
US7294148B2 (en) | 2004-04-29 | 2007-11-13 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
US20050256566A1 (en) | 2004-05-03 | 2005-11-17 | Shlomo Gabbay | Apparatus and method for improving ventricular function |
US7374573B2 (en) | 2004-05-03 | 2008-05-20 | Shlomo Gabbay | System and method for improving ventricular function |
CA2563426C (en) | 2004-05-05 | 2013-12-24 | Direct Flow Medical, Inc. | Unstented heart valve with formed in place support structure |
US7390329B2 (en) | 2004-05-07 | 2008-06-24 | Usgi Medical, Inc. | Methods for grasping and cinching tissue anchors |
US20060122692A1 (en) | 2004-05-10 | 2006-06-08 | Ran Gilad | Stent valve and method of using same |
US20050256532A1 (en) | 2004-05-12 | 2005-11-17 | Asha Nayak | Cardiovascular defect patch device and method |
US7452376B2 (en) | 2004-05-14 | 2008-11-18 | St. Jude Medical, Inc. | Flexible, non-planar annuloplasty rings |
EP3143944B1 (en) | 2004-05-14 | 2018-08-01 | Evalve, Inc. | Locking mechanisms for fixation devices |
PL1768630T3 (en) | 2004-06-16 | 2015-07-31 | Machine Solutions Inc | Stent crimping device |
US8043354B2 (en) | 2004-06-16 | 2011-10-25 | William A. Cook Australia Pty. Ltd. | Thoracic deployment device and stent graft |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US20050288778A1 (en) | 2004-06-29 | 2005-12-29 | Emanuel Shaoulian | Selectively adjustable cardiac valve implants |
US20070118215A1 (en) | 2005-11-16 | 2007-05-24 | Micardia Corporation | Magnetic engagement of catheter to implantable device |
US7462191B2 (en) | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
US7276078B2 (en) | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
EP1774692A2 (en) | 2004-07-01 | 2007-04-18 | Staccato Communications, Inc. | Multiband receiver synchronization |
US7556632B2 (en) | 2004-07-09 | 2009-07-07 | Reza Zadno | Device and method for repairing tissue |
US8308789B2 (en) | 2004-07-16 | 2012-11-13 | W. L. Gore & Associates, Inc. | Deployment system for intraluminal devices |
US20060030863A1 (en) | 2004-07-21 | 2006-02-09 | Fields Antony J | Implanted bronchial isolation device delivery devices and methods |
US8012202B2 (en) | 2004-07-27 | 2011-09-06 | Alameddine Abdallah K | Mitral valve ring for treatment of mitral valve regurgitation |
US20060041189A1 (en) | 2004-08-17 | 2006-02-23 | Vancaillie Thierry G | Grummet |
US7126289B2 (en) | 2004-08-20 | 2006-10-24 | O2 Micro Inc | Protection for external electrode fluorescent lamp system |
JP2008511401A (en) | 2004-08-27 | 2008-04-17 | クック インコーポレイテッド | Apparatus for arranging a plurality of intraluminal medical devices in a body cavity |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
FR2874813B1 (en) | 2004-09-07 | 2007-06-22 | Perouse Soc Par Actions Simpli | VALVULAR PROSTHESIS |
CA2580053C (en) | 2004-09-14 | 2014-07-08 | Edwards Lifesciences Ag. | Device and method for treatment of heart valve regurgitation |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
AU2005289474B2 (en) | 2004-09-27 | 2010-12-09 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US20060085012A1 (en) | 2004-09-28 | 2006-04-20 | Medtronic Vascular, Inc. | Torquing device delivered over a guidewire to rotate a medical fastener |
WO2006037131A2 (en) | 2004-09-28 | 2006-04-06 | Surgical Solutions Llc | Suture anchor |
US6951571B1 (en) | 2004-09-30 | 2005-10-04 | Rohit Srivastava | Valve implanting device |
US20070083168A1 (en) | 2004-09-30 | 2007-04-12 | Whiting James S | Transmembrane access systems and methods |
US20090043381A1 (en) | 2004-10-05 | 2009-02-12 | Macoviak John A | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
US7347868B2 (en) | 2004-10-26 | 2008-03-25 | Baronova, Inc. | Medical device delivery catheter |
US7458987B2 (en) | 2004-10-29 | 2008-12-02 | Cook Incorporated | Vascular valves having implanted and target configurations and methods of preparing the same |
US7470256B2 (en) | 2004-10-29 | 2008-12-30 | Merit Medical Systems, Inc., | Self-suturing anchor device for a catheter |
ATE507799T1 (en) | 2004-11-02 | 2011-05-15 | Mach Solutions Inc | STENT SHEATH TECHNOLOGY |
US7455688B2 (en) | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
US7744642B2 (en) | 2004-11-19 | 2010-06-29 | Biomedical Research Associates, Inc. | Prosthetic venous valves |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
US20070219630A1 (en) | 2004-11-24 | 2007-09-20 | Xi Chu | Devices and Methods for Beating Heart Cardiac Surgeries |
WO2006062019A1 (en) | 2004-12-07 | 2006-06-15 | Olympus Corporation | Treatment instrument for endoscope and cartridge in which treatment instrument is received |
ATE435616T1 (en) | 2004-12-15 | 2009-07-15 | Cook Urological Inc | X-RAY OPERASIVE MANIPULATION DEVICES |
US20060178700A1 (en) | 2004-12-15 | 2006-08-10 | Martin Quinn | Medical device suitable for use in treatment of a valve |
US7355461B2 (en) | 2004-12-15 | 2008-04-08 | Asahi Kasei Microsystems Co., Ltd. | Waveform generating circuit and spread spectrum clock generator |
SE0403046D0 (en) | 2004-12-15 | 2004-12-15 | Medtentia Ab | A device and method for improving the function of a heart valve |
US7758640B2 (en) | 2004-12-16 | 2010-07-20 | Valvexchange Inc. | Cardiovascular valve assembly |
US7578838B2 (en) | 2005-01-12 | 2009-08-25 | Cook Incorporated | Delivery system with helical shaft |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
CA2597066C (en) | 2005-02-07 | 2014-04-15 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US8470028B2 (en) | 2005-02-07 | 2013-06-25 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
CA2822801A1 (en) | 2005-02-07 | 2006-08-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US8220466B2 (en) | 2005-02-08 | 2012-07-17 | Koninklijke Philips Electronics N.V. | System and method for percutaneous palate remodeling |
DE602006013946D1 (en) | 2005-02-08 | 2010-06-10 | Koninkl Philips Electronics Nv | SYSTEM FOR PERCUTANEOUS GLOSSOPLASTICS |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
WO2006089236A1 (en) | 2005-02-18 | 2006-08-24 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
US20060195186A1 (en) | 2005-02-28 | 2006-08-31 | Drews Michael J | Connectors for two piece heart valves and methods for implanting such heart valves |
US8083793B2 (en) | 2005-02-28 | 2011-12-27 | Medtronic, Inc. | Two piece heart valves including multiple lobe valves and methods for implanting them |
US7955385B2 (en) | 2005-02-28 | 2011-06-07 | Medtronic Vascular, Inc. | Device, system, and method for aiding valve annuloplasty |
CN102247225B (en) | 2005-02-28 | 2015-07-22 | 梅德坦提亚国际有限公司 | Device for improving the function of heart valve and kit |
US20070213810A1 (en) | 2005-03-14 | 2007-09-13 | Richard Newhauser | Segmented endoprosthesis |
US8608797B2 (en) | 2005-03-17 | 2013-12-17 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
US8608726B2 (en) | 2005-03-24 | 2013-12-17 | The Cleveland Clinic Foundation | Vascular guidewire control apparatus |
US8864823B2 (en) | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
WO2006105084A2 (en) | 2005-03-25 | 2006-10-05 | Mitralsolutions, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US20060271171A1 (en) | 2005-04-01 | 2006-11-30 | Mcquinn Tim C | Artificial heart valve |
US8062359B2 (en) | 2005-04-06 | 2011-11-22 | Edwards Lifesciences Corporation | Highly flexible heart valve connecting band |
US7513909B2 (en) | 2005-04-08 | 2009-04-07 | Arbor Surgical Technologies, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
EP1893131A1 (en) | 2005-04-20 | 2008-03-05 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
SE531468C2 (en) | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
FR2885794B1 (en) | 2005-05-19 | 2007-08-17 | Perouse Soc Par Actions Simpli | NECESSARY FOR LANDING A CAVITY TREATMENT BODY AND METHOD FOR PREPARING A TREATMENT BODY THEREFOR |
EP3292838A1 (en) | 2005-05-24 | 2018-03-14 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US8317855B2 (en) | 2005-05-26 | 2012-11-27 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
CN101991478B (en) | 2005-05-27 | 2013-04-24 | 心叶科技公司 | Stentless support structure |
US8211169B2 (en) | 2005-05-27 | 2012-07-03 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US7500989B2 (en) | 2005-06-03 | 2009-03-10 | Edwards Lifesciences Corp. | Devices and methods for percutaneous repair of the mitral valve via the coronary sinus |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US20060287716A1 (en) | 2005-06-08 | 2006-12-21 | The Cleveland Clinic Foundation | Artificial chordae |
US7780723B2 (en) | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
WO2007006057A1 (en) | 2005-07-06 | 2007-01-11 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
EP1919397B1 (en) | 2005-07-13 | 2013-01-02 | Medtronic, Inc. | Two-piece percutaneous prosthetic heart valves |
US7776084B2 (en) | 2005-07-13 | 2010-08-17 | Edwards Lifesciences Corporation | Prosthetic mitral heart valve having a contoured sewing ring |
DE102006017873A1 (en) | 2005-07-14 | 2007-01-25 | Qualimed Innovative Medizinprodukte Gmbh | Temporary stent |
ATE442108T1 (en) | 2005-07-15 | 2009-09-15 | Cleveland Clinic Foundation | DEVICE FOR REMODELING A HEART VALVE RING |
US7927371B2 (en) | 2005-07-15 | 2011-04-19 | The Cleveland Clinic Foundation | Apparatus and method for reducing cardiac valve regurgitation |
US7875056B2 (en) | 2005-07-22 | 2011-01-25 | Anpa Medical, Inc. | Wedge operated retainer device and methods |
EP1906873A2 (en) | 2005-07-27 | 2008-04-09 | Georgia Tech Research Corporation | Implantable prosthetic vascular valve |
US20070027533A1 (en) | 2005-07-28 | 2007-02-01 | Medtronic Vascular, Inc. | Cardiac valve annulus restraining device |
US20070027528A1 (en) | 2005-07-29 | 2007-02-01 | Cook Incorporated | Elliptical implantable device |
US20070055206A1 (en) | 2005-08-10 | 2007-03-08 | Guided Delivery Systems, Inc. | Methods and devices for deployment of tissue anchors |
US20070038295A1 (en) | 2005-08-12 | 2007-02-15 | Cook Incorporated | Artificial valve prosthesis having a ring frame |
EP1933777B1 (en) | 2005-08-22 | 2017-06-14 | Incept, LLC | Flared stents and apparatus for using them |
US7611534B2 (en) | 2005-08-25 | 2009-11-03 | The Cleveland Clinic Foundation | Percutaneous atrioventricular valve and method of use |
US9492277B2 (en) | 2005-08-30 | 2016-11-15 | Mayo Foundation For Medical Education And Research | Soft body tissue remodeling methods and apparatus |
US20070078297A1 (en) | 2005-08-31 | 2007-04-05 | Medtronic Vascular, Inc. | Device for Treating Mitral Valve Regurgitation |
AU2006287211B2 (en) | 2005-09-01 | 2012-09-27 | Cardinal Health 529, Llc | Patent foramen ovale closure method |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US8968379B2 (en) | 2005-09-02 | 2015-03-03 | Medtronic Vascular, Inc. | Stent delivery system with multiple evenly spaced pullwires |
EP1922030B1 (en) | 2005-09-07 | 2015-12-30 | Medtentia International Ltd Oy | A device and method for improving the function of a heart valve |
US7731741B2 (en) | 2005-09-08 | 2010-06-08 | Boston Scientific Scimed, Inc. | Inflatable bifurcation stent |
CA2660892A1 (en) | 2005-09-09 | 2007-03-15 | Edwards Lifesciences Corporation | Device and method for reshaping mitral valve annulus |
US7530253B2 (en) | 2005-09-09 | 2009-05-12 | Edwards Lifesciences Corporation | Prosthetic valve crimping device |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
CA2561034C (en) | 2005-09-30 | 2014-12-09 | Sherwood Services Ag | Flexible endoscopic catheter with an end effector for coagulating and transfecting tissue |
US7695510B2 (en) | 2005-10-11 | 2010-04-13 | Medtronic Vascular, Inc. | Annuloplasty device having shape-adjusting tension filaments |
US8038720B2 (en) | 2005-10-18 | 2011-10-18 | Wallace Jeffrey M | Methods and devices for intragastrointestinal prostheses |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
CN101466316B (en) | 2005-10-20 | 2012-06-27 | 阿普特斯内系统公司 | Devices systems and methods for prosthesis delivery and implantation including the use of a fastener tool |
DE102005051849B4 (en) | 2005-10-28 | 2010-01-21 | JenaValve Technology Inc., Wilmington | Device for implantation and attachment of heart valve prostheses |
US8343204B2 (en) | 2005-10-31 | 2013-01-01 | Cook Medical Technologies Llc | Composite stent graft |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
EP1951352B1 (en) | 2005-11-10 | 2017-01-11 | Edwards Lifesciences CardiAQ LLC | Balloon-expandable, self-expanding, vascular prosthesis connecting stent |
US20070112418A1 (en) | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
US7632302B2 (en) | 2005-11-14 | 2009-12-15 | Ev3 Inc. | Stent and stent delivery system for ostial locations in a conduit |
US8764820B2 (en) | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
WO2007062054A2 (en) | 2005-11-21 | 2007-05-31 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US8043368B2 (en) | 2005-11-23 | 2011-10-25 | Traves Dean Crabtree | Methods and apparatus for atrioventricular valve repair |
US7632308B2 (en) | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
EP1959866B1 (en) | 2005-12-15 | 2019-03-06 | Georgia Tech Research Corporation | Papillary muscle position control devices and systems |
WO2007078772A1 (en) | 2005-12-15 | 2007-07-12 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant valve |
US20070142907A1 (en) | 2005-12-16 | 2007-06-21 | Micardia Corporation | Adjustable prosthetic valve implant |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
DE602005015238D1 (en) | 2005-12-28 | 2009-08-13 | Sorin Biomedica Cardio Srl | Denture for annuloplasty with auxetic structure |
US9375215B2 (en) | 2006-01-20 | 2016-06-28 | W. L. Gore & Associates, Inc. | Device for rapid repair of body conduits |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US8403981B2 (en) | 2006-02-27 | 2013-03-26 | CardiacMC, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US8219229B2 (en) | 2006-03-02 | 2012-07-10 | Edwards Lifesciences Corporation | Virtual heart valve |
US7635386B1 (en) | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
US7431692B2 (en) | 2006-03-09 | 2008-10-07 | Edwards Lifesciences Corporation | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
JP5102279B2 (en) | 2006-03-10 | 2012-12-19 | メドトロニック,インコーポレイテッド | Artificial valve introducer, method for producing the same and method for using the same |
US20070219558A1 (en) | 2006-03-15 | 2007-09-20 | Allen Deutsch | Method and apparatus for arthroscopic surgery using suture anchors |
US20070225759A1 (en) | 2006-03-22 | 2007-09-27 | Daniel Thommen | Method for delivering a medical device to the heart of a patient |
DE102006013770A1 (en) | 2006-03-24 | 2007-09-27 | Occlutech Gmbh | Occlusion instrument and method for its production |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
WO2007115110A2 (en) | 2006-03-29 | 2007-10-11 | The Catheter Exchange, Inc. | Method and device for cavity obliteration |
CN101049269B (en) | 2006-04-03 | 2010-12-29 | 孟坚 | Medical use obstruction appliance |
US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
US20070239208A1 (en) | 2006-04-05 | 2007-10-11 | Crawford Bruce S | Surgical implantation device and method |
US7524331B2 (en) | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
US7699892B2 (en) | 2006-04-12 | 2010-04-20 | Medtronic Vascular, Inc. | Minimally invasive procedure for implanting an annuloplasty device |
WO2007121314A2 (en) | 2006-04-12 | 2007-10-25 | Medtronic Vascular, Inc. | Annuloplasty device having a helical anchor and methods for its use |
US20070244555A1 (en) | 2006-04-12 | 2007-10-18 | Medtronic Vascular, Inc. | Annuloplasty Device Having a Helical Anchor and Methods for its Use |
US20070244546A1 (en) | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc. | Stent Foundation for Placement of a Stented Valve |
US20070270755A1 (en) | 2006-04-21 | 2007-11-22 | Abbott Laboratories | Guidewire handling device |
US7442207B2 (en) | 2006-04-21 | 2008-10-28 | Medtronic Vascular, Inc. | Device, system, and method for treating cardiac valve regurgitation |
US8551161B2 (en) | 2006-04-25 | 2013-10-08 | Medtronic Vascular, Inc. | Cardiac valve annulus restraining device |
WO2007136532A2 (en) | 2006-05-03 | 2007-11-29 | St. Jude Medical, Inc. | Soft body tissue remodeling methods and apparatus |
WO2007130537A1 (en) | 2006-05-05 | 2007-11-15 | Children's Medical Center Corporation | Transcatheter heart valve prostheses |
JP5258754B2 (en) | 2006-05-15 | 2013-08-07 | エドワーズ・ライフサイエンシス・アーゲー | System and method for altering heart geometry |
US20080234660A2 (en) | 2006-05-16 | 2008-09-25 | Sarah Cumming | Steerable Catheter Using Flat Pull Wires and Method of Making Same |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
EP2032044A2 (en) | 2006-05-25 | 2009-03-11 | Mitralign, Inc. | Lockers for surgical tensioning members and methods of using the same to secure surgical tensioning members |
US7811316B2 (en) | 2006-05-25 | 2010-10-12 | Deep Vein Medical, Inc. | Device for regulating blood flow |
US20070282429A1 (en) | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
ITTO20060413A1 (en) | 2006-06-07 | 2007-12-08 | Arrigo Lessana | REPLACEMENT DEVICE OF THE TENDONE ROPES OF AN ATRIOVENTRICULAR VALVE |
KR101376374B1 (en) | 2006-06-14 | 2014-03-20 | 옵티비아 메디칼 엘엘씨 | Medical device introduction systems and methods |
EP2034929A4 (en) | 2006-06-20 | 2010-04-07 | Aortx Inc | Prosthetic heart valves, support structures and systems and methods for implanting the same |
CN101506538A (en) | 2006-06-20 | 2009-08-12 | 奥尔特克斯公司 | Torque shaft and torque drive |
CA2657446A1 (en) | 2006-06-21 | 2007-12-27 | Aortx, Inc. | Prosthetic valve implantation systems |
US7934506B2 (en) | 2006-06-21 | 2011-05-03 | Koninklijke Philips Electronics N.V. | System and method for temporary tongue suspension |
US20070295172A1 (en) | 2006-06-23 | 2007-12-27 | Darian Swartz | Fastener Holding Device |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
JP2008017549A (en) * | 2006-07-03 | 2008-01-24 | Jtekt Corp | Steering device for vehicle |
US8613698B2 (en) | 2006-07-10 | 2013-12-24 | Mcneil-Ppc, Inc. | Resilient device |
US7955315B2 (en) | 2006-07-24 | 2011-06-07 | Ethicon, Inc. | Articulating laparoscopic device and method for delivery of medical fluid |
WO2008013915A2 (en) | 2006-07-28 | 2008-01-31 | Arshad Quadri | Percutaneous valve prosthesis and system and method for implanting same |
US7871432B2 (en) | 2006-08-02 | 2011-01-18 | Medtronic, Inc. | Heart valve holder for use in valve implantation procedures |
US8167894B2 (en) | 2006-08-09 | 2012-05-01 | Coherex Medical, Inc. | Methods, systems and devices for reducing the size of an internal tissue opening |
US8529597B2 (en) | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8430926B2 (en) | 2006-08-11 | 2013-04-30 | Japd Consulting Inc. | Annuloplasty with enhanced anchoring to the annulus based on tissue healing |
WO2008022077A2 (en) | 2006-08-14 | 2008-02-21 | Buch Wally S | Methods and apparatus for mitral valve repair |
US20080097595A1 (en) | 2006-08-22 | 2008-04-24 | Shlomo Gabbay | Intraventricular cardiac prosthesis |
AU2007294534B2 (en) | 2006-09-08 | 2012-11-01 | Edwards Lifesciences Corporation | Integrated heart valve delivery system |
US8348995B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies, Ltd. | Axial-force fixation member for valve |
FR2906454B1 (en) | 2006-09-28 | 2009-04-10 | Perouse Soc Par Actions Simpli | IMPLANT INTENDED TO BE PLACED IN A BLOOD CIRCULATION CONDUIT. |
AU2007305383A1 (en) | 2006-09-28 | 2008-04-10 | Cook Incorporated | Thoracic aortic aneurysm repair apparatus and method |
US20080082083A1 (en) | 2006-09-28 | 2008-04-03 | Forde Sean T | Perforated expandable implant recovery sheath |
US7534261B2 (en) | 2006-10-02 | 2009-05-19 | Edwards Lifesciences Corporation | Sutureless heart valve attachment |
US8029556B2 (en) | 2006-10-04 | 2011-10-04 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US7879087B2 (en) | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
US8163011B2 (en) | 2006-10-06 | 2012-04-24 | BioStable Science & Engineering, Inc. | Intra-annular mounting frame for aortic valve repair |
US7674276B2 (en) | 2006-10-06 | 2010-03-09 | Biomet Sports Medicine, Llc | Rotational securing of a suture |
WO2008046092A2 (en) | 2006-10-13 | 2008-04-17 | Creighton University | Implantable valve prosthesis |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US7935144B2 (en) | 2006-10-19 | 2011-05-03 | Direct Flow Medical, Inc. | Profile reduction of valve implant |
WO2008051554A2 (en) | 2006-10-24 | 2008-05-02 | Beth Israel Deaconess Medical Center | Percutaneous aortic valve assembly |
US7771467B2 (en) | 2006-11-03 | 2010-08-10 | The Cleveland Clinic Foundation | Apparatus for repairing the function of a native aortic valve |
EP3329860A1 (en) | 2006-11-07 | 2018-06-06 | David Stephen Celermajer | Devices for the treatment of heart failure |
SE530568C2 (en) | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
EP2088965B1 (en) | 2006-12-05 | 2012-11-28 | Valtech Cardio, Ltd. | Segmented ring placement |
US20080140003A1 (en) | 2006-12-06 | 2008-06-12 | Advanced Cardiovascular Systems, Inc. | Balloon catheter having a regrooming sheath and method for collapsing an expanded medical device |
AU2007329243B2 (en) | 2006-12-06 | 2014-04-03 | Medtronic CV Luxembourg S.a.r.l | System and method for transapical delivery of an annulus anchored self-expanding valve |
FR2910170B1 (en) | 2006-12-13 | 2009-04-03 | Areva Np Sas | LOWER CAP WITH AN ANTI-DEBRIS DEVICE FOR CHICAN NUCLEAR FUEL ASSEMBLY AND CORRESPONDING ASSEMBLY |
US8070799B2 (en) * | 2006-12-19 | 2011-12-06 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
JP5443169B2 (en) | 2007-01-03 | 2014-03-19 | ミトラル・ソリューションズ・インコーポレイテッド | Implantable device for controlling the size and shape of an anatomical structure or lumen |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US20100249920A1 (en) | 2007-01-08 | 2010-09-30 | Millipede Llc | Reconfiguring heart features |
US20080167705A1 (en) | 2007-01-10 | 2008-07-10 | Cook Incorporated | Short wire stent delivery system with splittable outer sheath |
WO2008097589A1 (en) | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Percutaneous valve, system, and method |
US8529431B2 (en) | 2007-02-14 | 2013-09-10 | Bfkw, Llc | Bariatric device and method |
US20080195126A1 (en) | 2007-02-14 | 2008-08-14 | Jan Otto Solem | Suture and method for repairing a heart |
US7871436B2 (en) | 2007-02-16 | 2011-01-18 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US7753949B2 (en) | 2007-02-23 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Valve prosthesis systems and methods |
US8070802B2 (en) | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US20080208327A1 (en) | 2007-02-27 | 2008-08-28 | Rowe Stanton J | Method and apparatus for replacing a prosthetic valve |
EP2120753B1 (en) | 2007-03-05 | 2022-09-28 | Tornier, Inc. | Tack anchor systems |
US8911461B2 (en) | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US20080228265A1 (en) | 2007-03-13 | 2008-09-18 | Mitralign, Inc. | Tissue anchors, systems and methods, and devices |
WO2008121380A1 (en) | 2007-03-31 | 2008-10-09 | Cook Incorporated | Medical device delivery system with sheath separation |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9387308B2 (en) | 2007-04-23 | 2016-07-12 | Cardioguidance Biomedical, Llc | Guidewire with adjustable stiffness |
US8273115B2 (en) | 2007-04-24 | 2012-09-25 | W. L. Gore & Associates, Inc. | Side branched endoluminal prostheses and methods of delivery thereof |
US7776080B2 (en) | 2007-04-25 | 2010-08-17 | Abbott Cardiovascualr Systems Inc. | Stent delivery catheter system and method of implanting a self-expanding stent with embolic protection |
JP2010524651A (en) | 2007-04-27 | 2010-07-22 | ボエッジ メディカル, インコーポレイテッド | Complex shape steerable tissue visualization and manipulation catheter |
US8529620B2 (en) | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US8147504B2 (en) | 2007-05-05 | 2012-04-03 | Medtronic, Inc. | Apparatus and methods for delivering fasteners during valve replacement |
US7931660B2 (en) | 2007-05-10 | 2011-04-26 | Tyco Healthcare Group Lp | Powered tacker instrument |
WO2008140796A1 (en) | 2007-05-11 | 2008-11-20 | William A. Cook Australia Pty. Ltd. | Stent grafts for the thoracic aorta |
GR20070100291A (en) | 2007-05-14 | 2008-12-19 | Κωνστατινος Σπαργιας | Anti-restenosis drug covered and eluting baloons for valvuloplasty of aortic valve stenosiis for the prevention of restenosis. |
EP3150171A1 (en) | 2007-05-15 | 2017-04-05 | JenaValve Technology, Inc. | Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandalbe heart valve stent |
US8740937B2 (en) | 2007-05-31 | 2014-06-03 | Cook Medical Technologies Llc | Suture lock |
US20090112159A1 (en) | 2007-10-31 | 2009-04-30 | David Slattery | Delivery System With Profiled Sheath Having Balloon-Oriented Position |
AU2008269018B2 (en) | 2007-06-26 | 2014-07-31 | St. Jude Medical, Inc. | Apparatus and methods for implanting collapsible/expandable prosthetic heart valves |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9814611B2 (en) | 2007-07-31 | 2017-11-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US8252035B2 (en) | 2007-08-01 | 2012-08-28 | Cappella, Inc. | Device delivery system with two stage withdrawal |
EP2190379B1 (en) | 2007-08-23 | 2016-06-15 | Direct Flow Medical, Inc. | Translumenally implantable heart valve with formed in place support |
US8728154B2 (en) | 2007-08-24 | 2014-05-20 | St. Jude Medical, Inc. | Prosthetic aortic heart valves |
EP2033593B1 (en) * | 2007-09-07 | 2012-10-31 | Sorin Biomedica Cardio S.R.L. | "Microprocessor controlled delivery system for cardiac valve prosthesis" |
US20120150218A1 (en) | 2007-09-13 | 2012-06-14 | Robert Tyler Sandgren | Medical device for occluding a heart defect and a method of manufacturing the same |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
EP2190385B8 (en) | 2007-09-26 | 2017-06-07 | St. Jude Medical, LLC | Collapsible prosthetic heart valves |
US20090088837A1 (en) | 2007-09-28 | 2009-04-02 | The Cleveland Clinic Foundation | Prosthetic chordae assembly and method of use |
US8784481B2 (en) | 2007-09-28 | 2014-07-22 | St. Jude Medical, Inc. | Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features |
US8454686B2 (en) | 2007-09-28 | 2013-06-04 | St. Jude Medical, Inc. | Two-stage collapsible/expandable prosthetic heart valves and anchoring systems |
EP2211779B1 (en) | 2007-10-15 | 2014-08-20 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
JP2011500221A (en) | 2007-10-19 | 2011-01-06 | ガイデッド デリバリー システムズ, インコーポレイテッド | Tether termination equipment |
US20090105816A1 (en) | 2007-10-19 | 2009-04-23 | Olsen Daniel H | System using a helical retainer in the direct plication annuloplasty treatment of mitral valve regurgitation |
EP2217153B1 (en) | 2007-10-19 | 2021-03-03 | Ancora Heart, Inc. | Systems for cardiac remodeling |
US8647381B2 (en) | 2007-10-25 | 2014-02-11 | Symetis Sa | Stents, valved-stents, and methods and systems for delivery thereof |
US8715337B2 (en) | 2007-11-09 | 2014-05-06 | Cook Medical Technologies Llc | Aortic valve stent graft |
US8057532B2 (en) | 2007-11-28 | 2011-11-15 | Cook Medical Technologies Llc | Implantable frame and valve design |
HUE048270T4 (en) | 2007-12-14 | 2022-02-28 | Edwards Lifesciences Corp | Prosthetic valve |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
EP2072027B1 (en) | 2007-12-21 | 2020-06-17 | Medtentia International Ltd Oy | pre-annuloplasty device and method |
WO2009086535A2 (en) | 2007-12-27 | 2009-07-09 | The Trustees Of Columbia University In The City Of New York | Systems and methods for forming patterned extracellular matrix materials |
FR2925838A1 (en) | 2007-12-28 | 2009-07-03 | Univ Franche Comte Etablisseme | AUTOMATED ANCILLARY INSERTION AND FIXATION BY STAPLING AN ANNULAR BODY, IN PARTICULAR A PROSTHESIS, ON AN ANNULAR RESILIENT VOLUME |
BRPI0906759A2 (en) | 2008-01-16 | 2015-07-07 | St Jude Medical | Apparatus for providing a foldable and re-expandable prosthetic heart valve to an implant site in a patient and method for operating the same. |
US8349002B2 (en) | 2008-01-16 | 2013-01-08 | QuickRing Medical Technologies, Ltd. | Adjustable annuloplasty rings |
WO2009094373A1 (en) | 2008-01-22 | 2009-07-30 | Cook Incorporated | Valve frame |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
DK2254514T3 (en) | 2008-01-24 | 2018-12-17 | Medtronic Inc | STENTS FOR HEART VALVE PROSTHESIS |
US20090222081A1 (en) | 2008-01-24 | 2009-09-03 | Coherex Medical, Inc. | Methods and apparatus for reducing valve prolapse |
CA2713934C (en) | 2008-02-06 | 2015-10-20 | Guided Delivery Systems, Inc. | Multi-window guide tunnel |
WO2009108615A1 (en) | 2008-02-25 | 2009-09-03 | Medtronic Vascular Inc. | Infundibular reducer devices |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US8728097B1 (en) | 2008-02-26 | 2014-05-20 | Mitralign, Inc. | Tissue plication devices and methods for their use |
US9241792B2 (en) | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
WO2009114316A2 (en) | 2008-03-03 | 2009-09-17 | Alaska Hand Research, Llc | Cannulated anchor and system |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8177836B2 (en) | 2008-03-10 | 2012-05-15 | Medtronic, Inc. | Apparatus and methods for minimally invasive valve repair |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US20090248148A1 (en) | 2008-03-25 | 2009-10-01 | Ellipse Technologies, Inc. | Systems and methods for adjusting an annuloplasty ring with an integrated magnetic drive |
EP2273948A4 (en) | 2008-04-03 | 2014-01-01 | Gardia Medical Ltd | Delivery catheter with constraining sheath and methods of deploying medical devices into a body lumen |
US20100121437A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US8262725B2 (en) | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
JP5324645B2 (en) | 2008-04-21 | 2013-10-23 | クイックリング メディカル テクノロジーズ リミテッド | Surgical stapling system |
US20090264859A1 (en) | 2008-04-21 | 2009-10-22 | Medtronic Vascular, Inc. | Catheter Having a Selectively Expandable Distal Tip |
EP3141219A1 (en) | 2008-04-23 | 2017-03-15 | Medtronic, Inc. | Stented heart valve devices |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
WO2009132187A1 (en) | 2008-04-23 | 2009-10-29 | Medtronic, Inc. | Stented heart valve devices |
US8136218B2 (en) | 2008-04-29 | 2012-03-20 | Medtronic, Inc. | Prosthetic heart valve, prosthetic heart valve assembly and method for making same |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US8152844B2 (en) | 2008-05-09 | 2012-04-10 | Edwards Lifesciences Corporation | Quick-release annuloplasty ring holder |
US9061119B2 (en) | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
WO2009140298A2 (en) | 2008-05-12 | 2009-11-19 | Wright John T M | Device and method for the surgical treatment of ischemic mitral regurgitation |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
GB0809357D0 (en) | 2008-05-22 | 2008-07-02 | Punjabi Prakash | Heart valve repair device |
US8317806B2 (en) | 2008-05-30 | 2012-11-27 | Ethicon Endo-Surgery, Inc. | Endoscopic suturing tension controlling and indication devices |
ES2645920T3 (en) | 2008-06-06 | 2017-12-11 | Edwards Lifesciences Corporation | Low profile transcatheter heart valve |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
EP2296744B1 (en) | 2008-06-16 | 2019-07-31 | Valtech Cardio, Ltd. | Annuloplasty devices |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
US20100121461A1 (en) | 2008-06-20 | 2010-05-13 | Vysera Biomedical Limited | Valve |
US8087142B2 (en) | 2008-07-02 | 2012-01-03 | Easylap Ltd. | Pivoting tacker |
EP2321069B1 (en) | 2008-07-04 | 2017-11-01 | Tata Steel UK Limited | Method for coating a steel substrate, and coated steel substrate |
US20100010538A1 (en) | 2008-07-11 | 2010-01-14 | Maquet Cardiovascular Llc | Reshaping the mitral valve of a heart |
EP4176845A1 (en) | 2008-07-15 | 2023-05-10 | St. Jude Medical, LLC | Collapsible and re-expandable prosthetic heart valve cuff designs |
WO2010008549A1 (en) | 2008-07-15 | 2010-01-21 | St. Jude Medical, Inc. | Axially anchoring collapsible and re-expandable prosthetic heart valves for various disease states |
AT507113B1 (en) | 2008-07-17 | 2010-07-15 | Siemens Vai Metals Tech Gmbh | METHOD AND APPARATUS FOR ENERGY AND CO2 EMISSION OPTIMIZED IRON PRODUCTION |
JP5123433B2 (en) | 2008-07-17 | 2013-01-23 | エヌヴェーテー アーゲー | Prosthetic heart valve system |
ES2851152T3 (en) | 2008-07-21 | 2021-09-03 | Jenesis Surgical Llc | Endoluminal support device and method for its manufacture |
US20100023118A1 (en) | 2008-07-24 | 2010-01-28 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
BRPI0916696A2 (en) | 2008-07-29 | 2015-11-17 | St Jude Medical Cardiology Div | method and system for long term adjustment of an implant device |
US8337390B2 (en) | 2008-07-30 | 2012-12-25 | Cube S.R.L. | Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart |
US8778016B2 (en) | 2008-08-14 | 2014-07-15 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
WO2010027485A1 (en) | 2008-09-05 | 2010-03-11 | Med Institute, Inc. | Apparatus and methods for improve stent deployment |
US8777990B2 (en) | 2008-09-08 | 2014-07-15 | Howmedica Osteonics Corp. | Knotless suture anchor for soft tissue repair and method of use |
US9408649B2 (en) | 2008-09-11 | 2016-08-09 | Innovasis, Inc. | Radiolucent screw with radiopaque marker |
US8945211B2 (en) | 2008-09-12 | 2015-02-03 | Mitralign, Inc. | Tissue plication device and method for its use |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US9314335B2 (en) | 2008-09-19 | 2016-04-19 | Edwards Lifesciences Corporation | Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation |
US8287591B2 (en) | 2008-09-19 | 2012-10-16 | Edwards Lifesciences Corporation | Transformable annuloplasty ring configured to receive a percutaneous prosthetic heart valve implantation |
KR101850855B1 (en) | 2008-09-24 | 2018-04-20 | 레스메드 센서 테크놀로지스 리미티드 | Contactless and minimal-contact monitoring of quality of life parameters for assessment and intervention |
WO2010037141A1 (en) | 2008-09-29 | 2010-04-01 | Cardiaq Valve Technologies, Inc. | Heart valve |
WO2010040009A1 (en) | 2008-10-01 | 2010-04-08 | Cardiaq Valve Technologies, Inc. | Delivery system for vascular implant |
JP2012505048A (en) | 2008-10-10 | 2012-03-01 | ガイデッド デリバリー システムズ, インコーポレイテッド | Termination device and related methods |
EP2617388B2 (en) | 2008-10-10 | 2019-11-06 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
AU2009302181B2 (en) | 2008-10-10 | 2015-08-06 | Ancora Heart, Inc. | Tether tensioning devices and related methods |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8449625B2 (en) | 2009-10-27 | 2013-05-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US8696717B2 (en) | 2008-11-05 | 2014-04-15 | K2M, Inc. | Multi-planar, taper lock screw with additional lock |
EP3613383B1 (en) | 2008-11-21 | 2023-08-30 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis |
DE102008058894B3 (en) | 2008-11-26 | 2010-06-17 | Vimecon Gmbh | laser applicator |
CA2779605A1 (en) | 2008-12-04 | 2010-06-10 | Georgia Tech Research Corporation | Method and apparatus for minimally invasive heart valve procedures |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
CN101925474B (en) | 2008-12-19 | 2013-04-03 | 松下电器产业株式会社 | Exterior component, manufacturing method thereof, and electronic equipment |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8323312B2 (en) | 2008-12-22 | 2012-12-04 | Abbott Laboratories | Closure device |
US8926697B2 (en) | 2011-06-23 | 2015-01-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
ES2873182T3 (en) | 2008-12-22 | 2021-11-03 | Valtech Cardio Ltd | Adjustable annuloplasty devices |
US8911494B2 (en) | 2009-05-04 | 2014-12-16 | Valtech Cardio, Ltd. | Deployment techniques for annuloplasty ring |
US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
US8808368B2 (en) | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
WO2010078121A2 (en) | 2008-12-31 | 2010-07-08 | Genesee Biomedical, Inc. | Semi-rigid annuloplasty ring and band |
US20110011917A1 (en) | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
EP2393451B1 (en) | 2009-01-07 | 2017-04-26 | Cook Medical Technologies LLC | Implantable valve prosthesis with independent frame elements |
US20100174363A1 (en) | 2009-01-07 | 2010-07-08 | Endovalve, Inc. | One Piece Prosthetic Valve Support Structure and Related Assemblies |
WO2010081033A1 (en) | 2009-01-08 | 2010-07-15 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9681950B2 (en) | 2009-01-12 | 2017-06-20 | Valve Medical Ltd. | System and method for placing a percutaneous valve device |
US8998982B2 (en) | 2009-01-12 | 2015-04-07 | Valve Medical Ltd. | Method and apparatus for fine adjustment of a percutaneous valve structure |
US9204965B2 (en) | 2009-01-14 | 2015-12-08 | Lc Therapeutics, Inc. | Synthetic chord |
WO2010085456A1 (en) | 2009-01-20 | 2010-07-29 | Guided Delivery Systems Inc. | Anchor deployment devices and related methods |
BRPI1007070A2 (en) | 2009-01-22 | 2016-02-10 | St Jude Medical Cardiology Div | implantable device system. |
JP2012515625A (en) | 2009-01-22 | 2012-07-12 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Magnetic docking system and method for long term adjustment of implantable devices |
JP5687634B2 (en) | 2009-02-06 | 2015-03-18 | セント・ジュード・メディカル,インコーポレイテッド | Adjustable annuloplasty ring support |
AU2010210404A1 (en) | 2009-02-09 | 2011-08-25 | St. Jude Medical, Cardiology Division, Inc. | Inflatable minimally invasive system for delivering and securing an annular implant |
US10258471B2 (en) | 2009-02-11 | 2019-04-16 | Vdyne, Llc | Catheter |
AU2010212842A1 (en) | 2009-02-16 | 2011-09-08 | Dokter Yves Fortems Bvba | Biopsy device |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
EP2401515B1 (en) | 2009-02-24 | 2015-12-02 | Flex Technology, Inc. | Flexible screw |
US20100217382A1 (en) * | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
BRPI1008902A2 (en) | 2009-02-27 | 2016-03-15 | St Jude Medical | prosthetic heart valve. |
US8021420B2 (en) | 2009-03-12 | 2011-09-20 | Medtronic Vascular, Inc. | Prosthetic valve delivery system |
US9078751B2 (en) | 2009-03-17 | 2015-07-14 | Mitrassist Medical Ltd. | Heart valve prosthesis with collapsible valve and method of delivery thereof |
US8052741B2 (en) | 2009-03-23 | 2011-11-08 | Medtronic Vascular, Inc. | Branch vessel prosthesis with a roll-up sealing assembly |
CA2757273C (en) | 2009-03-30 | 2017-05-02 | Cardiovantage Medical, Inc. | Sutureless valve prostheses and devices and methods for delivery |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
EP3081195B1 (en) | 2009-04-10 | 2018-10-03 | Lon Sutherland Annest | An implantable scaffolding containing an orifice for use with a prosthetic or bio-prosthetic valve |
US20100262233A1 (en) | 2009-04-12 | 2010-10-14 | Texas Tech University System | Mitral Valve Coaptation Plate For Mitral Valve Regurgitation |
EP2419050B2 (en) | 2009-04-15 | 2023-10-18 | Edwards Lifesciences CardiAQ LLC | Vascular implant and delivery system |
AU2010241596B2 (en) | 2009-04-29 | 2013-10-24 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
WO2010128501A1 (en) | 2009-05-04 | 2010-11-11 | V-Wave Ltd. | Device and method for regulating pressure in a heart chamber |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US8523881B2 (en) | 2010-07-26 | 2013-09-03 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
US20120053676A1 (en) | 2009-05-07 | 2012-03-01 | Ku David N | Implantable Prosthetic Vascular Valves |
US20100286628A1 (en) | 2009-05-07 | 2010-11-11 | Rainbow Medical Ltd | Gastric anchor |
US8075611B2 (en) | 2009-06-02 | 2011-12-13 | Medtronic, Inc. | Stented prosthetic heart valves |
US20120083832A1 (en) | 2009-06-03 | 2012-04-05 | Symetis Sa | Closure device and methods and systems for using same |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
WO2010150178A2 (en) | 2009-06-26 | 2010-12-29 | Simcha Milo | Surgical stapler and method of surgical stapling |
WO2011002996A2 (en) | 2009-07-02 | 2011-01-06 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
US8475522B2 (en) | 2009-07-14 | 2013-07-02 | Edwards Lifesciences Corporation | Transapical delivery system for heart valves |
US20110022165A1 (en) | 2009-07-23 | 2011-01-27 | Edwards Lifesciences Corporation | Introducer for prosthetic heart valve |
US8845722B2 (en) | 2009-08-03 | 2014-09-30 | Shlomo Gabbay | Heart valve prosthesis and method of implantation thereof |
US8801706B2 (en) | 2009-08-27 | 2014-08-12 | Medtronic, Inc. | Paravalvular leak closure devices and methods |
EP2470122B1 (en) | 2009-08-28 | 2019-10-09 | Medtronic 3F Therapeutics, Inc. | Crimping device and method of use |
KR101116867B1 (en) | 2009-08-28 | 2012-03-06 | 김준홍 | The device for delivering optimal tension safaely and effectively in cerclage annuloplasty procedure |
EP2475328B1 (en) | 2009-09-11 | 2014-08-27 | GI Dynamics, Inc. | Anchors with open heads |
EP2477555B1 (en) | 2009-09-15 | 2013-12-25 | Evalve, Inc. | Device for cardiac valve repair |
US8459302B2 (en) | 2009-09-21 | 2013-06-11 | Gulf Sea Ventures LLC | Fluid-directing multiport rotary valve |
US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
US8652203B2 (en) | 2010-09-23 | 2014-02-18 | Cardiaq Valve Technologies, Inc. | Replacement heart valves, delivery devices and methods |
US20110077730A1 (en) | 2009-09-30 | 2011-03-31 | Fenster Michael S | Bifurcated balloon stent |
US20110082538A1 (en) | 2009-10-01 | 2011-04-07 | Jonathan Dahlgren | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US20190060070A1 (en) | 2009-10-06 | 2019-02-28 | Adam Groothuis | Systems and methods for treating lumenal valves |
EP2485689B1 (en) | 2009-10-09 | 2020-03-18 | Boston Scientific Scimed, Inc. | Stomach bypass |
US20110093002A1 (en) | 2009-10-20 | 2011-04-21 | Wilson-Cook Medical Inc. | Stent-within-stent arrangements |
JP5875986B2 (en) | 2009-10-26 | 2016-03-02 | カーディオキネティックス・インコーポレイテッドCardiokinetix, Inc. | Ventricular volume reduction |
US8277502B2 (en) | 2009-10-29 | 2012-10-02 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US8690939B2 (en) | 2009-10-29 | 2014-04-08 | Valtech Cardio, Ltd. | Method for guide-wire based advancement of a rotation assembly |
WO2011057087A1 (en) | 2009-11-05 | 2011-05-12 | The Trustees University Of Pennsylvania | Valve prosthesis |
DE102009046769A1 (en) | 2009-11-17 | 2011-05-19 | Robert Bosch Gmbh | exhaust treatment device |
US8734467B2 (en) | 2009-12-02 | 2014-05-27 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
US20130190861A1 (en) | 2012-01-23 | 2013-07-25 | Tendyne Holdings, Inc. | Prosthetic Valve for Replacing Mitral Valve |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2011072084A2 (en) | 2009-12-08 | 2011-06-16 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US20110144742A1 (en) | 2009-12-15 | 2011-06-16 | Edwards Lifesciences Corporation | Expansion Device for Treatment of Vascular Passageways |
EP2512385B1 (en) | 2009-12-17 | 2018-05-23 | Cook Medical Technologies LLC | Delivery system with retractable proximal end |
ES2647826T3 (en) | 2009-12-18 | 2017-12-26 | Coloplast A/S | A urological device |
US20110230961A1 (en) | 2010-01-05 | 2011-09-22 | Micardia Corporation | Dynamically adjustable annuloplasty ring and papillary muscle repositioning suture |
US9504562B2 (en) | 2010-01-12 | 2016-11-29 | Valve Medical Ltd. | Self-assembling modular percutaneous valve and methods of folding, assembly and delivery |
GB201001075D0 (en) | 2010-01-22 | 2010-03-10 | Cyclacel Ltd | Crystalline forms |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US8961596B2 (en) | 2010-01-22 | 2015-02-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
WO2011097251A1 (en) | 2010-02-03 | 2011-08-11 | Genesee Biomedical, Inc. | Semi-flexible annuloplasty ring |
US9107749B2 (en) | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
US8926693B2 (en) | 2010-02-17 | 2015-01-06 | Medtronic, Inc. | Heart valve delivery catheter with safety button |
US20110208293A1 (en) | 2010-02-23 | 2011-08-25 | Medtronic, Inc. | Catheter-Based Heart Valve Therapy System with Sizing Balloon |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US9522062B2 (en) | 2010-02-24 | 2016-12-20 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
US9072603B2 (en) | 2010-02-24 | 2015-07-07 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
US8545552B2 (en) | 2010-02-26 | 2013-10-01 | Silk Road Medical, Inc. | Systems and methods for transcatheter aortic valve treatment |
CA2800232C (en) | 2010-03-01 | 2015-08-11 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
CA2791390C (en) | 2010-03-05 | 2019-04-16 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US20110238094A1 (en) | 2010-03-25 | 2011-09-29 | Thomas Jonathan D | Hernia Patch |
US8992599B2 (en) | 2010-03-26 | 2015-03-31 | Thubrikar Aortic Valve, Inc. | Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen |
US9320597B2 (en) | 2010-03-30 | 2016-04-26 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system with recapturing feature and method |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8491650B2 (en) | 2010-04-08 | 2013-07-23 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system and method with stretchable stability tube |
US8512400B2 (en) | 2010-04-09 | 2013-08-20 | Medtronic, Inc. | Transcatheter heart valve delivery system with reduced area moment of inertia |
US8926692B2 (en) | 2010-04-09 | 2015-01-06 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery device with partial deployment and release features and methods |
US8512401B2 (en) | 2010-04-12 | 2013-08-20 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system with funnel recapturing feature and method |
US20110251676A1 (en) | 2010-04-12 | 2011-10-13 | Medtronic Vascular, Inc. | Sheath for Controlled Delivery of a Heart Valve Prosthesis |
US8579963B2 (en) | 2010-04-13 | 2013-11-12 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery device with stability tube and method |
US20110257721A1 (en) | 2010-04-15 | 2011-10-20 | Medtronic, Inc. | Prosthetic Heart Valves and Delivery Methods |
US8357195B2 (en) | 2010-04-15 | 2013-01-22 | Medtronic, Inc. | Catheter based annuloplasty system and method |
US8623075B2 (en) | 2010-04-21 | 2014-01-07 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system and method with controlled expansion of prosthetic heart valve |
US8740976B2 (en) | 2010-04-21 | 2014-06-03 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system with flush report |
US8876892B2 (en) | 2010-04-21 | 2014-11-04 | Medtronic, Inc. | Prosthetic heart valve delivery system with spacing |
EP3581151B1 (en) | 2010-04-21 | 2021-03-10 | Medtronic, Inc. | Prosthetic valve with sealing members |
US9629719B2 (en) | 2010-04-23 | 2017-04-25 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8623079B2 (en) | 2010-04-23 | 2014-01-07 | Medtronic, Inc. | Stents for prosthetic heart valves |
US8568474B2 (en) | 2010-04-26 | 2013-10-29 | Medtronic, Inc. | Transcatheter prosthetic heart valve post-dilatation remodeling devices and methods |
US9795482B2 (en) | 2010-04-27 | 2017-10-24 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve repair |
AU2011248657B2 (en) | 2010-04-27 | 2014-12-04 | Medtronic Inc. | Transcatheter prosthetic heart valve delivery device with passive trigger release |
CN102917668B (en) | 2010-04-27 | 2015-01-28 | 美敦力公司 | Transcatheter prosthetic heart valve delivery device with biased release features |
US8974475B2 (en) | 2010-04-30 | 2015-03-10 | Medtronic, Inc. | Methods and devices for cardiac valve repair or replacement |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
CN103124537B (en) | 2010-05-10 | 2015-08-26 | 心叶科技公司 | Without rack supporting structure |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
US20110288435A1 (en) | 2010-05-19 | 2011-11-24 | George Michael Christy | Tactile sensory testing instrument |
US9433501B2 (en) | 2010-05-19 | 2016-09-06 | Direct Flow Medical, Inc. | Inflation media for implants |
US9603708B2 (en) | 2010-05-19 | 2017-03-28 | Dfm, Llc | Low crossing profile delivery catheter for cardiovascular prosthetic implant |
US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
US9561102B2 (en) | 2010-06-02 | 2017-02-07 | Medtronic, Inc. | Transcatheter delivery system and method with controlled expansion and contraction of prosthetic heart valve |
EP3441045B1 (en) | 2010-06-07 | 2020-07-29 | Valtech Cardio, Ltd. | Apparatus to draw first and second portions of tissue toward each other |
US9301864B2 (en) | 2010-06-08 | 2016-04-05 | Veniti, Inc. | Bi-directional stent delivery system |
US20130030522A1 (en) | 2010-06-16 | 2013-01-31 | Rowe Stanton J | Devices and methods for heart treatments |
WO2011163275A2 (en) | 2010-06-21 | 2011-12-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valve |
US8408214B2 (en) | 2010-07-08 | 2013-04-02 | Benjamin Spenser | Method for implanting prosthetic valve |
US9326852B2 (en) | 2010-07-08 | 2016-05-03 | Benjamin Spenser | Method for implanting prosthetic valve |
EP2590595B1 (en) | 2010-07-09 | 2015-08-26 | Highlife SAS | Transcatheter atrio-ventricular valve prosthesis |
US9095277B2 (en) | 2010-07-09 | 2015-08-04 | Mitralign, Inc. | Delivery catheter with forward-looking ultrasound imaging |
US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP4098227A1 (en) | 2010-07-23 | 2022-12-07 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US8518107B2 (en) | 2010-08-04 | 2013-08-27 | Valcare, Inc. | Percutaneous transcatheter repair of heart valves |
AU2011292012B2 (en) | 2010-08-17 | 2014-05-08 | Palmaz Scientific, Inc. | Transluminal cardiac ball valve and method for deployment thereof |
AU2011292463B2 (en) | 2010-08-17 | 2014-01-23 | St. Jude Medical, Inc. | Tip for medical implant delivery system |
US10426606B2 (en) | 2010-08-23 | 2019-10-01 | Edwards Lifesciences Corporation | Color-coded prosthetic valve system and methods for using the same |
US20120053680A1 (en) | 2010-08-24 | 2012-03-01 | Bolling Steven F | Reconfiguring Heart Features |
JP5970458B2 (en) | 2010-09-01 | 2016-08-17 | ムバルブ・テクノロジーズ・リミテッド | Heart valve support structure |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
EP2611388B1 (en) | 2010-09-01 | 2022-04-27 | Medtronic Vascular Galway | Prosthetic valve support structure |
US20120059337A1 (en) | 2010-09-01 | 2012-03-08 | Eran Eilat | Catheter with asymmetric or collapsible-expandable cross-section |
WO2012031204A2 (en) | 2010-09-03 | 2012-03-08 | Guided Delivery Systems Inc. | Devices and methods for anchoring tissue |
CA2808673C (en) | 2010-09-10 | 2019-07-02 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US10076327B2 (en) | 2010-09-14 | 2018-09-18 | Evalve, Inc. | Flexible actuator mandrel for tissue apposition systems |
US9439795B2 (en) | 2010-09-17 | 2016-09-13 | St. Jude Medical, Cardiology Division, Inc. | Retainers for transcatheter heart valve delivery systems |
USD653341S1 (en) | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Surgical stent |
USD660967S1 (en) | 2010-09-20 | 2012-05-29 | St. Jude Medical, Inc. | Surgical stent |
USD652927S1 (en) | 2010-09-20 | 2012-01-24 | St. Jude Medical, Inc. | Surgical stent |
EP4176842A1 (en) | 2010-09-20 | 2023-05-10 | St. Jude Medical, Cardiology Division, Inc. | Valve leaflet attachment in collapsible prosthetic valves |
USD660433S1 (en) | 2010-09-20 | 2012-05-22 | St. Jude Medical, Inc. | Surgical stent assembly |
ES2601832T3 (en) | 2010-09-24 | 2017-02-16 | Symetis Sa | Stent valve and carrier |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
PT3590472T (en) | 2010-10-05 | 2021-04-14 | Edwards Lifesciences Corp | Prosthetic heart valve |
US8568475B2 (en) | 2010-10-05 | 2013-10-29 | Edwards Lifesciences Corporation | Spiraled commissure attachment for prosthetic valve |
CN103153232B (en) | 2010-10-21 | 2016-09-21 | 美敦力公司 | There is the mitral of low ventricle profile |
US8968335B2 (en) | 2010-10-27 | 2015-03-03 | Mitralign, Inc. | Hand operated device for controlled deployment of a tissue anchor and method of using the same |
GB2485338B (en) | 2010-11-02 | 2012-12-05 | Cook Medical Technologies Llc | Introducer assembly and dilator tip therefor |
US9414944B2 (en) | 2010-11-11 | 2016-08-16 | W. L. Gore & Associates, Inc. | Deployment sleeve shortening mechanism |
US9468547B2 (en) | 2010-11-11 | 2016-10-18 | W. L. Gore & Associates, Inc. | Deployment of endoluminal devices |
US9005279B2 (en) | 2010-11-12 | 2015-04-14 | Shlomo Gabbay | Beating heart buttress and implantation method to prevent prolapse of a heart valve |
US9095466B2 (en) | 2010-11-16 | 2015-08-04 | W. L. Gore & Associates, Inc. | Apposition fiber for use in endoluminal deployment of expandable devices in tortuous anatomies |
US20120130475A1 (en) | 2010-11-16 | 2012-05-24 | Shaw Edward E | Sleeves for expandable medical devices |
US9675487B2 (en) | 2010-11-17 | 2017-06-13 | Cook Medical Technologies Llc | Prosthesis deployment system for vascular repair |
JP2014502859A (en) | 2010-11-18 | 2014-02-06 | パビリオン・メディカル・イノベーションズ・リミテッド・ライアビリティ・カンパニー | Tissue restraint device and method of use |
US9078750B2 (en) | 2010-11-30 | 2015-07-14 | Edwards Lifesciences Corporation | Ergonomic mitral heart valve holders |
US20120158021A1 (en) | 2010-12-19 | 2012-06-21 | Mitralign, Inc. | Steerable guide catheter having preformed curved shape |
US8657866B2 (en) | 2010-12-22 | 2014-02-25 | Cook Medical Technologies Llc | Emergency vascular repair prosthesis deployment system |
CA3035048C (en) | 2010-12-23 | 2021-05-04 | Mark Deem | System for mitral valve repair and replacement |
EP2663258B1 (en) | 2011-01-11 | 2018-11-21 | Hans Reiner Figulla | Prosthetic valve for replacing an atrioventricular heart valve |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8932343B2 (en) | 2011-02-01 | 2015-01-13 | St. Jude Medical, Cardiology Division, Inc. | Blunt ended stent for prosthetic heart valve |
JP2014511220A (en) | 2011-02-02 | 2014-05-15 | セント・ジュード・メディカル,インコーポレイテッド | System and method for loading a collapsible heart valve into a delivery device |
WO2012112378A2 (en) | 2011-02-18 | 2012-08-23 | Vascor Inc. | Blood flow assist systems |
EP2675515B1 (en) | 2011-02-18 | 2020-07-15 | Ancora Heart, Inc. | Systems and methods for variable stiffness tethers |
WO2012161769A1 (en) | 2011-02-18 | 2012-11-29 | Guided Delivery Systems Inc. | Implant retrieval device |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
WO2012158186A1 (en) | 2011-05-17 | 2012-11-22 | Boston Scientific Scimed, Inc. | Percutaneous mitral annulus mini-plication |
US8523940B2 (en) | 2011-05-17 | 2013-09-03 | Boston Scientific Scimed, Inc. | Annuloplasty ring with anchors fixed by curing polymer |
WO2012158187A1 (en) | 2011-05-17 | 2012-11-22 | Boston Scientific Scimed, Inc. | Corkscrew annuloplasty device |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
US9180009B2 (en) | 2011-05-25 | 2015-11-10 | Medtronic, Inc. | Droop tester apparatus and method |
US9289282B2 (en) | 2011-05-31 | 2016-03-22 | Edwards Lifesciences Corporation | System and method for treating valve insufficiency or vessel dilatation |
US9402721B2 (en) | 2011-06-01 | 2016-08-02 | Valcare, Inc. | Percutaneous transcatheter repair of heart valves via trans-apical access |
US10117765B2 (en) | 2011-06-14 | 2018-11-06 | W.L. Gore Associates, Inc | Apposition fiber for use in endoluminal deployment of expandable implants |
US8840664B2 (en) | 2011-06-15 | 2014-09-23 | Edwards Lifesciences Corporation | Heart valve prosthesis anchoring device and methods |
WO2012175483A1 (en) | 2011-06-20 | 2012-12-27 | Jacques Seguin | Prosthetic leaflet assembly for repairing a defective cardiac valve and methods of using the same |
EP3964176A1 (en) | 2011-06-21 | 2022-03-09 | Twelve, Inc. | Prosthetic heart valve devices |
EP3725269A1 (en) | 2011-06-23 | 2020-10-21 | Valtech Cardio, Ltd. | Closure element for use with annuloplasty structure |
US8920482B2 (en) | 2011-06-30 | 2014-12-30 | Cook Medical Technologies Llc | Stent delivery system |
US9358107B2 (en) | 2011-06-30 | 2016-06-07 | Edwards Lifesciences Corporation | Systems, dies, and methods for processing pericardial tissue |
AU2012281087B2 (en) | 2011-07-12 | 2016-07-21 | Rush University Medical Center | Vessel bifurcation stent deployment system with zippered catheters |
US20130018450A1 (en) | 2011-07-13 | 2013-01-17 | Hunt James B | Prosthesis delivery system with retention sleeve |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20130041451A1 (en) | 2011-08-09 | 2013-02-14 | Cook Medical Technologies Llc | Prosthesis deployment system for open surgical repair |
CA2957442C (en) | 2011-08-11 | 2019-06-04 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
EP2742063A1 (en) | 2011-08-11 | 2014-06-18 | Yeda Research and Development Co. Ltd. | Compositions and methods for modulating apoptosis |
US20130331929A1 (en) | 2011-09-09 | 2013-12-12 | Endoluminal Sciences Pty Ltd. | Means for Controlled Sealing of Endovascular Devices |
US20130190857A1 (en) | 2011-09-09 | 2013-07-25 | Endoluminal Sciences Pty Ltd. | Means for controlled sealing of endovascular devices |
US20130178929A1 (en) | 2011-09-09 | 2013-07-11 | National Cerebral And Cardiovascular Center | Valved stent, base material for forming valved stent, and method for producing valved stent |
US9387075B2 (en) | 2011-09-12 | 2016-07-12 | Highlife Sas | Transcatheter valve prosthesis |
US9662206B2 (en) | 2011-09-12 | 2017-05-30 | Highlife Sas | Transcatheter valve prosthesis |
US10080651B2 (en) * | 2011-09-12 | 2018-09-25 | Highlife Sas | Transcatheter valve prosthesis |
US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US9011468B2 (en) | 2011-09-13 | 2015-04-21 | Abbott Cardiovascular Systems Inc. | Independent gripper |
US8900295B2 (en) | 2011-09-26 | 2014-12-02 | Edwards Lifesciences Corporation | Prosthetic valve with ventricular tethers |
US10624664B2 (en) | 2011-09-28 | 2020-04-21 | Evalve, Inc. | Apparatuses and methods for cutting a tissue bridge and/or removing a heart valve clip or suture |
US9554904B2 (en) | 2011-09-28 | 2017-01-31 | Medtronic CV Luxembourg S.a.r.l. | Distal tip assembly for a heart valve delivery catheter |
US9770256B2 (en) | 2011-09-28 | 2017-09-26 | Mitracore Technologies Inc. | Apparatuses and methods for cutting a tissue bridge and/or removing a heart valve clip or suture |
US8764798B2 (en) | 2011-10-03 | 2014-07-01 | Smith & Nephew, Inc. | Knotless suture anchor |
CN202313807U (en) * | 2011-10-14 | 2012-07-11 | 邹煜 | Artificial-valve bicuspid-valve membrane-covered stent with asymmetrical atrioventricular fixing structure |
AU2012325809B2 (en) * | 2011-10-19 | 2016-01-21 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
WO2013056898A1 (en) | 2011-10-21 | 2013-04-25 | Jenavalve Technology Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
US20130116776A1 (en) | 2011-11-04 | 2013-05-09 | Valtech Cardio, Ltd. | External aortic ring and spool mechanism therefor |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
US9724192B2 (en) | 2011-11-08 | 2017-08-08 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
EP2591754B1 (en) | 2011-11-10 | 2015-02-25 | Medtentia International Ltd Oy | A device and a method for improving the function of a heart valve |
US9877858B2 (en) | 2011-11-14 | 2018-01-30 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9782282B2 (en) | 2011-11-14 | 2017-10-10 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
US9387097B2 (en) | 2011-11-16 | 2016-07-12 | W. L. Gore & Associates, Inc. | Implant assembly with tactile indicator |
FR2982763B1 (en) | 2011-11-17 | 2015-07-17 | Ct Hospitalier Regional Universitaire D Amiens | IMPLANT FOR PLACEMENT IN BLOOD CIRCULATION PASSAGE AND TREATMENT DEVICE THEREFOR |
WO2013076724A2 (en) | 2011-11-21 | 2013-05-30 | Mor Research Applications Ltd. | Device for placement in the tricuspid annulus |
WO2013078497A1 (en) | 2011-12-01 | 2013-06-06 | Milijasevic, Zoran | Endoluminal prosthesis |
US9364359B2 (en) | 2011-12-08 | 2016-06-14 | W. L. Gore & Associates, Inc. | Systems and methods for delivery of a medical device |
EP4049625A1 (en) | 2011-12-09 | 2022-08-31 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
CA2858149C (en) | 2011-12-12 | 2017-04-18 | David Alon | Heart valve repair device |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
EP2793751B1 (en) | 2011-12-21 | 2019-08-07 | The Trustees of The University of Pennsylvania | Platforms for mitral valve replacement |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
FR2985659B1 (en) | 2012-01-13 | 2015-03-06 | Assist Publ Hopitaux De Paris | DEVICE FOR ANCHORING A PROTHETIC CARDIAC VALVE. |
KR101198775B1 (en) | 2012-01-18 | 2012-11-12 | 박광태 | Surgical instrument, and surgical mesh and surgical retractor for the same, and surgical method using the same |
EP2620125B1 (en) | 2012-01-24 | 2017-10-11 | Medtentia International Ltd Oy | An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve |
US8961602B2 (en) | 2012-01-27 | 2015-02-24 | St. Jude Medical, Cardiology Division, Inc. | Adjustment suture markers for adjustable annuloplasty ring |
US10226339B2 (en) | 2012-01-31 | 2019-03-12 | Mitral Valve Technologies Sarl | Mitral valve docking devices, systems and methods |
US9687371B2 (en) | 2012-02-14 | 2017-06-27 | W. L. Gore & Associates, Inc. | Endoprosthesis having aligned legs for ease of cannulation |
EP2818139A4 (en) | 2012-02-24 | 2015-10-21 | Terumo Corp | Stent-graft delivery device |
US20130304197A1 (en) | 2012-02-28 | 2013-11-14 | Mvalve Technologies Ltd. | Cardiac valve modification device |
CN104334119B (en) | 2012-02-28 | 2016-10-12 | M阀门技术有限公司 | Monocycle cardiac valve support structure |
US20150094802A1 (en) | 2012-02-28 | 2015-04-02 | Mvalve Technologies Ltd. | Single-ring cardiac valve support |
EP3542758B1 (en) | 2012-02-29 | 2022-12-14 | Valcare, Inc. | Percutaneous annuloplasty system with anterior-posterior adjustment |
US9180008B2 (en) | 2012-02-29 | 2015-11-10 | Valcare, Inc. | Methods, devices, and systems for percutaneously anchoring annuloplasty rings |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9375308B2 (en) | 2012-03-13 | 2016-06-28 | W. L. Gore & Associates, Inc. | External steerable fiber for use in endoluminal deployment of expandable devices |
EP2641569B1 (en) | 2012-03-23 | 2015-01-28 | Sorin Group Italia S.r.l. | A collapsible valve prosthesis |
US9066800B2 (en) | 2012-03-28 | 2015-06-30 | Medtronic, Inc. | Dual valve prosthesis for transcatheter valve implantation |
US8926694B2 (en) | 2012-03-28 | 2015-01-06 | Medtronic Vascular Galway Limited | Dual valve prosthesis for transcatheter valve implantation |
US9011515B2 (en) | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
US9427315B2 (en) | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
US9314325B2 (en) | 2012-04-27 | 2016-04-19 | Cook Medical Technologies Llc | Anti-aspiration prosthesis |
US9427303B2 (en) | 2012-04-27 | 2016-08-30 | Cook Medical Technologies Llc | Anti-aspiration valve |
US9277990B2 (en) | 2012-05-04 | 2016-03-08 | St. Jude Medical, Cardiology Division, Inc. | Hypotube shaft with articulation mechanism |
DE202013011734U1 (en) | 2012-05-16 | 2014-04-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | A catheter delivery system for inserting an expandable heart valve prosthesis and a medical device for treating a valvular defect |
CN104684505B (en) | 2012-05-20 | 2017-07-07 | 戴尔马修墨医学研究内结构和服务有限公司 | Artificial mitral valves |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
DE102012010798A1 (en) | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
US9241791B2 (en) | 2012-06-29 | 2016-01-26 | St. Jude Medical, Cardiology Division, Inc. | Valve assembly for crimp profile |
US9918837B2 (en) | 2012-06-29 | 2018-03-20 | St. Jude Medical, Cardiology Division, Inc. | System to assist in the release of a collapsible stent from a delivery device |
EP2872077B1 (en) | 2012-07-12 | 2017-10-04 | Boston Scientific Scimed, Inc. | Low profile heart valve delivery system |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US9486349B2 (en) | 2012-08-10 | 2016-11-08 | W. L. Gore & Associates, Inc. | Systems and methods of deployment of endoluminal devices |
US9232995B2 (en) | 2013-01-08 | 2016-01-12 | Medtronic, Inc. | Valve prosthesis and method for delivery |
US10206775B2 (en) | 2012-08-13 | 2019-02-19 | Medtronic, Inc. | Heart valve prosthesis |
US9717595B2 (en) | 2012-09-05 | 2017-08-01 | Medtronic Vascular Galway | Trans-aortic delivery system with containment capsule centering device |
US20140067048A1 (en) | 2012-09-06 | 2014-03-06 | Edwards Lifesciences Corporation | Heart Valve Sealing Devices |
US10188536B2 (en) | 2012-09-27 | 2019-01-29 | Symetis Sa | Stent-valve, delivery apparatus, and stent-holder therefor |
US9216018B2 (en) | 2012-09-29 | 2015-12-22 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
US20140099726A1 (en) | 2012-10-10 | 2014-04-10 | Two Pore Guys, Inc. | Device for characterizing polymers |
US20140106951A1 (en) | 2012-10-15 | 2014-04-17 | W. L. Gore & Associates, Inc. | Methods and systems for securing a sleeve for endoluminal devices |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9763817B2 (en) | 2012-10-29 | 2017-09-19 | Cook Medical Technologies Llc | Delivery system with curved preloaded catheter |
US10010654B2 (en) | 2012-10-30 | 2018-07-03 | W. L. Gore & Associates, Inc. | Sleeve for medical device assembly |
US9023099B2 (en) | 2012-10-31 | 2015-05-05 | Medtronic Vascular Galway Limited | Prosthetic mitral valve and delivery method |
US9610183B2 (en) | 2012-11-12 | 2017-04-04 | W.L. Gore & Associates, Inc. | Friction fiber sleeve retraction system |
US9387105B2 (en) | 2012-11-12 | 2016-07-12 | W.L. Gore & Associates, Inc | Sleeves for expandable medical devices and methods of making the same |
US8628571B1 (en) | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US20140142688A1 (en) | 2012-11-20 | 2014-05-22 | Medtronic CV Luxembourg S.a.r.l. | Medical Device Delivery System and Methods of Delivering a Medical Device |
WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9498361B2 (en) | 2012-12-19 | 2016-11-22 | Cook Medical Technologies Llc | Repositionable diameter constraints |
US10321986B2 (en) | 2012-12-19 | 2019-06-18 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic heart valve |
CN103908729B (en) | 2012-12-28 | 2016-12-28 | 米特拉利根公司 | Energy aid in tissue sting device and using method thereof |
WO2014105760A1 (en) | 2012-12-31 | 2014-07-03 | Edwards Lifesciences Corporation | Post-implant expandable surgical heart valve configurations |
US9066801B2 (en) | 2013-01-08 | 2015-06-30 | Medtronic, Inc. | Valve prosthesis and method for delivery |
WO2014108895A2 (en) | 2013-01-08 | 2014-07-17 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
US9132007B2 (en) | 2013-01-10 | 2015-09-15 | Medtronic CV Luxembourg S.a.r.l. | Anti-paravalvular leakage components for a transcatheter valve prosthesis |
US20140194970A1 (en) | 2013-01-10 | 2014-07-10 | Trivascular, Inc. | Gate wire for contralateral leg access |
JPWO2014115273A1 (en) | 2013-01-23 | 2017-01-19 | テルモ株式会社 | Self-expanding stent system |
US9681952B2 (en) | 2013-01-24 | 2017-06-20 | Mitraltech Ltd. | Anchoring of prosthetic valve supports |
GB2510151B (en) | 2013-01-25 | 2015-07-22 | Cook Medical Technologies Llc | Vascular plug |
CN109938878B (en) | 2013-02-04 | 2021-08-31 | 托尔福公司 | Hydraulic delivery systems for prosthetic heart valve devices and related methods |
US9456897B2 (en) | 2013-02-21 | 2016-10-04 | Medtronic, Inc. | Transcatheter valve prosthesis and a concurrently delivered sealing component |
WO2014134183A1 (en) | 2013-02-26 | 2014-09-04 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
JP6473089B2 (en) | 2013-03-05 | 2019-02-20 | メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. | Reinforcing valve |
US10583002B2 (en) * | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
US8986375B2 (en) * | 2013-03-12 | 2015-03-24 | Medtronic, Inc. | Anti-paravalvular leakage component for a transcatheter valve prosthesis |
US20140277358A1 (en) | 2013-03-13 | 2014-09-18 | DePuy Synthes Products, LLC | Striped stent introducer |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US9011526B2 (en) | 2013-03-14 | 2015-04-21 | Cormatrix Cardiovascular, Inc | Tubular extracellular matrix prosthetic valve |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US9226839B1 (en) | 2013-03-14 | 2016-01-05 | W. L. Gore & Associates, Inc. | Torque sleeve |
KR102423195B1 (en) | 2013-03-15 | 2022-07-20 | 네비게이트 카디악 스트럭쳐스, 인크. | Catheter-guided replacement valves apparatus and methods |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
US9232994B2 (en) | 2013-03-15 | 2016-01-12 | Medtronic Vascular Galway Limited | Stented prosthetic heart valve and methods for making |
CN109199639B (en) | 2013-03-15 | 2021-07-16 | 托尔福公司 | Prosthetic heart valve devices, prosthetic mitral valves, and associated systems and methods |
US20140296969A1 (en) | 2013-04-02 | 2014-10-02 | Tendyne Holdlings, Inc. | Anterior Leaflet Clip Device for Prosthetic Mitral Valve |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
FR3004638B1 (en) | 2013-04-19 | 2015-05-29 | Invalv Lab | IMPLANT, IN PARTICULAR TO BE PLACED IN A CARDIAC AURICULO-VENTRICULAR VALVE, COMPRISING A PROXIMAL ARM SPLITTING SYSTEM |
DE102013208038B4 (en) | 2013-05-02 | 2016-09-08 | Michael Siegenthaler | Catheter-based cardiac assist system |
KR102245192B1 (en) | 2013-05-06 | 2021-04-29 | 온테라 인크. | Target detection with nanopore |
ES2704902T3 (en) | 2013-05-06 | 2019-03-20 | Two Pore Guys Inc | A method of detecting biological targets using a nanopore and a fusion protein binding agent |
US10188515B2 (en) | 2013-05-13 | 2019-01-29 | Medtronic Vascular Inc. | Devices and methods for crimping a medical device |
WO2014189977A1 (en) | 2013-05-20 | 2014-11-27 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
CN105578991B (en) | 2013-05-29 | 2017-11-14 | M阀门技术有限公司 | It is equipped with valve leaflets heart valve support device |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
CA2914408C (en) | 2013-06-06 | 2019-02-26 | David Alon | Heart valve repair and replacement |
US9788983B2 (en) | 2013-06-21 | 2017-10-17 | Abbott Cardiovascular Systems Inc. | Removable sheath assembly for a polymer scaffold |
EP3013250A4 (en) | 2013-06-25 | 2017-05-31 | Mitralign, Inc. | Percutaneous valve repair by reshaping and resizing right ventricle |
US20140379076A1 (en) | 2013-06-25 | 2014-12-25 | Tendyne Holdings, Inc. | Halo Wire Fluid Seal Device for Prosthetic Mitral Valves |
US10048245B2 (en) | 2013-06-25 | 2018-08-14 | Two Pore Guys, Inc. | Multiplexed biomarker quantitation by nanopore analysis of biomarker-polymer complexes |
WO2015006575A1 (en) | 2013-07-10 | 2015-01-15 | Medtronic Inc. | Helical coil mitral valve annuloplasty systems and methods |
US10524904B2 (en) | 2013-07-11 | 2020-01-07 | Medtronic, Inc. | Valve positioning device |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
AU2014296147A1 (en) * | 2013-08-01 | 2016-02-18 | iMFLUX Inc. | Injection molding machines and methods for accounting for changes in material properties during injection molding runs |
WO2015031399A1 (en) | 2013-08-26 | 2015-03-05 | Two Pore Guys, Inc. | Molecule detection using boronic acid substituted probes |
USD730521S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
USD730520S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
US9393111B2 (en) | 2014-01-15 | 2016-07-19 | Sino Medical Sciences Technology Inc. | Device and method for mitral valve regurgitation treatment |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US9421094B2 (en) | 2013-10-23 | 2016-08-23 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
EP3073965A1 (en) | 2013-11-28 | 2016-10-05 | Mvalve Technologies Ltd. | Intracardiac devices comprising stabilizing elements having improved fatigue resistance |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9980832B2 (en) | 2014-01-28 | 2018-05-29 | Sanford Health | Pararenal and thoracic arch stent graft and methods for use |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9072604B1 (en) | 2014-02-11 | 2015-07-07 | Gilberto Melnick | Modular transcatheter heart valve and implantation method |
MX2016010303A (en) | 2014-02-21 | 2017-04-27 | Mitral Valve Tech Sarl | Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device. |
USD755384S1 (en) | 2014-03-05 | 2016-05-03 | Edwards Lifesciences Cardiaq Llc | Stent |
CA2937566C (en) | 2014-03-10 | 2023-09-05 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US10143551B2 (en) | 2014-03-31 | 2018-12-04 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular sealing via extended cuff mechanisms |
US10149758B2 (en) | 2014-04-01 | 2018-12-11 | Medtronic, Inc. | System and method of stepped deployment of prosthetic heart valve |
US9833346B2 (en) | 2014-04-04 | 2017-12-05 | W. L. Gore & Associates, Inc. | Deployment handle for a medical device deployment system |
BR112016025723B1 (en) | 2014-05-06 | 2022-02-22 | Dsm Ip Assets B.V. | Prosthetic valve, set of leaflets and manufacturing method of said prosthetic valve |
US10195025B2 (en) | 2014-05-12 | 2019-02-05 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US20170074855A1 (en) | 2014-05-15 | 2017-03-16 | Two Pore Guys, Inc. | Scaffold Data Storage and Target Detection in a Sample Using a Nanopore |
EP3142608B1 (en) | 2014-05-16 | 2024-05-15 | TruLeaf Medical Ltd. | Replacement heart valve |
WO2015179423A1 (en) | 2014-05-19 | 2015-11-26 | Cardiaq Valve Technologies, Inc. | Replacement mitral valve with annular flap |
US9687345B2 (en) | 2014-05-29 | 2017-06-27 | Edwards Lifesciences Cardiaq Llc | Prosthesis, delivery device and methods of use |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
US9662203B2 (en) | 2014-06-11 | 2017-05-30 | Medtronic Vascular, Inc. | Prosthetic valve with vortice-inducing baffle |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
WO2016016899A1 (en) | 2014-07-30 | 2016-02-04 | Mitraltech Ltd. | Articulatable prosthetic valve |
AU2015305868B2 (en) | 2014-08-18 | 2018-09-20 | Edwards Lifesciences Corporation | Frame with integral sewing cuff for prosthetic valves |
AU2015319825A1 (en) | 2014-09-26 | 2017-04-27 | Nooma Bio, Inc. | Target sequence detection by nanopore sensing of synthetic probes |
US10507101B2 (en) | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
CN107205817B (en) | 2014-12-04 | 2020-04-03 | 爱德华兹生命科学公司 | Percutaneous clamp for repairing heart valve |
CR20170245A (en) | 2014-12-05 | 2017-09-14 | Edwards Lifesciences Corp | DIRIGIBLE CATETER WITH TRACTION CABLE |
EP4306080A3 (en) | 2014-12-09 | 2024-04-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
EP4344676A1 (en) | 2014-12-14 | 2024-04-03 | Trisol Medical Ltd. | Prosthetic valve and deployment system |
US11141142B2 (en) | 2014-12-15 | 2021-10-12 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
US9855141B2 (en) | 2014-12-18 | 2018-01-02 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
AU2016215453A1 (en) | 2015-02-02 | 2017-08-10 | Two Pore Guys, Inc. | Nanopore detection of target polynucleotides from sample background |
CA2973729A1 (en) | 2015-02-02 | 2016-08-11 | Two Pore Guys, Inc. | Labile linkers for biomarker detection |
US20160220367A1 (en) | 2015-02-04 | 2016-08-04 | Medtronic Vascular, Inc. | Balloon valvuloplasty delivery system |
CN110141399B (en) | 2015-02-05 | 2021-07-27 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with axially sliding frame |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
EP3258883A4 (en) | 2015-02-20 | 2019-02-27 | 4C Medical Technologies, Inc. | Devices, systems and methods for cardiac treatment |
US9983191B2 (en) | 2015-03-11 | 2018-05-29 | Two Pore Guys, Inc. | Nanopore detection of small molecules through competition assays |
US10327899B2 (en) | 2015-03-13 | 2019-06-25 | Medtronic Vascular, Inc. | Delivery device for prosthetic heart valve with capsule adjustment device |
AU2016233216B2 (en) | 2015-03-19 | 2020-08-20 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
WO2016150806A1 (en) | 2015-03-20 | 2016-09-29 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath |
US10456256B2 (en) | 2015-03-23 | 2019-10-29 | St. Jude Medical, Cardiology Division, Inc | Heart valve repair |
US10441416B2 (en) | 2015-04-21 | 2019-10-15 | Edwards Lifesciences Corporation | Percutaneous mitral valve replacement device |
US10232564B2 (en) | 2015-04-29 | 2019-03-19 | Edwards Lifesciences Corporation | Laminated sealing member for prosthetic heart valve |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US20160338706A1 (en) | 2015-05-20 | 2016-11-24 | Edwards Lifesciences Corporation | Atrial septal closure device for re-access |
WO2016209970A1 (en) | 2015-06-22 | 2016-12-29 | Edwards Lifescience Cardiaq Llc | Actively controllable heart valve implant and methods of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
ITUB20152409A1 (en) | 2015-07-22 | 2017-01-22 | Sorin Group Italia Srl | VALVE SLEEVE FOR VALVULAR PROSTHESIS AND CORRESPONDING DEVICE |
EP3334382B1 (en) | 2015-08-14 | 2020-12-16 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US11357499B2 (en) | 2015-08-18 | 2022-06-14 | Lsi Solutions, Inc. | Apparatus for mitral valve repair and methods thereof |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
EP4327786A3 (en) | 2015-09-18 | 2024-05-01 | Terumo Corporation | Pushable implant delivery system |
US10456243B2 (en) | 2015-10-09 | 2019-10-29 | Medtronic Vascular, Inc. | Heart valves prostheses and methods for percutaneous heart valve replacement |
CN112826638A (en) | 2015-10-13 | 2021-05-25 | 静脉医学有限责任公司 | Implantable valve and method |
US10327929B2 (en) | 2015-10-30 | 2019-06-25 | Ram Medical Innovations, Llc | Apparatus and method for stabilization of procedural catheter in tortuous vessels |
US10376364B2 (en) | 2015-11-10 | 2019-08-13 | Edwards Lifesciences Corporation | Implant delivery capsule |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
WO2017117109A1 (en) | 2015-12-28 | 2017-07-06 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10321992B2 (en) | 2016-02-01 | 2019-06-18 | Medtronic, Inc. | Heart valve prostheses having multiple support arms and methods for percutaneous heart valve replacement |
US10265059B2 (en) | 2016-02-04 | 2019-04-23 | Edwards Lifesciences Corporation | Trans-septal closure and port device |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10888420B2 (en) | 2016-03-14 | 2021-01-12 | Medtronic Vascular, Inc. | Stented prosthetic heart valve having a wrap and delivery devices |
KR20240050449A (en) | 2016-05-06 | 2024-04-18 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | Annuloplasty procedures, related devices and methods |
WO2017201196A1 (en) | 2016-05-17 | 2017-11-23 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with inflow stitching |
US10716691B2 (en) | 2016-06-24 | 2020-07-21 | Edwards Lifesciences Corporation | Compact crimping device |
US10350062B2 (en) | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
WO2018025260A1 (en) | 2016-07-31 | 2018-02-08 | Mvalve Technologies Ltd. | Intracardiac devices comprising wire-supported valve leaflets |
US20190231525A1 (en) | 2016-08-01 | 2019-08-01 | Mitraltech Ltd. | Minimally-invasive delivery systems |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
CN109789018B (en) | 2016-08-10 | 2022-04-26 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
EP3500214A4 (en) | 2016-08-19 | 2019-07-24 | Edwards Lifesciences Corporation | Steerable delivery system for replacement mitral valve and methods of use |
CN109843219B (en) | 2016-08-26 | 2022-04-05 | 爱德华兹生命科学公司 | Multi-part replacement heart valve prosthesis |
US10722359B2 (en) | 2016-08-26 | 2020-07-28 | Edwards Lifesciences Corporation | Heart valve docking devices and systems |
CR20190069A (en) | 2016-08-26 | 2019-05-14 | Edwards Lifesciences Corp | Heart valve docking coils and systems |
US10758348B2 (en) | 2016-11-02 | 2020-09-01 | Edwards Lifesciences Corporation | Supra and sub-annular mitral valve delivery system |
FR3058632B1 (en) | 2016-11-14 | 2019-01-25 | Laboratoires Invalv | DEVICE FOR TREATING A BIOLOGICAL VALVE WITH PUSH BODY OF THE VALVE |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
JP7440263B2 (en) | 2016-12-16 | 2024-02-28 | エドワーズ ライフサイエンシーズ コーポレイション | Deployment systems, tools, and methods for delivering anchoring devices for prosthetic valves |
CR20190308A (en) | 2016-12-20 | 2020-01-24 | Edwards Lifesciences Corp | Systems and mechanisms for deploying a docking device for a replacement heart valve |
US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
EP3568107A1 (en) | 2017-01-11 | 2019-11-20 | Mitrassist Medical Ltd. | Heart valve prosthesis |
EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CN110621260B (en) | 2017-01-23 | 2022-11-25 | 科菲瓣膜技术有限公司 | Replacement mitral valve |
US10675017B2 (en) | 2017-02-07 | 2020-06-09 | Edwards Lifesciences Corporation | Transcatheter heart valve leaflet plication |
JP6788746B2 (en) | 2017-02-10 | 2020-11-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Implantable equipment and delivery system for reshaping the heart valve annulus |
US10952852B2 (en) | 2017-02-24 | 2021-03-23 | Abbott Cardiovascular Systems Inc. | Double basket assembly for valve repair |
US20180250126A1 (en) | 2017-03-06 | 2018-09-06 | Boston Scientific Scimed, Inc. | Replacement heart valve system having docking station with sacrificial valve |
JP7204665B2 (en) | 2017-04-18 | 2023-01-16 | エドワーズ ライフサイエンシーズ コーポレイション | Heart valve sealing device and its delivery device |
US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10327895B2 (en) | 2017-05-05 | 2019-06-25 | Vdyne, Llc | Pressure differential actuated prosthetic medical device |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
US12064341B2 (en) | 2017-05-31 | 2024-08-20 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
WO2018226915A1 (en) | 2017-06-08 | 2018-12-13 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
CA3071090A1 (en) | 2017-08-03 | 2019-02-07 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
WO2019027507A1 (en) | 2017-08-04 | 2019-02-07 | Mvrx, Inc. | Delivery system and methods for reshaping a heart valve annulus, including the use of magnetic tools |
WO2019035966A1 (en) | 2017-08-16 | 2019-02-21 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11135060B2 (en) | 2017-08-24 | 2021-10-05 | Medtronic Vascular, Inc. | Transseptal delivery systems having a deflecting segment and methods of use |
US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
US10856982B2 (en) | 2017-09-19 | 2020-12-08 | St. Jude Medical, Cardiology Division, Inc. | Transapical mitral valve delivery system |
US10881511B2 (en) | 2017-09-19 | 2021-01-05 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors configured to exert opposing clamping forces on native valve tissue |
US9895226B1 (en) | 2017-10-19 | 2018-02-20 | Mitral Tech Ltd. | Techniques for use with prosthetic valve leaflets |
WO2019081453A1 (en) | 2017-10-23 | 2019-05-02 | Symetis Sa | Prosthetic valve leaflet |
US20190175339A1 (en) | 2017-12-12 | 2019-06-13 | Vdyne, Llc | Septomarginal trabecula attachment for heart valve repair |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
US20190183639A1 (en) | 2017-12-19 | 2019-06-20 | St. Jude Medical, Cardiology Division, Inc. | Transcatheter Mitral Valve: Off-Center Valve Design |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
JP7343393B2 (en) | 2018-01-09 | 2023-09-12 | エドワーズ ライフサイエンシーズ コーポレイション | Natural heart valve repair devices and procedures |
US10130475B1 (en) | 2018-01-09 | 2018-11-20 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10507109B2 (en) | 2018-01-09 | 2019-12-17 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
US10568740B2 (en) | 2018-01-15 | 2020-02-25 | Vdyne, Llc | Device and method to plicate the tricuspid valve |
WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
EP3781085A1 (en) | 2018-04-19 | 2021-02-24 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
EP3793478A1 (en) | 2018-05-15 | 2021-03-24 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US10779937B2 (en) | 2018-06-22 | 2020-09-22 | Vdyne, Inc. | Transcatheter heart valve with plication window and tissue anchors |
US10765511B2 (en) | 2018-06-22 | 2020-09-08 | Vdyne, Inc. | Transcatheter heart valve with plication tissue anchors |
US11083571B2 (en) | 2018-06-27 | 2021-08-10 | Edwards Lifesciences Corporation | Frame for prosthetic heart valve |
US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
EP4233698A3 (en) | 2018-11-29 | 2023-10-25 | Edwards Lifesciences Corporation | Catheterization method and apparatus |
US10888644B2 (en) | 2019-02-06 | 2021-01-12 | inQB8 Medical Technologies, LLC | Intra-cardiac left atrial and dual support systems |
CN113747858A (en) | 2019-02-11 | 2021-12-03 | 爱德华兹生命科学公司 | Heart valve sealing device and delivery device thereof |
WO2021072209A1 (en) | 2019-10-11 | 2021-04-15 | Evalve, Inc. | Repair clip for variable tissue thickness |
WO2021092460A1 (en) | 2019-11-08 | 2021-05-14 | Evalve, Inc. | Medical device delivery system with locking system |
WO2021156866A1 (en) | 2020-02-04 | 2021-08-12 | Cardiovalve Ltd. | Support-guided steering of a catheter |
CA3122187C (en) | 2020-03-17 | 2023-09-05 | Cardiovalve Ltd. | Leaflet-grouping system |
-
2016
- 2016-02-03 CN CN201910449820.1A patent/CN110141399B/en active Active
- 2016-02-03 CA CA3162308A patent/CA3162308A1/en active Pending
- 2016-02-03 EP EP16706913.7A patent/EP3253333B1/en active Active
- 2016-02-03 CN CN201680008328.5A patent/CN107205818B/en active Active
- 2016-02-03 WO PCT/IL2016/050125 patent/WO2016125160A1/en active Application Filing
- 2016-02-03 CA CA2973940A patent/CA2973940C/en active Active
-
2017
- 2017-08-03 US US15/668,659 patent/US10918481B2/en active Active
- 2017-08-22 US US15/682,789 patent/US10449047B2/en active Active
-
2018
- 2018-05-31 US US15/994,022 patent/US10390952B2/en active Active
- 2018-06-01 US US15/995,725 patent/US10682227B2/en active Active
- 2018-06-14 US US16/008,618 patent/US10507105B2/en active Active
- 2018-07-20 US US16/041,208 patent/US10667908B2/en active Active
- 2018-07-23 US US16/042,129 patent/US10463488B2/en active Active
- 2018-07-23 US US16/042,028 patent/US10463487B2/en active Active
-
2019
- 2019-07-10 US US16/507,357 patent/US10524903B2/en active Active
- 2019-07-23 US US16/520,289 patent/US10888422B2/en active Active
- 2019-09-03 US US16/559,365 patent/US10722360B2/en active Active
- 2019-09-27 US US16/585,349 patent/US10849748B2/en active Active
- 2019-10-02 US US16/591,330 patent/US10736742B2/en active Active
- 2019-10-22 US US16/660,231 patent/US10864078B2/en active Active
- 2019-11-08 US US16/678,355 patent/US10973636B2/en active Active
- 2019-12-30 US US16/730,090 patent/US10695177B2/en active Active
-
2020
- 2020-05-21 US US16/879,952 patent/US11534298B2/en active Active
- 2020-06-22 US US16/907,615 patent/US11672658B2/en active Active
-
2021
- 2021-01-05 US US17/141,853 patent/US11801135B2/en active Active
-
2023
- 2023-09-14 US US18/368,250 patent/US20240074856A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029296A2 (en) * | 2006-02-16 | 2008-03-13 | Endocor Pte Ltd. | Minimally invasive heart valve replacement |
WO2013059747A1 (en) * | 2011-10-19 | 2013-04-25 | Foundry Newco Xii, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US20140222136A1 (en) * | 2013-02-04 | 2014-08-07 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
WO2014164364A1 (en) * | 2013-03-13 | 2014-10-09 | Aortic Innovations, Llc | Dual frame stent and valve devices and implantation |
US20140358224A1 (en) * | 2013-05-30 | 2014-12-04 | Tendyne Holdlings, Inc. | Six cell inner stent device for prosthetic mitral valves |
Cited By (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10548726B2 (en) | 2009-12-08 | 2020-02-04 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US10610359B2 (en) | 2009-12-08 | 2020-04-07 | Cardiovalve Ltd. | Folding ring prosthetic heart valve |
US11141268B2 (en) | 2009-12-08 | 2021-10-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper and lower skirts |
US11839541B2 (en) | 2009-12-08 | 2023-12-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper skirt |
US11351026B2 (en) | 2009-12-08 | 2022-06-07 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US10512456B2 (en) | 2010-07-21 | 2019-12-24 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10531872B2 (en) | 2010-07-21 | 2020-01-14 | Cardiovalve Ltd. | Valve prosthesis configured for deployment in annular spacer |
US11426155B2 (en) | 2010-07-21 | 2022-08-30 | Cardiovalve Ltd. | Helical anchor implantation |
US11969163B2 (en) | 2010-07-21 | 2024-04-30 | Cardiovalve Ltd. | Valve prosthesis configured for deployment in annular spacer |
US11291547B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US10702385B2 (en) | 2011-08-05 | 2020-07-07 | Cardiovalve Ltd. | Implant for heart valve |
US11344410B2 (en) | 2011-08-05 | 2022-05-31 | Cardiovalve Ltd. | Implant for heart valve |
US11291546B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US11517429B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Apparatus for use at a heart valve |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
US11864995B2 (en) | 2011-08-05 | 2024-01-09 | Cardiovalve Ltd. | Implant for heart valve |
US11517436B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Implant for heart valve |
US11951005B2 (en) | 2011-08-05 | 2024-04-09 | Cardiovalve Ltd. | Implant for heart valve |
US11369469B2 (en) | 2011-08-05 | 2022-06-28 | Cardiovalve Ltd. | Method for use at a heart valve |
US11690712B2 (en) | 2011-08-05 | 2023-07-04 | Cardiovalve Ltd. | Clip-secured implant for heart valve |
US10695173B2 (en) | 2011-08-05 | 2020-06-30 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10376361B2 (en) | 2011-08-05 | 2019-08-13 | Cardiovalve Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US10500040B2 (en) | 2012-11-13 | 2019-12-10 | Cardiovalve Ltd. | Percutaneously-deliverable dual-frame valve |
US10631982B2 (en) | 2013-01-24 | 2020-04-28 | Cardiovale Ltd. | Prosthetic valve and upstream support therefor |
US11844691B2 (en) | 2013-01-24 | 2023-12-19 | Cardiovalve Ltd. | Partially-covered prosthetic valves |
US11135059B2 (en) | 2013-01-24 | 2021-10-05 | Cardiovalve Ltd. | Prosthetic valve and upstream support therefor |
US10524910B2 (en) | 2014-07-30 | 2020-01-07 | Mitraltech Ltd. 3 Ariel Sharon Avenue | Articulatable prosthetic valve |
US10492908B2 (en) | 2014-07-30 | 2019-12-03 | Cardiovalve Ltd. | Anchoring of a prosthetic valve |
US11701225B2 (en) | 2014-07-30 | 2023-07-18 | Cardiovalve Ltd. | Delivery of a prosthetic valve |
US11872130B2 (en) | 2014-07-30 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic heart valve implant |
US12053380B2 (en) | 2014-07-30 | 2024-08-06 | Cardiovalve Ltd. | Anchoring of a prosthetic valve |
US10864078B2 (en) | 2015-02-05 | 2020-12-15 | Cardiovalve Ltd. | Prosthetic valve with separably-deployable valve body and tissue anchors |
US11793638B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US10524903B2 (en) | 2015-02-05 | 2020-01-07 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10722360B2 (en) | 2015-02-05 | 2020-07-28 | Cardiovalve Ltd. | Prosthetic valve with radially-deflectable tissue anchors |
US10736742B2 (en) | 2015-02-05 | 2020-08-11 | Cardiovalve Ltd. | Prosthetic valve with atrial arms |
US10758344B2 (en) | 2015-02-05 | 2020-09-01 | Cardiovalve Ltd. | Prosthetic valve with angularly offset frames |
US10357360B2 (en) | 2015-02-05 | 2019-07-23 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US10390952B2 (en) | 2015-02-05 | 2019-08-27 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
US10426610B2 (en) | 2015-02-05 | 2019-10-01 | Cardiovalve Ltd. | Prosthetic valve with radially-deflectable tissue anchors |
US10849748B2 (en) | 2015-02-05 | 2020-12-01 | Cardiovalve Ltd. | Prosthetic valve delivery system with independently-movable capsule portions |
US10682227B2 (en) | 2015-02-05 | 2020-06-16 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US10667908B2 (en) | 2015-02-05 | 2020-06-02 | Cardiovalve Ltd. | Prosthetic valve with S-shaped tissue anchors |
US11534298B2 (en) | 2015-02-05 | 2022-12-27 | Cardiovalve Ltd. | Prosthetic valve with s-shaped tissue anchors |
US10449047B2 (en) | 2015-02-05 | 2019-10-22 | Cardiovalve Ltd. | Prosthetic heart valve with compressible frames |
US10888422B2 (en) | 2015-02-05 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic valve with flexible tissue anchor portions |
US10695177B2 (en) | 2015-02-05 | 2020-06-30 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10918481B2 (en) | 2015-02-05 | 2021-02-16 | Cardiovalve Ltd. | Techniques for deployment of a prosthetic valve |
US10463487B2 (en) | 2015-02-05 | 2019-11-05 | Cardiovalve Ltd. | Prosthetic valve delivery system with independently-movable capsule portions |
US10973636B2 (en) | 2015-02-05 | 2021-04-13 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors free from lateral interconnections |
US11793635B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with angularly offset frames |
US10463488B2 (en) | 2015-02-05 | 2019-11-05 | Cardiovalve Ltd. | Prosthetic valve with separably-deployable valve body and tissue anchors |
US10507105B2 (en) | 2015-02-05 | 2019-12-17 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors free from lateral interconnections |
US11672658B2 (en) | 2015-02-05 | 2023-06-13 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US11801135B2 (en) | 2015-02-05 | 2023-10-31 | Cardiovalve Ltd. | Techniques for deployment of a prosthetic valve |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11937795B2 (en) | 2016-02-16 | 2024-03-26 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11298117B2 (en) | 2016-02-16 | 2022-04-12 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10952850B2 (en) | 2016-08-01 | 2021-03-23 | Cardiovalve Ltd. | Minimally-invasive delivery systems |
US12053379B2 (en) | 2016-08-01 | 2024-08-06 | Cardiovalve Ltd. | Minimally-invasive delivery systems |
US10779939B2 (en) | 2016-08-10 | 2020-09-22 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
WO2019030753A1 (en) | 2016-08-10 | 2019-02-14 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
US11779458B2 (en) | 2016-08-10 | 2023-10-10 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
FR3058631A1 (en) * | 2016-11-14 | 2018-05-18 | Laboratoires Invalv | IMPLANT FOR TREATING A BIOLOGICAL VALVE |
EP3570779B1 (en) | 2017-01-23 | 2023-02-15 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US12029646B2 (en) | 2017-08-03 | 2024-07-09 | Cardiovalve Ltd. | Prosthetic heart valve |
WO2019026059A1 (en) | 2017-08-03 | 2019-02-07 | Cardiovalve Ltd. | Prosthetic heart valve |
US12090048B2 (en) * | 2017-08-03 | 2024-09-17 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
USD841812S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
CN111163727A (en) * | 2017-08-03 | 2020-05-15 | 卡迪尔维尔福股份有限公司 | Artificial heart valve |
USD841813S1 (en) | 2017-08-03 | 2019-02-26 | Cardiovalve Ltd. | Prosthetic heart valve element |
US20240081983A1 (en) * | 2017-08-03 | 2024-03-14 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11571298B2 (en) | 2017-08-03 | 2023-02-07 | Cardiovalve Ltd. | Prosthetic valve with appendages |
US10905549B2 (en) | 2017-09-19 | 2021-02-02 | Cardiovalve Ltd. | Prosthetic valve with overlapping atrial tissue anchors and ventricular tissue anchors |
US10905548B2 (en) | 2017-09-19 | 2021-02-02 | Cardio Valve Ltd. | Prosthetic valve with protective sleeve around an outlet rim |
US10799345B2 (en) | 2017-09-19 | 2020-10-13 | Cardiovalve Ltd. | Prosthetic valve with protective fabric covering around tissue anchor bases |
US20190083254A1 (en) * | 2017-09-19 | 2019-03-21 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors configured to exert opposing clamping forces on native valve tissue |
US20190083252A1 (en) * | 2017-09-19 | 2019-03-21 | Cardiovalve Ltd. | Prosthetic valve with angularly offset atrial anchoring arms and ventricular anchoring legs |
US10856972B2 (en) | 2017-09-19 | 2020-12-08 | Cardiovalve Ltd. | Prosthetic valve with angularly offset atrial anchoring arms and ventricular anchoring legs |
US10881511B2 (en) | 2017-09-19 | 2021-01-05 | Cardiovalve Ltd. | Prosthetic valve with tissue anchors configured to exert opposing clamping forces on native valve tissue |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US12023243B2 (en) | 2017-09-19 | 2024-07-02 | Cardiovalve Ltd. | Prosthetic valve with protective fabric covering around tissue anchor bases |
US11864996B2 (en) | 2017-09-19 | 2024-01-09 | Cardiovalve Ltd. | Prosthetic valve with protective sleeve around an outlet rim |
US11337804B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Prosthetic valve with radially-deformable tissue anchors configured to restrict axial valve migration |
US11337802B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Heart valve delivery systems and methods |
US11337803B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Prosthetic valve with inner and outer frames connected at a location of tissue anchor portion |
US11318015B2 (en) | 2017-09-19 | 2022-05-03 | Cardiovalve Ltd. | Prosthetic valve configured to fill a volume between tissue anchors with native valve tissue |
US11819405B2 (en) | 2017-09-19 | 2023-11-21 | Cardiovalve Ltd. | Prosthetic valve with inflatable cuff configured for radial extension |
US11318014B2 (en) * | 2017-09-19 | 2022-05-03 | Cardiovalve Ltd. | Prosthetic valve delivery system with multi-planar steering |
US11304806B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility |
US11304805B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors |
US11304804B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve, Ltd. | Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions |
US11065122B2 (en) | 2017-10-19 | 2021-07-20 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11648122B2 (en) | 2017-10-19 | 2023-05-16 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
US11980547B2 (en) | 2017-10-19 | 2024-05-14 | Cardiovalve Ltd. | Techniques for use with prosthetic valve leaflets |
WO2019116369A1 (en) | 2017-12-13 | 2019-06-20 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11872131B2 (en) | 2017-12-13 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
EP4248915A3 (en) * | 2017-12-13 | 2023-12-13 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11382746B2 (en) | 2017-12-13 | 2022-07-12 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
EP4248915A2 (en) | 2017-12-13 | 2023-09-27 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
EP3723664B1 (en) * | 2017-12-13 | 2023-08-30 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11872124B2 (en) | 2018-01-10 | 2024-01-16 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
US11633277B2 (en) | 2018-01-10 | 2023-04-25 | Cardiovalve Ltd. | Temperature-control during crimping of an implant |
WO2019202579A1 (en) | 2018-04-19 | 2019-10-24 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11883293B2 (en) | 2018-09-17 | 2024-01-30 | Cardiovalve Ltd. | Leaflet-grouping system |
US11491011B2 (en) | 2018-09-17 | 2022-11-08 | Cardiovalve Ltd. | Leaflet-grouping system |
US11026792B2 (en) | 2018-09-17 | 2021-06-08 | Cardiovalve Ltd. | Leaflet-grouping system |
US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10736742B2 (en) | Prosthetic valve with atrial arms | |
US11793638B2 (en) | Prosthetic valve with pivoting tissue anchor portions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16706913 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15541783 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2973940 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2016706913 Country of ref document: EP |